-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CQL8ZBc6vii38Ro2zinKlY5oF0ffapHKHFgQasbNm74v5XRcOKa+CUS29OAftoUm YgeDlpW2oPWaGV9u6TztYg== 0000950152-05-008943.txt : 20051108 0000950152-05-008943.hdr.sgml : 20051108 20051108172915 ACCESSION NUMBER: 0000950152-05-008943 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20051108 DATE AS OF CHANGE: 20051108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARDINAL HEALTH INC CENTRAL INDEX KEY: 0000721371 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 310958666 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11373 FILM NUMBER: 051187227 BUSINESS ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147573033 MAIL ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: CARDINAL DISTRIBUTION INC DATE OF NAME CHANGE: 19920703 10-K/A 1 l16445ae10vkza.htm CARDINAL HEALTH, INC. FORM 10-K/A CARDIANL HEALTH, INC. Form 10-K/A
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
     
þ   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For The Fiscal Year Ended June 30, 2004
or
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 1-11373
CARDINAL HEALTH, INC.
(Exact name of Registrant as specified in its charter)
     
OHIO   31-0958666
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
7000 CARDINAL PLACE, DUBLIN, OHIO   43017
(Address of principal executive offices)   (Zip Code)
(614) 757-5000
Registrant’s telephone number, including area code
Securities Registered Pursuant to Section 12(b) of the Act:
     
COMMON SHARES (WITHOUT PAR VALUE)   NEW YORK STOCK EXCHANGE
(Title of Class)   (Name of each exchange on which registered)
Securities Registered Pursuant to Section 12(g) of the Act: None.
     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ      No o
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).
Yes þ      No o
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o     No þ
     The aggregate market value of voting stock held by non-affiliates of the Registrant on December 31, 2004, based on the closing price on December 31, 2004, was approximately $24,836,921,934.
     The number of Registrant’s Common Shares outstanding as of October 31, 2005, was as follows: Common Shares, without par value: 428,229,195.
 
 

 


Table of Contents

EXPLANATORY NOTE
     Cardinal Health, Inc. (an Ohio corporation) is filing this Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended June 30, 2004, as filed with the Securities and Exchange Commission on October 26, 2004, solely to refile with the Form 10-K revised versions of Exhibits 10.02, 10.03, 10.04, 10.06 and 10.07. The redactions to these exhibits were amended in accordance with revised applications for confidential treatment filed separately by Cardinal Health, Inc. with the Securities and Exchange Commission.
     Included in this filing are (1) the complete text of Item 15 of Part IV, including the list of exhibits pursuant to Item 15(b) of Part IV, (2) the signature page and (3) the certifications required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, which have been re-executed and re-filed as of the date of the Amendment as Exhibits 31.03 and 31.04, respectively. With the exception of the foregoing, no other information in the Annual Report on Form 10-K for the fiscal year ended June 30, 2004 has been supplemented, updated or amended.

2


TABLE OF CONTENTS

PART IV
Item 15: Exhibits, Financial Statement Schedules
SIGNATURES
EX-10.02
EX-10.03
EX-10.04
EX-10.06
EX-10.07
EX-31.03
EX-31.04


Table of Contents

PART IV
Item 15: Exhibits, Financial Statement Schedules
(a)(1) The following financial statements are included in Item 8 of this report:
         
    Page  
Independent Auditors’ Reports
    47  
Financial Statements:
       
Consolidated Statements of Earnings for the Fiscal Years Ended June 30, 2004, 2003 and 2002
    48  
Consolidated Balance Sheets at June 30, 2004 and 2003
    49  
Consolidated Statements of Shareholders’ Equity for the Fiscal Years Ended June 30, 2004, 2003 and 2002
    50  
Consolidated Statements of Cash Flows for the Fiscal Years Ended June 30, 2004, 2003 and 2002
    51  
Notes to Consolidated Financial Statements
    52  
(a)(2) The following Supplemental Schedule is included in this report:
         
    Page  
Schedule II — Valuation and Qualifying Accounts
    128  
     All other schedules not listed above have been omitted as not applicable or because the required information is included in the Consolidated Financial Statements or in notes thereto.
(b) Exhibits required by Item 601 of Regulation S-K:
     
Exhibit    
Number   Exhibit Description
3.01
  Amended and Restated Articles of Incorporation, as amended (24)
 
   
3.02
  Restated Code of Regulations, as amended (14)
 
   
4.01
  Specimen Certificate for the Registrant’s Common Shares (17)
 
   
4.02
  Indenture, dated as of May 1, 1993, between the Registrant and Bank One, Indianapolis, NA, Trustee, relating to the Registrant’s 61/2% Notes Due 2004 and 6% Notes Due 2006 (1)
 
   
4.03
  Indenture, dated as of April 18, 1997, between the Registrant and Bank One, Columbus, NA, Trustee, relating to the Registrant’s 61/4% Notes Due 2008, 63/4% Notes Due 2011, 4.45% Notes Due 2005 and 4.00% Notes Due 2015 (2)
 
   
4.04
  Indenture, dated as of October 1, 1996, between Allegiance Corporation and PNC Bank, Kentucky, Inc. (“PNC”), Trustee; and First Supplemental Indenture, dated as of February 3, 1999, by and among Allegiance Corporation, the Registrant and Chase Manhattan Trust Company, National Association (as successor in interest to PNC), Trustee (3)
 
   
4.05
  Indenture, dated as of January 1, 1994, between R.P. Scherer International Corporation and Comerica Bank, Trustee; First Supplemental Indenture, dated as of February 28, 1995, by and among R.P. Scherer International Corporation, R.P. Scherer Corporation and Comerica Bank, Trustee; and Second Supplemental Indenture, dated as of August 7, 1998, by and among R.P. Scherer Corporation, the Registrant and NBD Bank (4)
 
   
4.06
  Form of Warrant Certificate to Purchase the Registrant’s Common Shares (5)
 
   
4.07
  Form of Debt Securities (16)

3


Table of Contents

     
Exhibit    
Number   Exhibit Description
10.01
  Pharmaceutical Services Agreement, dated as of August 1, 1996, between the Registrant and Kmart Corporation, as amended (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act, with respect to the last amendment filed) (9), (15) and (19)
 
   
10.02
  Wholesale Supply Agreement, dated January 1, 2004, between the Registrant and CVS Pharmacy, Inc. (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act)
 
   
10.03
  First Amendment to Wholesale Supply Agreement, dated May 26, 2004, between the Registrant and CVS Pharmacy, Inc. (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act)
 
   
10.04
  Second Amendment to Wholesale Supply Agreement, dated June 2, 2004, between the Registrant and CVS Pharmacy, Inc. (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act)
 
   
10.05
  Prime Vendor Agreement, dated as of July 1, 2001, between the Registrant and Express Scripts, Inc., as amended on January 15, 2003 (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act) (20)
 
   
10.06
  Second Amendment to Prime Vendor Agreement, dated as of November 19, 2003, between the Registrant and Express Scripts, Inc. (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act)
 
   
10.07
  Third Amendment to Prime Vendor Agreement, dated as of April 9, 2004, between the Registrant and Express Scripts, Inc. (Confidential treatment has been requested for confidential commercial and financial information, pursuant to Rule 24b-2 under the Exchange Act)
 
   
10.08
  Form of Commercial Paper Dealer Agreement 4(2) Program, dated as of August 26, 1999, between the Registrant, as Issuer, and certain entities, each as Dealer, concerning notes to be issued pursuant to Issuing and Paying Agency Agreement, dated as of June 28, 1999, between the Issuer and The First National Bank of Chicago, as Issuing and Paying Agent (15)
 
   
10.09
  Five-year Credit Agreement, dated as of March 27, 2003, between the Registrant, certain subsidiaries of the Registrant, certain lenders, Bank One, NA, as Administrative Agent, Bank of America N.A., as Syndication Agent, Wachovia Bank, National Association, as Syndication Agent, Barclays Bank PLC, as Documentation Agent, Credit Suisse First Boston, as Documentation Agent, Deutsche Bank Securities, Inc., as Documentation Agent, and Banc One Capital Markets, Inc., as Lead Arranger and Book Manager (20)
 
   
10.10
  First Amendment to Credit Agreement, Agency Agreement and Amendment to Guaranty, dated as of March 24, 2004, between the Registrant, certain subsidiaries of the Registrant, certain lenders, Bank One, NA and Wachovia Bank, National Association (23)
 
   
10.11
  Five-year Credit Agreement, dated as of March 23, 2004, between the Registrant, certain subsidiaries of the Registrant, certain lenders, Wachovia Bank, National Association, as Administrative Agent, Bank One, NA, as Syndication Agent, Bank of America N.A., as Syndication Agent, Barclays Bank PLC, as Documentation Agent, Deutsche Bank Securities, Inc., as Documentation Agent, Wachovia Capital Markets, LLC, as Lead Arranger and Book Manager, and Banc One Capital Markets, Inc., as Lead Arranger and Book Manager (23)

4


Table of Contents

     
Exhibit    
Number   Exhibit Description
10.12
  Partnership Agreement of R.P. Scherer GmbH & Co. KG (4)
 
   
10.13
  Stock Incentive Plan, as amended (6)*
 
   
10.14
  Directors’ Stock Option Plan, as amended and restated (6)*
 
   
10.15
  Amended and Restated Equity Incentive Plan, as amended (15) and (17)*
 
   
10.16
  Form of Nonqualified Stock Option Agreement under the Amended and Restated Equity Incentive Plan, as amended (21)*
 
   
10.17
  Form of Restricted Share Units Agreement under the Amended and Restated Equity Incentive Plan, as amended (21)*
 
   
10.18
  Form of Directors’ Stock Option Agreement under the Amended and Restated Equity Incentive Plan, as amended (21)*
 
   
10.19
  Outside Directors Equity Incentive Plan (11)*
 
   
10.20
  Form of Directors’ Stock Option Agreement under the Outside Directors Equity Incentive Plan (21)*
 
   
10.21
  Broadly-based Equity Incentive Plan, as amended (18)
 
   
10.22
  Deferred Compensation Plan, as amended and restated (10)*
 
   
10.23
  First Amendment to Deferred Compensation Plan (21)*
 
   
10.24
  Second Amendment to Deferred Compensation Plan (24)*
 
   
10.25
  Directors Deferred Compensation Plan, as amended and restated (24)*
 
   
10.26
  Global Employee Stock Purchase Plan (24)
 
   
10.27
  Performance-Based Incentive Compensation Plan, as amended (13)*
 
   
10.28
  R.P. Scherer Corporation 1997 Stock Option Plan (8)*
 
   
10.29
  R.P. Scherer Corporation 1990 Nonqualified Performance Stock Option Plans, as amended (8)*
 
   
10.30
  Allegiance Corporation 1996 Incentive Compensation Program (7)*
 
   
10.31
  Allegiance Corporation 1998 Incentive Compensation Program (7)*
 
   
10.32
  Allegiance Corporation 1996 Outside Director Incentive Compensation Plan (7)*
 
   
10.33
  Amended and Restated Employment Agreement, effective as of February 1, 2004, between the Registrant and Robert D. Walter (22)*
 
   
10.34
  Employment Agreement, effective as of February 1, 2004, between the Registrant and George L. Fotiades (22)*

5


Table of Contents

     
Exhibit    
Number   Exhibit Description
10.35
  Employment Agreement, dated and effective as of February 5, 2003, between the Registrant and Stephen S. Thomas (19)*
 
   
10.36
  Employment Agreement, dated and effective as of November 5, 2003, between the Registrant and Ronald K. Labrum (21)*
 
   
10.37
  Employment Agreement, dated and effective as of July 26, 2004, between the Registrant and J. Michael Losh (24)*
 
   
10.38
  Form of Indemnification Agreement between the Registrant and individual Directors (24)*
 
   
10.39
  Form of Indemnification Agreement between the Registrant and individual Officers (24)*
 
   
10.40
  Restricted Share Units Agreement, dated October 15, 2001, between the Registrant and Robert D. Walter (18)*
 
   
10.41
  Nonqualified Stock Option Agreement, dated November 19, 2001, between the Registrant and Robert D. Walter (10)*
 
   
10.42
  Restricted Share Units Agreement, dated November 20, 2001, between the Registrant and Robert D. Walter (10)*
 
   
10.43
  Restricted Share Units Agreement, dated December 31, 2001, between the Registrant and Robert D. Walter (18)*
 
   
10.44
  Restricted Share Units Agreement, dated December 31, 2001, between the Registrant and George L. Fotiades (10)*
 
   
10.45
  Restricted Share Units Agreement, dated December 31, 2001, between the Registrant and Stephen S. Thomas (10)*
 
   
10.46
  Form of Restricted Share Units Agreement, dated December 31, 2001, between the Registrant and each of Messrs. Miller and Rucci (10)*
 
   
10.47
  Restricted Share Units Agreement, dated February 1, 2002, between the Registrant and Robert D. Walter (18)*
 
   
10.48
  Restricted Share Units Agreement, dated February 1, 2002, between the Registrant and Robert D. Walter (18)*
 
   
10.49
  Restricted Share Units Agreement, dated April 2002, between the Registrant and Stephen S. Thomas (18)*
 
   
18.01
  Letter Regarding Change in Accounting Principle (14)
 
   
18.02
  Letter Regarding Change in Accounting Principle (24)
 
   
21.01
  List of Subsidiaries of the Registrant (24)
 
   
23.01
  Consent of Ernst and Young LLP (24)

6


Table of Contents

     
Exhibit    
Number   Exhibit Description
31.01
  Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (24)
 
   
31.02
  Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (24)
 
   
31.03
  Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
31.04
  Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
32.02
  Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (24)
 
   
99.02
  Special Code Section 401(a)(9) Amendment to the Cardinal Health Profit Sharing, Retirement and Savings Plan (24)
 
   
99.03
  First Amendment to the Cardinal Health Profit Sharing, Retirement and Savings Plan (Amended and Restated Effective as of July 1, 1998) (Revised as of 2002) (24)
 
   
99.04
  First Amendment to the Cardinal Health Profit Sharing, Retirement and Savings Plan (As amended and restated July 1, 2002) (24)
 
   
99.05
  Second Amendment to the Cardinal Health Profit Sharing, Retirement and Savings Plan (As amended and restated July 1, 2002) (24)
 
   
99.06
  Cardinal Health, Inc. Employee Stock Purchase Plan, as amended (24)
 
*   Management contract or compensation plan or arrangement.
 
(1)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 1994 (File No. 1-11373) and incorporated herein by reference.
 
(2)   Included as an exhibit to the Registrant’s Current Report on Form 8-K filed April 21, 1997 (File No. 1-11373) and incorporated herein by reference.
 
(3)   Included as an exhibit to the Registrant’s Registration Statement on Form S-4 (No. 333-74761) and incorporated herein by reference.
 
(4)   Included as an exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1998 (File No. 1-11373) and incorporated herein by reference.
 
(5)   Included as an exhibit to the Registrant’s Registration Statement on Form S-4 (No. 333-30889) and incorporated herein by reference.
 
(6)   Included as an exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994 (File No. 1-11373) and incorporated herein by reference.
 
(7)   Included as an exhibit to the Registrant’s Post-Effective Amendment No. 1 on Form S-8 to Form S-4 Registration Statement (No. 333-68819) and incorporated herein by reference.
 
(8)   Included as an exhibit to the Registrant’s Post-effective Amendment No. 1 on Form S-8 to Form S-4 Registration Statement (No. 333-56655) and incorporated herein by reference.

7


Table of Contents

(9)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1996 (File No. 1-11373) and incorporated herein by reference.
 
(10)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2001 (File No. 1-11373) and incorporated herein by reference.
 
(11)   Included as an exhibit to the Registrant’s Registration Statement on Form S-8 (No. 333-38192) and incorporated herein by reference.
 
(12)   Included as an exhibit to the Company’s Post-Effective Amendment No. 1 of Form S-8 to Form S-4 Registration Statement (No. 333-53394) and incorporated herein by reference.
 
(13)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1998 (File No. 1-11373) and incorporated herein by reference.
 
(14)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2001 (File No. 1-11373) and incorporated herein by reference.
 
(15)   Included as an exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1999 (File No. 1-11373) and incorporated herein by reference.
 
(16)   Included as an exhibit to the Registrant’s Registration Statement on Form S-3 (No. 333-62944) and incorporated herein by reference.
 
(17)   Included as an exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2001 (File No. 1-11373) and incorporated herein by reference.
 
(18)   Included as an exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2002 (File No. 1-11373) and incorporated herein by reference.
 
(19)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2002 (File No. 1-11373) and incorporated herein by reference.
 
(20)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2003 (File No. 1-11373) and incorporated herein by reference.
 
(21)   Included as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2003 (File No. 1-11373) and incorporated herein by reference.
 
(22)   Included as an exhibit to the Registrant’s Current Report on Form 8-K filed February 6, 2004 (File No. 1-11373) and incorporated herein by reference.
 
(23)   Included as an exhibit to the Registrant’s Current Report on Form 8-K filed October 20, 2004 (File No. 1-11373) and incorporated herein by reference.
 
(24)   Filed as with the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2004 (File No. 1-11373) on October 26, 2004.

8


Table of Contents

SIGNATURES
     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 8, 2005.
         
    CARDINAL HEALTH, INC.
 
 
  By:   /s/ Robert D. Walter
 
       
    Robert D. Walter, Chairman and
       Chief Executive Officer

9

EX-10.02 2 l16445aexv10w02.txt EX-10.02 EXHIBIT 10.02 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. January 1, 2004 WHOLESALE SUPPLY AGREEMENT This letter will confirm the agreement ("AGREEMENT") between Cardinal Health* ("CARDINAL") and CVS Pharmacy Inc. ("CVS") under which CVS will purchase certain pharmaceutical and other products from Cardinal on the following terms and conditions: SECTION 1. DESIGNATION AS PRIMARY WHOLESALER. (a) Retail Pharmacies. During the term of this Agreement, CVS will designate Cardinal as the primary wholesale pharmaceutical supplier to designated pharmacies operated by CVS (collectively, the "PHARMACIES" and individually, a "PHARMACY") subject to Section 1(a) Disclosure Schedule. A list of the Pharmacies (the "DESIGNATED PHARMACY LIST") will be provided by CVS to Cardinal from time to time during the term of this Agreement. (b) Distribution Centers. During the term of this Agreement, CVS will designate Cardinal as the primary wholesale pharmaceutical supplier to all distribution centers operated by CVS ("CVS PHARMACY DCS") subject to Section 1(b) Disclosure Schedule. A comprehensive list of all of the CVS Pharmacy DCs as of January 1, 2004 (the date of this agreement) (the "TOTAL DC LIST") is set forth in the Section 1(b) Disclosure Schedule. (c) CVS PharmaCare. This Agreement specifically excludes purchases which are made by CVS on behalf of the CVS division known as PharmaCare. (d) CVS Commitment. This Agreement pertains only to CVS' Pharmacies and CVS Pharmacy DCs as of January 1, 2004 plus or minus the organic growth related to Pharmacies. SECTION 2. SALE OF MERCHANDISE AND BROKERAGE PURCHASES. (a) Primary Requirements. Each of the Pharmacies and the CVS Pharmacy DCs will purchase from Cardinal during the term of this Agreement its Primary Wholesale Requirements (as defined in the Section 2(a) Disclosure Schedule) of pharmaceutical products ("RX PRODUCTS"), which consist of purchases of Rx Products for (a) delivery directly to the Pharmacies ("STORE RX PURCHASES"); and (b) delivery directly to the CVS Pharmacy DCs ("BROKERAGE PURCHASES"). CVS 1 may purchase from Cardinal, at CVS' discretion, for delivery directly to the Pharmacies, its health and beauty aids, home health care products and other inventory carried by Cardinal ("STORE OTHER Purchases"). For purposes of this Agreement, the term "QUALIFIED PURCHASES" with respect to a period means all purchases of Merchandise made and paid for by CVS (and in some circumstances, either the CVS Pharmacy DCs or the Pharmacies are specifically designated) from Cardinal during that period, net of all returns and credits validated by CVS (related to ordering, shipping or accounting errors). For purposes of this Agreement, the term "MERCHANDISE" will mean the Rx Products (and Store Other Purchases, with respect to the Pharmacies only). Notwithstanding anything in this Agreement to the contrary, CVS retains the right to purchase from any other source Rx Products which are unavailable from Cardinal. (b) Brokerage Purchases. The Section 2(b) Disclosure Schedule describes the terms by which CVS will make its Brokerage Purchases through Cardinal. (c) Discontinued Merchandise. Cardinal will stock certain Merchandise that Cardinal would not otherwise stock but for CVS' request, except [***] and Merchandise [***] ("SPECIALLY STOCKED MERCHANDISE"), subject to such credit considerations concerning the applicable manufacturer as Cardinal may reasonably consider appropriate (including but not limited to, potential insolvency or outstanding balance owed to Cardinal without legitimate reason for dispute). CVS guarantees that at least [***] ([***]) pieces of each item of Specially Stocked Merchandise detailed in Section 2(c) Disclosure Schedule will be purchased from each of Cardinal's distribution centers servicing CVS Pharmacies per month. If Cardinal notifies CVS that less than [***] ([***]) pieces of an item of Specially Stocked Merchandise were purchased in a month from one of Cardinal's servicing distribution centers, then Cardinal may elect to discontinue carrying such item in its distribution centers. If Cardinal elects to discontinue carrying any such item, CVS will accept and purchase the remaining Specially Stocked Merchandise at the [***] for such Specially Stocked Merchandise until the Specially Stocked Merchandise is depleted. Cardinal will use reasonable efforts to ensure that Specially Stocked Merchandise is discontinued in the most cost-effective manner, which may include, but not be limited to, returning such item directly to the manufacturer. Alternatively, Cardinal and CVS may mutually agree to a [***] arrangement in lieu of Cardinal stocking the item. (d) Generally. CVS will be liable for any payment owed to Cardinal from any Pharmacy or CVS Pharmacy DC for purchases made hereunder. Cardinal reserves the right [***] to determine what Merchandise it will carry based upon product quality, manufacturer indemnity, insurance, and other policies, and other standards determined by it, and may [***] from its available inventory items of Merchandise with limited or no movement activity (in which event CVS shall have the right to purchase such merchandise from [***]). Notwithstanding the foregoing, Cardinal's decision not to carry certain Merchandise for reasons other than product quality (relative to FDA instructions), manufacturer indemnity, and insurability shall not excuse Cardinal from complying with the service levels 2 detailed in Section 2(b) Disclosure Schedule and Section 9 Disclosure Schedule. Both parties agree that Cardinal's inability to provide CVS with the service levels detailed in Section 2(b) Disclosure Schedule and Section 9 Disclosure Schedule represents a material breach of this Agreement. (e) Representation of Status. Cardinal represents that it is, and will continue to be during the term of this Agreement, an industry leader in implementation of processes, practices and safeguards to prevent the distribution of all product that is contaminated, mislabeled, not approved for sale in the United States, counterfeit or otherwise unfit for use by consumers (collectively "UNFIT RX PRODUCT"). SECTION 3. PURCHASE PRICE. As further described in Sections 3(a) and 3(b) Disclosure Schedules, CVS will pay a purchase price ("COST OF GOODS") for products purchased under this Agreement as follows: (a) Store Rx Purchases and Store Other Purchases. CVS will pay a Cost of Goods for Merchandise in an amount equal to Cardinal's Cost plus the percentage set forth in the Section 3(a) Disclosure Schedule. The term "CARDINAL'S COST" as used herein means the [***] for Merchandise as of the date CVS orders said product, adjusted to reflect any then-applicable [***] pricing, but without reduction for [***]. Manufacturer [***] quantity discounts and [***] which are intended by the manufacturer to be passed through to Cardinal's retail national chain accounts will be made available to CVS. By way of illustration only and not as a limitation, the [***] CVS receives based on CVS' [***] warehouse and DSD purchases, is retained [***]% by CVS. In the event that a vendor would begin to pass an "[***]" [***] to Cardinal, Cardinal would pass [***]% of this allowance to CVS, based on CVS purchases (Pharmacies and CVS Pharmacy DCs, if applicable). Notwithstanding the foregoing, Cardinal will not accept any other [***] on CVS' behalf relating to CVS' purchase volume (warehouse or DSD) without CVS' expressed written consent. It will be Cardinal's sole responsibility to notify in writing any pharmaceutical supplier (with copy to CVS subject to Section 13) offering a [***] to Cardinal related to CVS' purchase volume that CVS utilizes [***] policy. As set forth in Section 3(a) Disclosure Schedule, the purchase price for selected Merchandise, including but not limited to, multisource pharmaceuticals, CardinalSOURCE(SM) generics, private label products, medical surgical supplies, home health care/durable medical equipment, Merchandise acquired from vendors not offering customary cash discount or other terms, and other non-pharmaceutical Merchandise will not be based upon Cardinal's [***] pricing described above but will instead be [***] in accordance with the terms and conditions established by Cardinal (including applicable [***]) for such Merchandise. Merchandise described in this paragraph is sometimes referred to as "SPECIALLY PRICED MERCHANDISE." CVS may, but will have no obligation to, purchase any specified volume or percentage of its requirements for Specially Priced Merchandise. 3 (b) Brokerage Purchases. CVS will pay a purchase price for all Brokerage Purchases in an amount equal to the cost set forth on the Section 3(b) Disclosure Schedule. (c) Cost of Goods Adjustment. CVS' Cost of Goods for Store Rx Purchases and Store Other Purchases will be subject to adjustment as described in the Section 3(c) Disclosure Schedule. (d) Generally. Each party hereto acknowledges and agrees that its obligation to pay the purchase price for all Brokerage Purchases, Store Rx Purchases, Store Other Purchases and other amounts due or to become due under this Agreement will not be subject to any [***], or [***] for any reason, except as further described in this Agreement. Each party acknowledges and agrees that its obligation to pay the other amounts due under this Agreement or become due under this Agreement will not be subject to any [***], or [***] for any reason, except as further described in this Agreement. If a party to this Agreement that is obligated to pay monies hereunder (the "Payor") fails to pay the other party (the "Payee") amounts due under this Agreement (which Payee reasonably believes it is due), then [***] amounts due Payor. Any [***] incorrectly or improperly recognized (i.e., excluding legitimately disputed amounts) by Payee will be paid to Payor as soon as possible and in any event no later than [***] ([***]) days following notification from Payor of such incorrect or improper [***]; provided Payee agrees that the [***] was incorrectly or improperly taken. Payee agrees to pay when due any amounts not in dispute. CVS and Cardinal commit to work with each other to mutually resolve any disputed amounts. Furthermore, it is both parties intention that all Agreement components and incentives stand on their own; there will be no [***] incentives, rebates, or performance measurements (Warehouse Logistics Program, Pharmacy Site Incentive, [***] Wrap Around Rebate, etc.). SECTION 4. PAYMENT TERMS. (a) Store Rx Purchases and Store Other Purchases. CVS will cause Cardinal to receive payment in full and remittance by automated clearinghouse ("ACH") for all Store Rx Purchases and Store Other Purchases according to the schedule set forth in the Section 4 Disclosure Schedule subject to the terms and conditions of this Agreement. (b) Brokerage Purchases. CVS will cause Cardinal to receive payment in full by ACH for all Brokerage Purchases according to the schedule set forth in the Section 4 Disclosure Schedule subject to the terms and conditions of this Agreement. 4 (c) Automated Clearinghouse. All payments made by CVS to Cardinal under this Agreement will be made via ACH, to a financial institution designated by Cardinal, so as to provide Cardinal with good funds immediately available to Cardinal on the date such payment is due according to the schedule set forth in the Section 4 Disclosure Schedule. In the event that ACH is temporarily interrupted or cannot be utilized, CVS and Cardinal will seek alternative payment methods to ensure that Cardinal receives good funds as soon as practical. To the extent that a specific payment is unnecessarily delayed due to an issue with the ACH, CVS agrees to work with Cardinal to make such payment as expeditiously as possible. As indicated in Section 4 Disclosure Schedule, CVS and Cardinal may mutually agree to a payment arrangement that is reflective of a change in normal terms to accommodate for late payment due to the fact that the ACH was temporarily interrupted or could not be utilized. (d) Generally. If Cardinal reasonably believes that CVS has suffered a material adverse effect with respect to its financial position, then Cardinal has the right to request that CVS provide it with information within [***] ([***]) business day from the date CVS receives the request (i.e., if CVS receives Cardinal's request at 3:00 p.m. Monday, the information will be provided no later than [***]) that further describes or refutes (as applicable), in reasonable detail, such material adverse effect, and that may resolve any such concerns raised by Cardinal. In addition, CVS agrees to promptly notify Cardinal in the event CVS has suffered a material adverse effect with respect to its financial position, including, but not limited to an acceleration event under its credit facilities. If Cardinal has requested such information or CVS has notified Cardinal as set forth above and Cardinal and CVS cannot promptly resolve any such issues pursuant to a reasonable solution, then Cardinal may (i) limit CVS' daily purchases thereafter to the [***] of CVS' Qualified Purchases during the immediately preceding [***] ([***]) day period; (ii) modify payment terms, and (iii) in the event that CVS is in Payment Default (as defined below), give CVS notice of the amount of required payment under this Agreement by 10:00 a.m. Eastern Standard Time on a business day and require CVS to wire electronic confirmation of payment of such amount by non-refundable wire transfer by 2:00 p.m. Eastern Standard Time on the [***] business [***]. As used within this paragraph, a "PAYMENT DEFAULT" shall mean a circumstance where CVS has failed to cause Cardinal to receive payment when due. If any of the foregoing actions are taken by Cardinal, the parties will meet every approximate [***] ([***]) days following the execution of such action to review CVS' financial condition, and to reasonably consider reinstating the payment terms which were in effect prior to execution of such action. If any of the foregoing actions are taken by Cardinal, then CVS may choose to terminate this Agreement with [***] ([***]) days written notice if it finds Cardinal's proposed terms unacceptable. If the Agreement is terminated pursuant to this Section 4(d), the Agreement shall remain in effect without modification (unless mutually agreed upon in writing by the parties) until expiration of the [***] ([***]) day notice period. 5 If CVS reasonably believes that Cardinal has suffered a material adverse effect with respect to its financial position that has materially, adversely affected (or will imminently materially, adversely affect) Cardinal's ability to perform any term or condition of this Agreement or Cardinal's ability to pay amounts due CVS, then CVS has the right to request that Cardinal provide it with information within [***] ([***]) business day from the date Cardinal receives the request (i.e., if Cardinal receives CVS' request at 3:00 p.m. Monday, the information will be provided no later than [***]) that further describes or refutes (as applicable), in reasonable detail, such material adverse effect, and that may resolve any such concerns raised by CVS. In addition, Cardinal agrees to promptly notify CVS in the event Cardinal believes it has suffered, or will imminently suffer a material adverse effect with respect to its financial position, including an acceleration event under its credit facilities, that has materially, adversely effected (or will imminently materially, adversely affect) Cardinal's ability to perform any term or condition of this Agreement, or Cardinal's ability to pay amounts due CVS. If CVS has requested such information or Cardinal has notified CVS as set forth above, then CVS may (i) accelerate payment of any [***] or any amounts due CVS, (ii) modify payment terms, and (iii) in the event that Cardinal is in Payment Default (as defined below), give Cardinal notice of the amount of required payment under this Agreement by 10:00 a.m. Eastern Standard Time on a business day and require Cardinal to wire electronic confirmation of payment of such amount by non-refundable wire transfer by 2:00 p.m. Eastern Standard Time on the same business day. As used within this paragraph, a "PAYMENT DEFAULT" shall mean a circumstance where Cardinal has failed to cause CVS to receive payment when due. If any of the foregoing actions are taken by CVS, the parties will meet every approximate [***] ([***]) days following the execution of such action to review Cardinal's financial condition, and to reasonably consider reinstating the payment terms which were in effect prior to execution of such action. If any of the foregoing actions are taken by CVS, then Cardinal may choose to terminate this Agreement with [***] ([***]) days written notice if it finds CVS' proposed terms unacceptable. If the Agreement is terminated pursuant to this Section 4(d), the Agreement shall remain in effect without modification (unless mutually agreed upon in writing by the parties) until expiration of the [***] ([***]) day notice period. (e) Unconditional Guaranty. As an inducement for Cardinal to supply Merchandise and provide services to the subsidiaries and affiliates of CVS, whether existing now or in the future, CVS Corporation guarantees to Cardinal the punctual and full payment (and not merely the ultimate collectablility) of all undisputed sums due from CVS to Cardinal under this Agreement. SECTION 5. DELIVERY/ORDER SUBMISSION PROCEDURES. Cardinal will deliver the Merchandise F.O.B. to the Pharmacies and exercise its good faith efforts to provide an efficient delivery schedule designed to meet the mutual needs of Cardinal and the Pharmacies. All deliveries will be accompanied by an invoice and all delivery costs (not including emergency deliveries) absorbed by Cardinal. Cardinal will deliver Merchandise to each Pharmacy [***] ([***]) days per week ([***] through [***], except Pharmacies 6 located outside of the continental United States or other Pharmacies mutually agreed upon by the parties from time to time) as mutually agreed upon by both parties (exclusive of holidays, etc.). Any additional deliveries will constitute emergency deliveries, which if required, will incur a separate delivery charge at Cardinal's cost for such deliveries. Delivery schedules and purchase order deadlines may be reviewed and changed from time to time as mutually agreed upon by Cardinal and CVS. Delivery of Brokerage Purchases will be subject to the terms and conditions set forth in the Section 2(b) Disclosure Schedule. The Pharmacies will submit all orders, except for orders for Schedule II drugs, for all Merchandise to Cardinal via Telxon units (to be provided by Cardinal) or other mutually agreed upon method. Any such equipment supplied by Cardinal will be returned to Cardinal by CVS upon the expiration or termination of this Agreement for any reason, or upon Cardinal's request, if in Cardinal's reasonable discretion, Cardinal's proprietary rights are threatened. In the event that electronic order entry is temporarily interrupted for reasons beyond the control of CVS or Cardinal, CVS may place orders manually and both parties will use reasonable efforts to rectify the problem. DEA Form 222 may be mailed, given to the delivery driver to be delivered to the applicable Cardinal distribution center, or other mutually agreed upon method. Schedule II orders will be delivered within [***] ([***]) business [***] of Cardinal's receipt of the signed original DEA Form 222. CVS acknowledges that if CVS gives the DEA Form 222s to the delivery driver, such forms will not be received by Cardinal until such time that the delivery driver physically delivers the DEA Form 222 to the applicable Cardinal distribution center. Notwithstanding the foregoing, no Schedule II orders will be delivered other than in compliance with DEA regulations. Additionally, CII orders must be shipped [***]% complete and courier must be [***] when order is received and checked in by CVS, CVS reserves the right to refuse any CII order that contains any shipping errors. SECTION 6. OTHER SERVICES. (a) CardinalCHOICE-HQ(TM). Cardinal will license [***] ([***]) CardinalCHOICE-HQ(TM) software systems to CVS' headquarters on the terms set forth in the Section 6(a) Disclosure Schedule. Such licensing will be pursuant to the terms and conditions of Cardinal's standard software license agreement for such software. In addition, Cardinal will provide CVS with the related hardware as described in the Section 6(a) Disclosure Schedule, pursuant to Cardinal's standard hardware purchase agreement. Cardinal will make available to all CVS locations (Pharmacies, CVS Pharmacy DCs, and support locations) access to Cardinal.com. (b) Management Information Services. Cardinal will provide to CVS those programs and services described in the Base Service Package set forth in Section 6(b) Disclosure Schedule on the terms and conditions described in that schedule. 7 (c) RAPIDistribution(SM). Cardinal will make available to the Pharmacies participation in Cardinal's RAPIDistribution(SM) program, pursuant to the standard terms of that program. (d) Employees. (i) CVS will engage a Pharmacy DSD employee with the necessary skill set to act as a liaison between Cardinal and CVS. During the term of this Agreement and for a [***] ([***]) year period thereafter, Cardinal will not directly or indirectly employ, engage, or otherwise solicit for employment or engagement such employee, or induce or encourage such employee to terminate or otherwise modify such employee's relationship with CVS. Furthermore, Cardinal will provide CVS with [***] as detailed in Section 6(d) Disclosure Schedules. The CVS Employee shall keep any and all information disclosed by Cardinal confidential pursuant to Section 17. (ii) Cardinal will also engage a Pharmacy employee with the necessary skill set to act as a liaison between Cardinal and CVS and work on matters related to this Agreement. This employee will travel to CVS on a [***] basis and perform his/her duties at the CVS Support Center [***] ([***]) business days per [***] on average. CVS and Cardinal will mutually agree on the appropriate candidate to fill this position as it becomes necessary from time to time. During the term of this Agreement and for a [***] ([***]) year period thereafter, CVS will not directly or indirectly employ, engage, or otherwise solicit for employment or engagement such employee, or induce or encourage such employee to terminate or otherwise modify such employee's relationship with Cardinal. The Cardinal Employee shall keep any and all information disclosed by CVS confidential pursuant to Section 17. (e) ProfitPak(R). CVS will participate in the ProfitPak(R) program as it relates to CVS' Authorized Repack Portfolio as amended from time to time, with CVS customized substitution logic, as more fully described in the Section 6(e) Disclosure Schedule. SECTION 7 CVS GENERIC FORMULARY AND CARDINALSOURCE(SM) PROGRAM. (a) Cardinal understands that CVS has established a preferred list of generic Rx Products, which includes items CVS stocks in the CVS Pharmacy DCs and certain other products as CVS designates (the "CVS GENERIC FORMULARY"). Whenever a Pharmacy orders a generic product Cardinal will automatically substitute the corresponding CVS Generic Formulary item if applicable. Generic product shall be defined as a multi-source drug as detailed by First Data Bank's (FDB) NDDF Plus(TM) data dictionary. A generic drug will have the following values assigned to the NDC level by FDB: - Generic Indicator (GI) [***] (multiple source product) 8 - Generic Price Indicator (GPI) [***] (product priced as a generic) All drug products classified with a GI [***] and a GPI [***] will be considered generic drugs. In the event CVS, for substitution purposes, decides to elect certain items as brand or generic, contrary to what the result from FDB is; CVS will furnish Cardinal with notification and the drug shall be coded as instructed by CVS. Cardinal will regularly update its files to ensure all generic classification criteria set forth above is refreshed expeditiously to ensure generic classification criteria reflects current marketplace conditions. As stated above, whenever a Pharmacy orders a generic product Cardinal will automatically substitute to the corresponding CVS Generic Formulary item if applicable. Substitution will be based on the five (5) digit GCN as defined by FDB or as specifically directed by CVS. In addition, the program will ensure the formulary package size is shipped to the store in a quantity [***] or [***] the ordered quantity, unless otherwise specifically directed by CVS. For example; if a Pharmacy orders [***] ([***]) units of an off-formulary item with a package size of [***] for which there is a corresponding CVS Formulary item with a package size of [***], then the program will ensure the total quantity shipped to the Pharmacy is [***] or [***] the ordered quantity, in this case [***] ([***]) unit of the CVS Formulary item in the [***]-package size. CVS' required substitution logic is further defined in Section 7(a) Disclosure Schedule. CVS will have the ability to designate certain items, at the GCN or NDC level, to be excluded from package size substitution. For example, items that are available and used in large package sizes (i.e. one pound topical creams). Although the CVS Formulary may have corresponding items in smaller package sizes (i.e. 15 grams), CVS would require the original package size ordered to be shipped. CVS may put any item it deems appropriate on this exclusion. In addition, all package sizes should be consistent for metric sizes (i.e., one pint equal to 473 or 480 ml, 1 ounce equal to 28.4 or 30.0 grams). Due to regulatory issues surrounding Schedule II (CIIs) these items will be excluded from package size substitution. Cardinal will also allow CVS the ability to adjust (up or down) the quantity shipped to the Pharmacies. This adjustment will be made at an NDC level based on a predetermined Threshold Quantity (as defined below) and adjustment percentage. Both the Threshold Quantity and adjustment percentage can be set to [***]. The "THRESHOLD QUANTITY" (both CVS and Cardinal agree that the Threshold Quantity functionality will be made available to CVS no later than November 1, 2004) will be a minimum quantity that must be surpassed in order for the adjustment percentage to be applied. If the Threshold Quantity is not exceeded, the item should be shipped as ordered. The adjustment percentage will only be applied to that portion of the quantity ordered which exceeds the Threshold Quantity. Once the adjustment percentage is applied and rounded up to 9 the nearest whole unit, the result should be added to the Threshold Quantity to determine final shipment quantity. For example, if CVS chooses to adjust orders for NDC 55555-4444-22 by [***]% subject to a Threshold Quantity of [***] ([***]) bottle and if it is determined based on the substitution program that NDC 55555-4444-22 should be shipped in a quantity of [***] ([***]) units, then the quantity in excess of the Threshold Quantity ([***]), will be subject to a [***]% adjustment percentage ([***]) and be rounded up to the nearest whole unit ([***]). The adjusted quantity [***] ([***]) will be added to the Threshold Quantity [***] ([***]), to determine final quantity to be shipped [***] ([***]). The adjustment percentage will be allowed to exceed [***]% to any level CVS deems appropriate. If the item ordered does not have a corresponding item on the CVS Formulary or if the item is unavailable, Cardinal will automatically substitute such item with the corresponding generic product, if any, from the CardinalSOURCE(SM) generic formulary (the "CARDINAL GENERIC FORMULARY") in the original package size ordered. In the event that the Cardinal Generic Formulary item is out-of-stock, then Cardinal will automatically substitute the item with the [***] corresponding item under the second tier CVS generic formulary (the "SECONDARY CVS GENERIC FORMULARY") in the original package size ordered. If a corresponding item is not available on the Secondary CVS Generic Formulary, Cardinal will ship the item as it was ordered. Notwithstanding anything in the foregoing to the contrary, CVS reserves the right to [***] Cardinal from substituting certain items and/or order methods from the Cardinal Generic Formulary and Secondary CVS Generic Formulary for corresponding items on the CVS Generic Formulary. CVS has provided Cardinal with a list of items on CVS' Generic Formulary as of January 1, 2004 (the date of this Agreement). As items on the CVS Generic Formulary change from time to time, CVS will provide Cardinal with electronic notice of such changes including the proposed effective date of such change. As it pertains to Cardinal non-previously stocked items only, Cardinal will ensure best efforts are made to stock, and have available for Pharmacies to order within fourteen (14) days of receipt of such notice. In the event that Cardinal's inventory level of any product being deleted from the CVS Generic Formulary [***] the amount anticipated to be purchased by CVS prior to CVS' proposed effective date of such deletion and the Rx Product is not on CardinalSOURCE(SM) or another of Cardinal's retail chain generic programs, then Cardinal will notify CVS of such situation and Cardinal and CVS will mutually agree upon the adjusted effective date of such deletion. In addition, CVS will provide Cardinal on a monthly basis, in an acceptable file format, with a list setting forth all items on CVS' Generic Formulary as of the end of the previous month. Cardinal will use the information on such files to verify its records of CVS' Generic Formulary and notify CVS of any discrepancies so that such discrepancies may be reconciled and corrected. 10 Cardinal will have the ability to perform package size substitution for branded items upon request by CVS. Branded items are defined as items for which either the GI or GPI indicators in FDB are not [***]. This definition specifically excludes items for which Cardinal has been notified by CVS to designate in a manner regardless of the GI or GPI indicators. In cases where an existing Rx Product's formulation is altered or changed and a new formulation is introduced, Cardinal will seek approval from CVS prior to any substitution to said new item. Cardinal will accommodate the [***] of inventory for CVS' [***] upon request by CVS on an item-by-item basis. CVS may in the future decide to institute an [***] program similar to the [***]. Cardinal will support any [***] program as designed by CVS. [***] will be based entirely on the FDB classification for Rx and OTC as well as brand and generic. Any and all data and pricing (GCN, brand/generic indicator, package size, AWP, etc.) must be in accordance with the most recent First Data Bank data that is available. Cardinal proprietary and specific data elements and pricing will not be passed to CVS. CVS may instruct Cardinal to override any FDB classification, specifically as it relates to generic indicator. (b) CVS will be entitled to a [***] (in the form of a [***]) based on the [***] of [***] Rx Products purchased by the Pharmacies as described in the Section 7(b) Disclosure Schedule. SECTION 8. CONTRACT ADMINISTRATION. Cardinal will recognize and administer supplier contracts between CVS and any manufacturer or supplier ("MANUFACTURER CONTRACTS") subject to their continued validity in accordance with applicable laws and subject to such credit considerations concerning the applicable manufacturer as Cardinal may reasonably consider appropriate. Notwithstanding the foregoing, Cardinal's decision not to recognize and administer a Manufacturer Contract, shall not excuse Cardinal from complying with the service level detailed in Section 9 Disclosure Schedule or extending the applicable manufacturer's pricing to CVS (i.e., CVS to be financially kept whole). Cardinal will begin recognizing and administering each new Manufacturer Contract, renewal, or replacement within the later of: (i) [***] ([***]) business days after Cardinal has received a copy of the new Manufacturer Contract, renewal or replacement from CVS, or (ii) the effective date of the new Manufacturer Contract, renewal or replacement. Manufacturer Contracts received by Cardinal directly from the manufacturer or supplier must be forwarded to CVS within [***] ([***]) hours for CVS' written approval prior to being administered. SECTION 9. SERVICE LEVEL. Cardinal will provide CVS with the service levels described in the Section 9 Disclosure Schedule and Section 2(b) Disclosure Schedules. 11 SECTION 10. RETURNED GOODS POLICY. (a) Cardinal will accept returns from the Pharmacies in accordance with the returns process as detailed in Section 10(a) Disclosure Schedule. Set forth in the Section 2(b) Disclosure Schedule is the return process for Brokerage Purchases. (b) As it relates to non-merchantable pharmaceutical returns (expired, damaged, recalls, etc) CVS and Cardinal will work in accordance with the returns process set forth in the Section 10(b) Disclosure Schedule. (c) As it relates to Unfit Rx Product, CVS shall use commercially reasonable efforts to immediately return all Unfit Rx Product (whether alleged or verified) to Cardinal for full credit. Cardinal will [***] reimburse CVS at CVS' [***] for any and all Unfit Rx Product returned to Cardinal by CVS and all other [***] incurred by CVS as it pertains to Unfit Rx Product and Cardinal's instructions related to Unfit Rx Product. SECTION 11. TERM. (a) The term of this Agreement will begin on January 1, 2004 (the "COMMENCEMENT DATE"), and will continue for fifty-four (54) months thereafter (the "INITIAL Term"). This Agreement may be renewed for successive renewal periods of one (1) year each upon mutual written agreement of the parties. In the event either party desires not to renew the Agreement at the expiration of the Initial Term or any renewal term, that party shall provide the other party with at least ninety (90) days written notice prior to the expiration of the then current term. In the event such notification is not provided with at least the ninety (90) day notice or if no notice is given, the then current term shall be extended for a period of ninety (90) days after the expiration of such term to provide for an adequate transition period. Any reference in this Agreement to the "term of this Agreement" will include the Initial Term and any renewal term. (b) Either party may effect an early termination of this Agreement for cause by giving written notice to the other party, provided such party has first given written notice to the other party of the occurrence of a material breach of this Agreement (which notice will specify the nature of such breach) and the other party has failed to cure such breach within sixty (60) days following its receipt of such notice or, in the event such breach is not capable of being cured in such sixty (60) day period, the breaching party's failure to diligently prosecute such cure thereafter. Notwithstanding the foregoing, any failure to make any payment when due under this Agreement or any failure by the other party to perform as described within this Agreement which negatively impacts the other party's ability to perform their respective business functions, such period in which to cure will be reduced to ten (10) days. (c) Either party will have the right to terminate this Agreement upon notice to the other party following the commencement of any bankruptcy or insolvency 12 proceeding (whether voluntary or involuntary) with respect to such other party or its assets, the general assignment for the benefit of creditors by such other party, or the appointment of a receiver, trustee, or liquidator by or for such other party. (d) CVS' and Cardinal's payment obligations to each other which have accrued to date of termination or expiration will survive termination or expiration of this Agreement as shall all other obligations which by their nature extend beyond the term of the agreement, including but not limited to the obligation in Sections 16, 17, and 18. CVS and Cardinal will mutually agree on the transition of services provided by the other. (e) Upon termination of this Agreement for any reason, CVS' rights as a licensee of CardinalCHOICE-HQ(TM) software and other Cardinal software will automatically expire, and CVS will (upon request) promptly return such software and any related hardware not purchased by CVS to a return location specified by Cardinal. Upon termination of this Agreement for any reason, Cardinal will use its reasonable efforts to provide CVS with access to CVS' historical purchase data. (f) This Agreement will supersede and replace that certain Wholesale Supply Agreement dated August 16, 2000 by and between Cardinal and CVS (the "ORIGINAL Agreement"), and all extensions thereof. Upon commencement of this Agreement, the Original Agreement will terminate and be of no further force or effect whatsoever. (g) For purposes of this Agreement the term "PROGRAM YEAR" means the twelve (12) month period beginning on January 1st and ending on December 31st, except for the final Program Year, which will be a six (6) month period beginning January 1st and ending June 30th of 2008. (h) In addition to all other termination rights set forth in this Agreement, either party shall have the right to terminate this Agreement for no cause with ninety (90) days advance written notice subject to a termination fee as described in the Section 11(h) Disclosure Schedule. SECTION 12. WAREHOUSE LOGISTICS PROGRAM. CVS and Cardinal will implement a Warehouse Logistics Program ("WLP") as described in the Section 12 Disclosure Schedule. SECTION 13. NOTICES. All notices required or permitted under this Agreement will be in writing to the other party at the address set forth below (or such other address as that party may give to the other party by written notice hereunder) and will be deemed given (a) if delivered personally (including by overnight express or messenger), upon delivery, (b) if delivered by first class, registered or certified mail (return receipt requested), upon the earlier of 13 actual delivery or three (3) days after being mailed, or (c) if given by telecopy, upon confirmation of receipt of automatic transmission report. If to: CVS Pharmacy, INC. CARDINAL HEALTH One CVS Drive 7000 Cardinal Place Woonsocket, RI 02895 Dublin, Ohio 43017 Attn: Vice President, Attn: Senior Vice President, Pharmacy Merchandising Retail Sales and Marketing Telecopy: (401) 769-9473 Telecopy: (614) 757-8787 with copy to: with copy to: General Counsel Chief Legal Officer at the same address at the same address Telecopy: (614) 757-8919 Telecopy: (401) 765-7887 SECTION 14. TAXES/COMPLIANCE WITH LAWS. CVS will pay when due any sales, use, excise, gross receipts, or other federal, state, or local taxes or other assessments (other than any tax based solely on the net income of Cardinal) and related interest and penalties in connection with or arising out of the transactions contemplated by this Agreement. If Cardinal pays any such amounts which CVS is obligated to pay under this section, then CVS will promptly reimburse Cardinal in an amount equal to the amount so paid by Cardinal. If CVS pays any such amounts which Cardinal is obligated to pay under this section, then Cardinal will promptly reimburse CVS in an amount equal to the amount so paid by CVS. If and to the extent any discounts, credits, rebates or other purchase incentives are paid or applied by Cardinal with respect to the Merchandise and/or Brokerage Purchases purchased under this Agreement, then applicable provisions of the Medicare/Medicaid and state health care fraud and abuse/anti-kickback laws (collectively, "fraud and abuse laws") may require disclosure of the applicable price reduction on CVS' claim or cost reports for reimbursement from governmental or other third parties. CVS agrees to comply with all applicable provisions of the fraud and abuse laws and to indemnify and hold Cardinal harmless for any failure on CVS' part to do so. CVS will certify to Cardinal that all of the Pharmacies are properly and completely licensed in compliance with all applicable state and federal laws, regulations, rules and orders. Such certification will be provided in the form of a schedule listing all of the Pharmacies, and their respective state and federal license numbers and expiration dates. CVS will provide Cardinal with an updated good faith schedule no later than the twenty-fifth (25th) day of each month which will include information for the following month. 14 SECTION 15. FORCE MAJEURE. One or more of Cardinal's or CVS' obligations under this Agreement will be excused if, but only if, and to the extent that any delay or failure to perform such obligations is due to fire or other casualty, validated (by Cardinal and CVS) product or material shortages, strikes or labor disputes, transportation delays, validated (by Cardinal and CVS) manufacturer out-of-stocks or delivery disruptions, acts of God, validated (by Cardinal and CVS)seasonal supply disruptions, or other causes beyond the reasonable control of Cardinal or CVS (a "FORCE MAJEURE EVENT"). During the period of any such delay or failure, CVS may purchase the Primary Wholesale Requirements for the affected Pharmacies or CVS Pharmacy DCs from others, but will recommence purchasing from Cardinal within a reasonable amount of time following cessation of such delay or failure. The Pharmacy Minimum Volume Requirement as set forth in the Section 3(a) Disclosure Schedule shall be reduced by the amounts that the affected Pharmacies are required to purchase from others due to the event of force majeure. SECTION 16. RECORDS AND AUDIT. (a) Cardinal will maintain records pertaining to the Merchandise purchased by CVS under this Agreement as required by applicable federal, state and local laws, rules and regulations. Not more than [***] in any [***] ([***]) month period, and following [***] ([***]) days' advance written notice to Cardinal, or as required by administrative ruling or court order, CVS will have the right to appoint one or more of its agents or employees to review those relevant records applicable to its pharmaceutical purchases for the sole purpose of verifying compliance with the pricing terms of this Agreement or compliance with any other material terms of this Agreement. Any such review will be limited to [***] ([***]) months of historical information as of the date such review begins, except if Cardinal is required by applicable law to maintain records pertaining to the Merchandise purchased by CVS under this Agreement for a period longer than [***] ([***]) months, then Cardinal will also allow CVS to access such information. The information will be subject to a confidentiality agreement prepared by Cardinal and CVS and signed by CVS and its employee(s) and agent(s) who will have access to the information prior to beginning the review. Notwithstanding the foregoing, CVS may only appoint agents who are employees of one of the top national accounting firms, as may be deemed reasonably acceptable to Cardinal and CVS. Further, with respect to contracts between Cardinal and certain manufacturers which must remain confidential pursuant to a contractual provision, CVS may only review records relating to such contracts through an employee of one of the top national accounting firms deemed reasonably acceptable to Cardinal (i.e., not a CVS employee) to verify compliance with the pricing terms of such contracts. Such accounting firm may confirm to CVS that Cardinal has (or has not) complied with the pricing terms of such contracts, but may not (and will not) otherwise disclose to CVS the confidential information. 15 (b) CVS will maintain records pertaining to the Merchandise purchased all Pharmacies and CVS Pharmacy DCs, whether now or hereafter owned, managed or operated by CVS, under this Agreement as required by applicable federal, state and local laws, rules and regulations. Not more than [***] in any [***] ([***]) month period, or as required by administrative ruling or court order, and following thirty (30) days' advance written notice to CVS, Cardinal will have the right to appoint one or more of its employees or agents to review those relevant records applicable to such purchases of Rx Products for the sole purposes of verifying that each CVS Pharmacy DC is purchasing its Primary Wholesale Requirements of Brokerage Purchases from Cardinal, as further described in the Section 2(a) Disclosure Schedule or compliance with any other material terms of this Agreement. Any such review will be limited to [***] ([***]) months of historical information as of the date such review begins, except if CVS is required by applicable law to maintain records pertaining to the Merchandise purchased by CVS under this Agreement for a period longer than [***] ([***]) months, then CVS will allow Cardinal to access such information also. The information will be subject to a confidentiality agreement prepared by CVS and Cardinal and signed by Cardinal and its employee(s) and agent(s) who will have access to the information prior to beginning the review. Notwithstanding the foregoing, Cardinal may only appoint agents who are employees of one of the top national accounting firms, as may be deemed reasonably acceptable to CVS and Cardinal. Further, with respect to contracts between CVS and certain manufacturers which must remain confidential pursuant to a contractual provision, Cardinal may only review records relating to such contracts through an employee of one of the top national accounting firms deemed reasonably acceptable to CVS (i.e., not a Cardinal employee) to verify compliance with the terms of such contracts. Such accounting firm may confirm to Cardinal that CVS terms of this Agreement, but may not (and will not) otherwise disclose to Cardinal the confidential information. SECTION 17. CONFIDENTIALITY. Each party acknowledges that as a result of this Agreement, that party and its employees and agents, will learn confidential information of the other party (including, but not limited to, the information Cardinal provides to CVS pursuant to the Warehouse Logistics Program set forth in the Section 12 Disclosure Schedule). Neither party will disclose any confidential information of the other party to any person or entity, or use, or permit any person or entity to use, any of such confidential information, excepting only: (a) disclosures on a confidential basis to and use by the directors, officers, employees, and agents of that party who have a reasonable need to know such information in connection with that party's performance of this Agreement, (b) disclosures which are required by law, as reasonably determined by that party or its legal counsel, (c) disclosures which are made on a confidential basis to that party's attorneys, accountants, and other professional advisors in connection with matters relating to this Agreement, (d) information which is or becomes available to the other party on a non-confidential basis from a source entitled to disclose it on a non-confidential basis, (e) information that is or becomes generally available to the public or within the industry to which such information relates other than as a result of disclosure by the other party or its representatives, and (f) routine 16 disclosures to IMS/DDD or similar organizations consistent with past practices, so long as confidential information regarding CVS is provided only on an aggregate or "blinded" basis and not identified specifically as CVS information other than as otherwise contemplated or described in this Agreement. The specific material terms of this Agreement will be deemed to be confidential information of each party. Each party will be responsible for any breach of this confidentiality provision by its representatives. The obligations of confidentiality hereunder will survive the termination of this Agreement for a period of two (2) years. Upon termination of this Agreement (for any reason) each party will promptly: (i) return to the other party all documentation and other materials (including copies of original documentation or other materials) containing any confidential information of the other party; or (ii) certify to the other party, pursuant to a certificate in form and substance reasonably satisfactory to the other party, as to the destruction of all such documentation and other materials. Notwithstanding the foregoing, each party may keep one copy of any documentation containing confidential information of the other party, provided that such copy will be retained and used solely by the legal department of that party. SECTION 18. INDEMNITY. Cardinal will indemnify and hold harmless CVS and all future parent corporations, subsidiaries and affiliates and each of their officers, directors, employees and representatives (collectively referred to in this paragraph as CVS) from and against those claims, damages or liabilities (including expenses and attorneys fees)(exclusive of any incidental damages, which are defined as claims, damages and liabilities associated with or related to actual damages but are in excess of repayment for actual losses, and exclusive of any consequential damages, which are defined as claims, damages and liabilities that do not flow directly and immediately from an act that would require indemnification hereunder but that result indirectly from such an act) directly attributable to Cardinal's negligence or wrongdoing or the failure of Cardinal to properly store, handle or distribute Merchandise in accordance with this Agreement or in accordance with applicable law, it being understood, however, that Cardinal is not the manufacturer of the Merchandise and that no indemnification of any type is being provided other than as specifically stated in this paragraph. In addition, Cardinal will transfer to CVS (on a non-exclusive basis) any representations, warranties and indemnities made by the manufacturers of the Merchandise to the extent that such representations, warranties and indemnities are assignable by Cardinal, and will cooperate with all reasonable requests made by CVS to enforce such representations, warranties and indemnities against such manufacturers. Notwithstanding anything to the contrary herein, Cardinal reserves its own rights under such representations, warranties and indemnities made by such manufacturers and the remedies available to it for any breach of such representations, warranties and indemnities by the manufacturers. CVS will indemnify and hold harmless Cardinal and all future parent corporations, subsidiaries and affiliates and each of their officers, directors, employees and representatives (collectively referred to in this paragraph as Cardinal) from and against those claims, damages or liabilities (exclusive of any incidental damages, which are 17 defined as claims, damages and liabilities associated with or related to actual damages but are in excess of repayment for actual losses, and exclusive of any consequential damages, which are defined as claims, damages and liabilities that do not flow directly and immediately from an act that would require indemnification hereunder but that result indirectly from such an act) directly attributable to CVS' negligence or wrongdoing, it being understood, however, that no indemnification of any type is being provided other than as specifically stated in this paragraph. The parties agree that neither CVS nor Cardinal will be obligated under this section 18 with respect to any claim that results solely from the negligence or intentional wrongdoing of the other party. SECTION 19. INSURANCE. Cardinal and CVS agree to maintain the insurance as set forth in the Section 19 Disclosure Schedule. SECTION 20. ENTIRE AGREEMENT; SUCCESSORS. This Agreement, together with the Disclosure Schedules referenced herein, constitutes the entire Agreement and understanding of the parties with respect to the subject matter hereof, and supersedes all prior and contemporaneous agreements, proposals, and understandings between the parties relative to the subject matter hereof. Cardinal may delegate its rights and obligations to any corporation that is controlled by or under common control with Cardinal Health, Inc. and CVS may delegate its rights and obligations to any corporation that is controlled by or under common control with CVS Corporation, provided that in each such assignment by Cardinal or CVS the assignor will remain the primary obligor for all payment obligations. If all or substantially all of the stock or assets of CVS Corporation are acquired by an unrelated third party (which expressly excludes a merger where CVS Corporation is the surviving entity), then Cardinal may elect (but will not be required) to terminate this Agreement during the thirty (30) day period following such acquisition, by providing written notice to CVS of its intent to terminate sixty (60) days prior to the intended termination date. Further, if all or substantially all of the stock or assets of Cardinal Health, Inc. are acquired by an unrelated third party (which expressly excludes a merger where Cardinal Health, Inc. is the surviving entity), then CVS may elect (but will not be required) to terminate this Agreement during the thirty (30) day period following such acquisition, by providing written notice to Cardinal of its intent to terminate sixty (60) days prior to the intended termination date. This Agreement will be binding on, and inure to the benefit of, and be enforceable by and against the respective successors and assigns of each party to this Agreement. SECTION 21. AMENDMENTS. No changes to this Agreement will be made or be binding on any party unless made in writing and signed by each party to this Agreement. 18 SECTION 22. WAIVER. Neither party's failure to enforce any provision of this Agreement will be considered a waiver of any future right to enforce such provision. SECTION 23. GOVERNING LAW. This Agreement will be governed by the laws of the State of Ohio, without regard to choice of law principles. SECTION 24. RELATIONSHIP OF THE PARTIES. The relationship of the parties is and will be that of independent contractors. This Agreement does not establish or create a partnership or joint venture among the parties. SECTION 25. SEVERABILITY. The intention of the parties is to fully comply with all applicable laws and public policies, and this Agreement will be construed consistently with all such laws and policies to the extent possible. If and to the extent that a court of competent jurisdiction determines that it is impossible to so construe any provision of this Agreement and consequently holds that provision to be invalid, such holding will in no way affect the validity of the other provisions of this Agreement, which will remain in full force and effect. SECTION 26. ANNOUNCEMENTS. CVS will not issue any press release or other public announcement, verbally or in writing, referring to Cardinal or any entity which is controlled by or under common control with Cardinal Health, Inc., without Cardinal's prior written consent and advice of counsel. CVS will provide Cardinal's Executive Vice President, Retail Sales and Marketing, 7000 Cardinal Place, Dublin, Ohio 43017, with a written copy of any such press release or other public announcement no less than seventy-two (72) hours prior to CVS' intent to issue such release or announcement. CVS is responsible for confirming in writing that Cardinal's Executive Vice President, Retail Sales and Marketing has received any such proposed press release. Any such press release or other public announcement proposed by CVS will be subject to Cardinal's revision and final approval. Nothing contained herein will limit the right of CVS to issue a press release if, in the opinion of CVS' counsel, such press release is required pursuant to state or federal securities laws, rules or regulations. Cardinal will not issue any press release or other public announcement, verbally or in writing, referring to CVS or any entity which is controlled by or under common control with CVS Pharmacy, Inc., without CVS' prior written consent and advice of counsel. Cardinal will provide CVS' Vice President of Pharmacy Merchandising and Director of Corporate Communications, One CVS Drive, Woonsocket, Rhode Island 02895, with a written copy of any such press release or other public announcement no less than seventy-two (72) hours prior to Cardinal's intent to issue such release or announcement. Cardinal is responsible for confirming in writing that CVS' Vice President of Pharmacy Merchandising and Director of Corporate Communications has received any such 19 proposed press release. Any such press release or other public announcement proposed by Cardinal will be subject to CVS' revision and final approval. Nothing contained herein will limit the right of Cardinal to issue a press release if, in the opinion of Cardinal's counsel, such press release is required pursuant to state or federal securities laws, rules or regulations. SECTION 27. AUTHORIZED SIGNATORIES. All signatories to this Agreement represent that they are authorized by their respective companies to execute and deliver this Agreement on behalf of their respective companies, and to bind such companies to the terms herein. Accepted and Agreed to by: Cardinal Health* By: /s/ Mark W. Parrish ------------------------------------ Its: Group President Date: May 17, 2004 CVS Pharmacy, INC. By: /s/ Matthew J. Leonard ------------------------------------ Its: VP Pharmacy Merchandising Date: June 1, 2004 And with respect to Section 4(e) only: CVS CORPORATION By: /s/ Zeonon Lankowsky ------------------------------------ Its: Secretary Date: 6/8/04 *The term "CARDINAL HEALTH" means the following pharmaceutical distribution companies: Cardinal Health 106, Inc. (formerly known as James W. Daly, Inc.), a Massachusetts corporation (Peabody, Massachusetts); Cardinal Health 103, Inc. (formerly known as Cardinal Southeast, Inc.), a Mississippi corporation (Madison, Mississippi); Cardinal Health 110, Inc. (formerly known as Whitmire Distribution Corporation), a Delaware corporation (Folsom, California) and any other subsidiary of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI. 20 SECTION 1(A) DISCLOSURE SCHEDULE DETERMINATION OF PHARMACIES THAT WILL DESIGNATE CARDINAL AS PRIMARY WHOLESALE PHARMACEUTICAL SUPPLIER As of the Commencement Date, and throughout the term of this Agreement, CVS will designate Cardinal as primary wholesale pharmaceutical supplier to the Pharmacies existing as of January 1, 2004 plus or minus the organic growth related to these specific Pharmacies. In the event CVS acquires by purchase, merger or other combination, a retail pharmacy (or multiple retail pharmacies) representing: (a) less than [***]% of CVS' Pharmacies as of January 1, 2004, then CVS will designate Cardinal as primary wholesale pharmaceutical supplier to such pharmacies pursuant to the terms and conditions of this Agreement in a timeframe so as not to compromise CVS' business operations; or (b) greater than or equal to [***]% of CVS' Pharmacies as of the January 1, 2004 (the date of this Agreement), then CVS may decide to award Cardinal any portion of said retail pharmacies at CVS' sole discretion (in which case Cardinal and CVS will meet to discuss the terms of said new business). In no event will CVS be required to terminate any wholesaler agreement which may exist related to any retail pharmacies CVS acquires by purchase, merger or other combination. DESIGNATED PHARMACY LIST. Upon Cardinal's request, as often as quarterly, CVS will provide Cardinal with the Designated Pharmacy List. For each of the Pharmacies, CVS agrees that each such Pharmacy will purchase its Primary Wholesale Requirements of Store Rx Purchases from Cardinal, as further described in the Section 2(a) Disclosure Schedule. 21 SECTION 1(B) DISCLOSURE SCHEDULE TOTAL DC LIST CVS New York, Inc. CVS D.S., Inc. Three Berry Drive 10017 Kingston Pike Lumberton, NJ 08048 Knoxville, TN 37922 CVS Pharmacy, Inc. CVS IN Distribution, Inc. 150 Industrial Drive 7590 Empire Drive North Smithfield, RI 02896 Indianapolis, IN 46219 CVS Texas Distribution L.P. 700 CVS Drive Ennis, TX 75119 (expected open date TBD) As CVS [***] additional [***] to support Pharmacies existing as of January 1, 2004 or additional Pharmacies related to the organic growth of the Pharmacies existing as of January 1, 2004, CVS will [***] such pharmacy [***] Cardinal as its/their [***] pursuant to the terms and conditions of this Agreement. For each of the CVS Pharmacy DCs set forth above, CVS agrees that each such CVS Pharmacy DC will purchase its Primary Wholesale Requirements of Brokerage Purchases from Cardinal, as further described in the Section 2(a) Disclosure Schedule. CVS will keep the Total DC List current and notify Cardinal of anticipated additions to or deletions from the Total DC List at least thirty (30) days prior to such addition or deletion. If such addition or deletion could not have been reasonably foreseen [***] ([***]) days in advance, CVS will notify Cardinal as soon as possible thereafter. In no event will Cardinal be required to service any CVS Pharmacy DC pursuant to the terms of this Agreement until [***] ([***]) days after CVS first notified Cardinal that the CVS Pharmacy DC would be added to the Total DC List. A CVS Pharmacy DC may only be deleted if it ceases operations. If CVS acquires or opens an additional distribution center or centers in support of acquired retail pharmacies (acquired by purchase, merger or other combination), CVS may designate Cardinal as the primary wholesale pharmaceutical supplier to such distribution centers (in which case Cardinal and CVS will meet to discuss the terms of said new business) in a timeframe so as not to compromise CVS' business operations. In no event will CVS be required to terminate any wholesaler agreement which may exist related to acquired retail pharmacies. 22 SECTION 2(A) DISCLOSURE SCHEDULE PRIMARY WHOLESALE REQUIREMENTS The term "PRIMARY WHOLESALE REQUIREMENTS" means: (a) with respect to the Pharmacies, Cardinal will be the [***] wholesale supplier of [***] Rx Products to such Pharmacies. Furthermore, CVS will meet or exceed the Pharmacy Minimum Volume Requirement (as described in the Section 3(a) Disclosure Schedule). (b) with respect to all of the CVS Pharmacy DCs, CVS will purchase from Cardinal [***] of Rx Products from indirect manufacturers as detailed in and subject to Section 12 Disclosure Schedule, excluding CVS' [***] and [***] purchases. Notwithstanding anything in this Agreement to the contrary, CVS retains the right to purchase from any other source Rx Products which are unavailable from Cardinal. 23 SECTION 2(B) DISCLOSURE SCHEDULE WAREHOUSE AND BROKERAGE PURCHASES -- TERMS AND CONDITIONS A. ORDERING/DELIVERY. All CVS purchase orders for [***] Products (except for [***] items) will be generated [***]. All orders referenced in this Section 2(b) Disclosure Schedule are intended to refer to orders generated [***]. All orders will be handled through [***] Department located at its corporate headquarters or such other departments designated by [***] from time to time. All references to Cardinal in this Section 2(b) Disclosure Schedule are to [***] or other such designated department. All orders will be generated by specified manufacturer and will include the NDC number, complete product description and to which CVS Pharmacy DC the product is designated to be shipped. Quantities ordered will meet manufacturer requirements for minimum and/or multiple case quantities and/or minimum order size. All orders will be subject to shipping restrictions, cut-backs, allocations, backorders, delays and other restrictions imposed by manufacturers from time to time. Cardinal may, at its option, [***] a [***] related to the Warehouse Logistics Program described in Section 12 Disclosure Schedule with [***] from [***]. The price for such product from [***] will be equal to the [***] as of CVS' PO date. Within [***] ([***]) business days of receipt of the order for product, Cardinal will ship the product on a [***] ([***]) day per week basis to the CVS Pharmacy DC for which such order was made. Payment for such product [***] in its inventory will be due at the greater of; [***] ([***]) days or a mutually agreed upon number of days from invoice date (invoice date will equal ship date) (by specific [***] as may be agreed upon from time to time and detailed in Section 12 Disclosure Schedule). Cardinal will pass through to CVS any applicable manufacturer [***] with respect to warehouse and Brokerage Purchases subject to Section 12 Disclosure Schedule. B. RECEIVING AND SHIPPING DISCREPANCIES. 1. GENERALLY. In the event a discrepancy in quantity arises with respect to any shipment, the applicable CVS Pharmacy DC will notify Cardinal of the discrepancy within [***] ([***]) business days of the receipt date of the shipment, and will pay the undisputed amount of any such shipment, in accordance with the process for taking deductions set forth within this disclosure schedule. In turn, Cardinal may notify the supplier (if other than Cardinal) relative to the disputed quantity or pricing. If CVS [***] has a [***] with a manufacturer or supplier and CVS reasonably believes such manufacture or supplier [***] to CVS, then CVS will [***] to Cardinal in the amount of such [***]. Cardinal may, at its sole discretion, correspondingly [***] from [***] to such manufacturer or supplier. [***] and [***] will be responsible to maintain detailed support documentation for any [***] or [***] request and will make such documentation, upon request, available to the requesting party. 24 [***] and [***] will not allow [***] if such [***] are not supported by detailed documentation. 2. CROSSDOCK, DROPSHIP, REPLENISHMENT WAREHOUSE DISCREPANCIES. A crossdock or dropship discrepancy is defined as one of the following scenarios: Shortage (Quantity) Item quantity on Cardinal invoice is greater than the quantity physically received by CVS Pharmacy DC Overage (Quantity) Item quantity on Cardinal invoice is less than the quantity physically received by CVS Pharmacy DC Wrong Item (Quantity) Cardinal invoices CVS for one item but CVS Pharmacy DC physically receives a different item Short Dated Cardinal invoices CVS for an item and CVS Pharmacy DC (Quantity) physically receives the item but cannot receive the item into its stock due to dating requirements [product expected to have minimum of [***] months dating unless pre-approved by ECR subject to Section 12 Disclosure Schedule] Damaged (Quantity) Cardinal invoices CVS for an item and CVS Pharmacy DC physically receives the item but cannot receive the item into its stock due to damage to the item
Each CVS Pharmacy DC will provide the applicable Cardinal division with notice (i.e., via Warehouse Discrepancy Notification ("WDN"), which will be transmitted electronically or via facsimile) of all inbound receiving discrepancies between physical product and the accompanying packing list within [***] ([***]) business days of CVS' physical receipt of the product. The WDN must be transmitted directly to the designated Cardinal DC associate with a copy to Cardinal's Corporate Purchasing Department. Cardinal will use all reasonable efforts to respond to a WDN within [***] ([***]) business days of receipt of each such WDN. Cardinal and the CVS Pharmacy DCs will communicate the crossdock or dropship discrepancies and corresponding resolution to their respective accounting departments. CVS will process a [***] Cardinal (subject to Section 2(b) Disclosure Schedule) for the value of the discrepancy. Cardinal may request and CVS will provide additional written documentation in support of [***]. If Cardinal, through its own review, has documentation which refutes CVS' claim, then CVS and Cardinal shall review such documentation and any necessary adjustment will be made. Discrepancies that remain unresolved [***] ([***]) business days following the date of the WDN will be presented to senior management at both Cardinal and CVS, for resolution. 3. CROSSDOCK, DROPSHIP, REPLENISHMENT ACCOUNTING DISCREPANCIES An accounting discrepancy is defined as one or more of the following scenarios: Shortage (quantity) Item quantity on Cardinal invoice is greater than the quantity physically received by CVS Pharmacy DC
25 Overage (quantity) Item quantity on Cardinal invoice is less than the quantity physically received by CVS Pharmacy DC Wrong item (quantity) Cardinal invoices CVS for one item but CVS Pharmacy DC physically receives a different item Short dated Cardinal invoices CVS for an item and CVS Pharmacy DC (quantity) physically received the item but cannot receive the item into its stock due to dating requirements [product expected to have minimum of [***] months dating unless pre-approved by ECR subject to Section 12 Disclosure Schedule] Damaged (quantity) Cardinal invoices CVS for an item and CVS Pharmacy DC physically receives the item but cannot receive the item into its inventory due to damage to the item Pricing Cardinal's invoice price for an item is different than the price CVS reasonably understands it should pay for such item Due Dating Cardinal's invoice reflects a due date that is different from the date that CVS reasonably understands payment on the invoice to be due Other Any discrepancy where CVS reasonably understands the payment amount to be different from the amount reflected on the Cardinal invoice
CVS' corporate accounting department will provide Cardinal with notice of all accounting discrepancies on or before the payment due date for the applicable invoice. Prior to submitting such notice to Cardinal, CVS agrees to re-verify the CVS Pharmacy DC's claim of the accounting discrepancy. The written notice for accounting discrepancies will take the form of an accounting discrepancy notification which will be generated and provided to Cardinal by CVS' accounting department (the "ADN"). This ADN will include the purchase order number, items involved, quantities, amounts and nature of the exception. CVS will [***] due Cardinal (subject to Section 2(b) Disclosure Schedule) for the [***] of the discrepancy. Cardinal may request and CVS will provide additional written documentation in support of [***]. If Cardinal, through its own review, has documentation which refutes CVS' claim, then CVS and Cardinal shall review such documentation and any necessary adjustment will be made. Cardinal and CVS will use all reasonable efforts to resolve the accounting discrepancies within [***] ([***]) calendar days of receipt from CVS of the fully completed ADN. Discrepancies that remain unresolved [***] ([***]) business days following the date of the ADN will be presented to senior management at both Cardinal and CVS for resolution. 4. WAREHOUSE RETURNS. A. CROSSDOCK VENDORS. CVS will return all product by reason of overage, wrong item, unapproved, short-dated or damage relating to replenishment crossdock and [***] (subject to Section 12 Disclosure Schedule) to the applicable Cardinal servicing division within [***] 26 ([***]) business days of physical receipt of the product. CVS will label the product as a return, attach a completed WDN, and clearly reference the original shipment. CVS will [***] against future payment due Cardinal in the amount of the return subject to Section 2(b) Disclosure Schedule. B. DROPSHIP VENDORS. CVS will return all product by reason of overage, wrong item, unapproved, short-dated or damage relating to replenishment dropship and [***] dropship (subject to Section 12 Disclosure Schedule) directly to the manufacturer, within [***] ([***]) business days of physical receipt of the product. In addition, if CVS discovers a concealed short or damaged Merchandise relating to [***] of such [***] (that arises while such Merchandise is out of [***] physical [***]), then CVS will return such Merchandise directly to the manufacturer. CVS will provide the applicable Cardinal servicing division with a completed WDN. CVS will [***] future payment due Cardinal in the amount of the return subject to Section 2(b) Disclosure Schedule C. DIRECT VENDORS. CVS will return all product resulting from replenishment direct and [***] direct (subject to Section 12 Disclosure Schedule) shipment directly to the manufacturer. CVS [***] from amounts CVS owes Cardinal with respect to such replenishment direct or [***] direct returned product subject to Section 12 Disclosure Schedule. CVS will return all [***] (but not related to [***]) or damaged product to CVS' designated third party returned goods processor, or directly to the manufacturer or manufacturer's processor, as CVS elects. All other return scenarios will be handled on an exception basis with a process to be mutually agreed upon by both CVS and Cardinal. C. CVS [***] (I.E., [***]) DISCREPANCIES. The following provisions apply to [***]. 1. [***] WAREHOUSE DISCREPANCIES. A warehouse discrepancy is defined as one of the following scenarios: Shortage (Quantity) Item is on [***] list but not physically received by [***] [complete line or part of line item] Overage (Quantity) Item is physically received by [***] not on [***] list [additional quantities to existing line item or new item] Wrong Item (Quantity) [***] physically receives item different than item on [***] (Quantity) [***] physically receives item from [***] that has less than [***] product [***] subject to Section 12 Disclosure Schedule.
27 Damaged (Quantity) [***] physically receives item damaged.
[***] provide the applicable [***] with a WDN (transmitted by electronic method mutually agreed to by both locations) of all [***] receiving discrepancies between physical product and the accompanying [***] packing list. Cardinal will use its reasonable efforts to notify CVS within [***] ([***]) business days of physical receipt of product; however, in order to protect the service level to CVS, replenishment transactions will be first priority which could defer receipt of [***] shipments up to an additional [***] ([***]) business days (except for controlled substances, which Cardinal will prioritize and use its reasonable efforts to notify CVS [***] within [***] ([***]) business days). The WDN must be transmitted directly to the designated CVS Pharmacy DC associate with a copy to CVS' corporate purchasing department. CVS will use all reasonable efforts to respond to a WDN within [***] ([***]) business days of receipt of each such WDN; however, in order to prioritize business critical transactions such notification may be delayed, but not to exceed [***] ([***]) business days. Cardinal and the CVS Pharmacy DC's will communicate the warehouse discrepancies and corresponding resolution to their respective accounting departments. CVS will [***] against [***] due Cardinal (subject to Section 2(b) Disclosure Schedule) for the [***] of the discrepancy. Cardinal may request and CVS will provide additional written documentation in support of [***]. If Cardinal, through its own review, has documentation which refutes CVS' claim, then CVS and Cardinal shall review such documentation and any necessary adjustment will be made. Discrepancies that remain unresolved [***] ([***]) business days following the date of the WDN will be presented to senior management at CVS and Cardinal distribution centers, for resolution. 2. [***] ACCOUNTING DISCREPANCIES. An accounting discrepancy is defined as one or more of the following scenarios: Shortage (Quantity) Item [***] list but not physically received by [***] [complete line or part of line item] Overage (Quantity) Item is physically received [***] but not on [***] list [additional quantities to existing line item or new item] Wrong Item (Quantity) [***] physically receives item different than item on [***] list (Quantity) [***] physically receives item from [***] that has less than [***] months product dating subject to Section 12 Disclosure Schedule. Damaged (Quantity) [***] physically receives item damaged.
As a result of the electronic notifications of a deductions (in an [***] format) created by CVS, Cardinal will produce a report detailing the accounting discrepancies that exist between the [***] taken by CVS and the merchandise [***] by Cardinal. Prior to submitting such accounting discrepancy report to CVS, Cardinal agrees to re- 28 verify the Cardinal DC's claim of the accounting discrepancy. The electronic notice for accounting discrepancies will take the form of a standard exception report (in a form mutually agreed to by both Cardinal and CVS) which will be generated and transmitted to CVS electronically by Cardinal's Brokerage accounting department. The ADN must include the [***] packing list, items involved, quantities received by CVS, quantities shipped to Cardinal, pricing and nature of the exception. CVS will [***] against [***] due Cardinal (subject to Section 2(b) Disclosure Schedule) for the [***] of the discrepancy. Cardinal may request and CVS will provide additional written documentation in support of [***]. If Cardinal, through its own review, has documentation which refutes CVS' claim, then CVS and Cardinal shall review such documentation and any necessary adjustment will be made. Cardinal and CVS will use all reasonable efforts to resolve the accounting discrepancies within [***] ([***]) calendar days of receipt from CVS of the fully completed ADN. Discrepancies that remain unresolved [***] ([***]) business days following the date of the ADN will be presented to senior management at both Cardinal and CVS for resolution. 29 D. VERIFICATION PROCESS. CARDINAL SHIPMENTS TO CVS REPLENISHMENT CROSSDOCK Shortage - CVS to verify shortage by recounting inbound shipment - CVS to review discrepancy against receiving worksheet/manifest from Cardinal to confirm shortage not due to UOM issue - CVS to check for merchandise on site but not received into system - CVS to check for open receiving (overage receiving against different purchase order) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - CVS to determine if shortage due to overage on other item - Cardinal to review receiving worksheet/manifest for error - Cardinal to review vendor packing list/BOL - Cardinal to cycle count on hand inventory - Cardinal to review inventory adjustment records Overage - CVS to verify overage by recounting inbound shipment - CVS to review discrepancy against receiving worksheet/manifest from Cardinal to confirm overage not due to UOM issue - CVS to determine if overage due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - Cardinal to review receiving worksheet/manifest for error - Cardinal to review vendor packing list/BOL - Cardinal to cycle count on hand inventory - Cardinal to review inventory adjustment records Wrong Product - CVS to determine if item is correct, just wrong NDC number - CVS to determine if wrong product is overage to product on purchase order or if product not on original purchase order - CVS to determine if wrong product is due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - Cardinal to review receiving worksheet/manifest for error - Cardinal to review vendor packing list/BOL - Cardinal to cycle count on hand inventory - Cardinal to review inventory adjustment records [***] Product - CVS to review receiving worksheet from Cardinal to determine if dating pre-approved - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision)
30 - Cardinal to review receiving worksheet/manifest for error Damaged Product - CVS to return product to Cardinal as per approved SOP Invalid Purchase Order - CVS to contact Cardinal customer operations coordinator
31 [***] (REPLENISHMENT FROM CARDINAL INVENTORY) Shortage - CVS to verify shortage by recounting inbound shipment - CVS to review discrepancy against receiving worksheet/manifest from Cardinal to confirm shortage not due to UOM issue - CVS to check for merchandise on site but not received into system - CVS to check for open receiving (overage receiving against different purchase order) - CVS to determine if shortage due to overage on other item - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - Cardinal to review receiving worksheet/manifest for error - Cardinal to Cycle Count on-hand inventory - Cardinal to review inventory adjustment records Overage - CVS to verify overage by recounting inbound shipment - CVS to Review discrepancy against receiving worksheet/manifest from Cardinal to confirm overage not due to UOM issue - CVS to determine if overage due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - Cardinal to review receiving worksheet/manifest for error - Cardinal to Cycle Count on-hand inventory - Cardinal to review inventory adjustment records Wrong Product - CVS to determine if item is correct, just wrong NDC number - CVS to determine if wrong product is overage to product on purchase order or if product not on original purchase order - CVS to determine if wrong product is due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - Cardinal to review receiving worksheet/manifest for error - Cardinal to Cycle Count on-hand inventory - Cardinal to review inventory adjustment records [***] Product - CVS to review receiving worksheet from Cardinal to determine if dating pre-approved - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - Cardinal to review receiving worksheet/manifest for error Damaged Product - CVS to return product to Cardinal as per approved SOP Invalid Purchase Order - CVS to contact Cardinal customer operations coordinator
32 REPLENISHMENT OR [***] DROPSHIP Shortage - CVS to verify shortage by recounting inbound shipment - CVS to review discrepancy against packing list/BOL from manufacturer to confirm shortage not due to UOM issue - CVS to check for merchandise on site but not received into system - CVS to check for open receiving (overage receiving against different purchase order) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - CVS to determine if shortage due to overage on other item - Cardinal to contact vendor to coordinate resolution Overage - CVS to verify overage by recounting inbound shipment - CVS to review discrepancy against packing list/BOL from vendor to confirm overage not due to UOM issue - CVS to determine if overage due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to Manufacturer (notify Cardinal of ECR decision) - CVS to cycle count on hand inventory - CVS to review inventory adjustment records - Cardinal to contact vendor to coordinate resolution Wrong Product - CVS to determine if item is correct, just wrong NDC number - CVS to determine if wrong product is overage to product on purchase order or if product not on original purchase order - CVS to determine if wrong product is due to shortage on other item - CVS to contact ECR to determine if product should be received or returned to manufacturer (notify Cardinal of ECR decision) - Cardinal to contact vendor to coordinate resolution [***] Product - CVS to contact ECR to determine if product should be received or returned to Cardinal (notify Cardinal of ECR decision) - Cardinal to contact vendor to coordinate resolution Damaged Product - CVS to return product to manufacturer as per manufacturer guidelines and notify Cardinal
33 CVS [***] [***] DROPSHIP / [***] DIRECT Shortage - [***] to verify shortage by recounting inbound shipment - [***] to review discrepancy against packing list [***] to confirm shortage not due to UOM issue - [***] to check for merchandise on site but not received into system - [***] to check for open receiving {overage receiving against different purchase order} - [***] to determine if shortage due to overage on other item - [***] to cycle count on hand inventory - [***] to review inventory adjustment records - [***] to review receiving paperwork and packing list to [***] for error - [***] to review vendor packing list/BOL - [***] to cycle count on hand inventory - [***] to review inventory adjustment records Overage - [***] to verify overage by recounting inbound shipment - [***] to review discrepancy against packing list [***] to confirm overage not due to UOM issue - [***] to determine if overage due to shortage on other item - [***] to contact Corporate Brokerage to determine if product should be received or returned to [***] (notify CVS of decision) - [***] to cycle count on hand inventory - [***] to review inventory adjustment records - [***] to review receiving paperwork and packing list to [***] for errors - [***] to review vendor packing list/BOL - [***] to cycle count on hand inventory - [***] to review inventory adjustment records Wrong Product - [***] to determine if item is correct, just wrong NDC number - [***] to determine if wrong product is overage to product on purchase order or if product not on original purchase order - [***] to determine if wrong product is due to shortage on other item - [***] to contact Corporate Brokerage to determine if product should be received or returned to[***] (notify CVS of decision) - [***] to review receiving paperwork and packing list to [***] for error - [***] to review vendor packing list/BOL - [***] to cycle count on hand inventory - [***] to review inventory adjustment records Product - [***] to note product dating on problem solver document to Corporate Brokerage - [***] to receive product into inventory Damaged Product - [***] to note product damage on problem solver document to Corporate Brokerage - [***] to receive product into inventory and initiate vendor return process
34 E. INDIRECT [***] PROCESS. The process relating to [***] pharmaceutical [***] is described in the Section 10(b) Disclosure Schedule. The following process applies to all other [***] manufacturer or supplier [***]. If CVS [***] has a [***] with a manufacturer or supplier and CVS reasonably believes such manufacture or supplier [***] to [***], then CVS will [***] from [***] to [***] in the amount of such funds. Cardinal may, at its sole discretion, correspondingly [***] from [***] Cardinal [***] to such [***]. CVS and Cardinal will be responsible to maintain detailed support documentation for any [***] request and will make such documentation, upon request, available to the requesting party. Cardinal and CVS will not allow [***] if such [***] are not supported by detailed documentation. The following terms and conditions apply to the indirect [***] process: a. CVS will [***] which CVS reasonably believes are to CVS by certain vendors with which [***] has a [***]. Cardinal may, at its sole discretion, correspondingly [***] from [***] Cardinal [***] to such manufacturer or supplier. b. CVS and Cardinal will notify each indirect manufacturer or indirect supplier of their relationship as customer/wholesaler. CVS will instruct each indirect manufacturer or indirect supplier to issue any and all credits to Cardinal for any and all amounts owed to CVS. From time to time, CVS may identify a need to process a [***] a specific [***] for which Cardinal [***], in these cases, CVS will [***] a [***] against [***] to Cardinal for all [***] reasonably [***]. Upon request, CVS will provide Cardinal with documentation (either in paper or electronic format) to substantiate [***]. This documentation may exclude pricing information if such information is deemed to be confidential information, as reasonably determined by CVS. c. Cardinal, at its sole discretion, will [***] such [***] from the applicable manufacturer's account. d. CVS and Cardinal will work together to mutually resolve any [***]. F. WAREHOUSE SERVICE LEVEL. Cardinal and CVS recognize the importance of maintaining adequate inventory of all CVS warehoused items, without compromising the inventory management objective embedded in this Agreement. To that end, Cardinal will provide CVS with a [***]% service level ("WAREHOUSE SERVICE LEVEL") ("WSL"). The WSL [***]% service level shall be defined as the aggregate [***] service level from the CVS Pharmacy DCs to the CVS Pharmacies, excluding [***] items, to be calculated on a [***] basis. The service level will be calculated using the following formula: [Total of CVS [***] items shipped [***] (excluding [***])][Total of CVS [***] (excluding [***]] This service level commitment is inclusive of any [***] or [***]. 35 The Warehouse Service Level shall be maintained with the aggregate number of inventory [***] in each of the CVS Pharmacy DCs to not exceed CVS' [***] as provided to Cardinal by CVS. Execution of the Warehouse Logistics Program detailed in Section 12 Disclosure Schedule will not negatively impact CVS' WSL, safety stock levels, or CVS'Rx Products. With respect to the WLP (as defined in Section 12 Disclosure Schedule) if CVS notifies Cardinal that the aggregate WSL to the CVS Pharmacy DCs through the WLP during any month is less than [***]%, then Cardinal will promptly use reasonable efforts to work with CVS to remedy its ordering practices to meet its service level commitments. Additionally, Cardinal commits to developing an out of stock solution "STOCKING INITIATIVE" by June 30, 2004 that will lead to a significant reduction in [***] at CVS Pharmacy DCs and Pharmacies. 36 SECTION 2(C) DISCLOSURE SCHEDULE SPECIALLY STOCKED MERCHANDISE As of January 1, 2004, Cardinal is not carrying any Specially Stocked Merchandise on CVS' behalf. 37 SECTION 3(A) DISCLOSURE SCHEDULE PHARMACIES PURCHASE PRICE PHARMACY MINIMUM VOLUME REQUIREMENTS. During the term of this Agreement (January 1, 2004 through June 30, 2008), the Pharmacies' aggregate purchases of generic Rx Products will meet or exceed $620 million (collectively referred to herein as the "PHARMACY MINIMUM VOLUME REQUIREMENT"). During Cardinal's quarterly business review, Cardinal will provide CVS with purchasing information to substantiate the Pharmacy Minimum Volume Requirement performance. COST OF GOODS FOR STORE RX PURCHASES AND STORE OTHER PURCHASES CVS will pay to Cardinal a Cost of Goods for Store Rx Purchases and Store Other Purchases as follows: Rx Products (FDB branded) [***]% CVS Formulary Generics [***] All other Generics [***] or "[***] Retail", [***] Home Health Care/DME "[***] Retail", [***] HBC/OTC "[***] Retail" [***]% Repackaged Merchandise "[***] Retail" [***]%
For the purpose of this Agreement "[***] Retail" shall mean CVS will [***] offered by Cardinal to a retail customer in the [***] CVS (i.e. a [***] retail [***] or [***] with a minimum [***] approximately [***] to that of CVS and approximately the [***] as CVS) for all Merchandise for which a purchase order has been issued as of the date the Merchandise was offered to a third party for such [***]. The prices of a purchase order shall be deemed automatically revised (by Cardinal to CVS) to equal the [***] at which Cardinal shall have sold or shall have offered such product to such a retailer. CII orders must be shipped [***]% complete and courier must [***] when order is received and checked in by CVS. CVS reserves the right to refuse any CII order that contains any shipping errors. All Merchandise being delivered from Cardinal to CVS Pharmacies must have at least [***] ([***]) months [***]. Under no circumstances will Merchandise be delivered to Pharmacies with [***] than [***] ([***]) months [***] remaining without expressed written approval by CVS' Vice President of Pharmacy Merchandising for each occurrence. Furthermore, Cardinal represents that it is, and will continue to be during the term of this Agreement, an industry leader in implementation of processes, practices and safeguards to prevent the distribution of Merchandise will less than [***] ([***]) months [***] remaining to Pharmacies. The foregoing Cost of Goods does not apply to Merchandise which is subject to a Manufacturer Contract, which will instead be priced at the CVS contract price for the 38 Pharmacies. Cardinal reserves the right to adjust the Cost of Goods of any item of Merchandise in the event that the manufacturer of such item implements a change in policy which eliminates or decreases the [***] effective on the Commencement Date with respect to such item. The adjustment to the Cost of Goods for such item will be equal to the decrease (or elimination) of the [***]. 39 SECTION 3(B) DISCLOSURE SCHEDULE COST OF GOODS FOR BROKERAGE PURCHASES CVS will pay to Cardinal its Brokerage Cost with respect to all Brokerage Purchases. "BROKERAGE COST" means the [***] for such Rx Product as of CVS' PO date. CVS will also receive applicable [***] and the benefit of applicable [***] offered by manufacturers to CVS (except as set forth in the Section 12 Disclosure Schedule) on its Brokerage Purchases at the time the manufacturer accepts Cardinal's order. 40 SECTION 3(C) DISCLOSURE SCHEDULE PHARMACY SITE INCENTIVE Pharmacies will be eligible for the following Cost of Goods adjustment based upon the [***] qualified monthly purchases per Pharmacy during a calendar [***] (the "PHARMACY SITE INCENTIVE"):
[***] QUALIFIED MONTHLY INVOICE COST COST OF GOODS NET COST OF GOODS PURCHASES PER PHARMACY OF GOODS ADJUSTMENT AFTER ADJUSTMENT - ----------------------- ------------ ------------- ----------------- $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] + [***]% [***]% [***]%
If CVS' [***] qualified monthly purchases per Pharmacy during a calendar quarter is less than $[***], a Cost of Goods adjustment will be mutually determined at a percentage that is greater than the next category Cost of Goods adjustment. At the end of each calendar quarter, Cardinal and CVS will evaluate CVS' [***] qualified monthly purchases per Pharmacy during such quarter (i.e., Store Rx Purchases and Store Other Purchases only) of all Pharmacies divided by the [***], adjusted as appropriate to reflect any additional or deleted Pharmacies). Payment will be paid to CVS in the form of a credit so that CVS receives such credit within [***] ([***]) days from the close of said [***]. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. The Pharmacy Site Incentive Payment calculation will be made as follows: Cardinal and CVS will evaluate CVS' [***] qualified monthly purchases per Pharmacy during a calendar [***]. Utilizing this calculation Cardinal and CVS will determine which tier to utilize for the payout calculation. For example, during a calendar [***], CVS' [***] qualified monthly purchases per Pharmacy was $[***], then CVS' Pharmacy Site Incentive (additional Cost of Goods adjustment) will be Cardinal's [***] an additional [***]%. Conversely, if CVS' [***] qualified monthly purchases per Pharmacy was $[***] during a calendar [***], then CVS' additional Cost of Goods adjustment would be Cardinal's [***] an additional [***]%. In addition, if CVS [***] a material [***] of Pharmacies which would place CVS' qualified monthly purchases per Pharmacy into a different Pharmacy Site Incentive volume category, then CVS may elect to notify Cardinal prior to Cardinal [***] Pharmacies, and ask Cardinal [***] these Pharmacies for the [***] ([***]) month period 41 following the date of acquisition for purposes of calculating the Pharmacy Site Incentive [***] only. If CVS does not notify Cardinal prior to Cardinal servicing such Pharmacies or CVS does not ask Cardinal to [***] such Pharmacies from the calculation of the Pharmacy Site Incentive, then such Pharmacy or Pharmacies will be subject to the terms and conditions of this Agreement. The Pharmacy Site Incentive is a "discount or other reduction in price" as such term is used under section 1128(B)(3)(A) of the Social Security Act, 42 U.S.C. 1320a-7b(b)(3)(a). CVS will disclose the Pharmacy Site Incentive and any other "discounts or other reductions in price" received by CVS from Cardinal under any state or federal program which provides cost or charge-based reimbursement to CVS for the Merchandise purchased by CVS under this Agreement. 42 SECTION 4 DISCLOSURE SCHEDULE PAYMENT TERMS STORE RX PURCHASES AND STORE OTHER PURCHASES. (i) Payment Term. Not later than the [***] of each [***], CVS will cause Cardinal to receive payment in full by ACH for all Merchandise delivered and services performed during the immediately preceding [***] (i.e., [***]). (ii) Form of Remittance. Each payment by CVS to Cardinal will be accompanied by a remittance in a form deemed acceptable to Cardinal and CVS (EDI 820 format). (iii) Late Payment; Finance Charges. At the end of each calendar quarter, Cardinal will evaluate CVS' payment history based on weighted average payment days in accordance with the table set forth below, adjusted to reflect legitimately disputed amounts (such as duplicative invoices and incorrect billing information). CVS and Cardinal acknowledge that CVS' Cost of Goods is based upon CVS achieving weighted average payment days of [***] days sales outstanding. CVS will pay Cardinal for late payment an amount equal to [***]% (an effective annual percentage rate of [***]%) per weighted average payment day that CVS' payments are late (i.e., where CVS' weighted average payment days are greater than [***]), up to [***] ([***]) days, calculated in accordance with the formula set forth below. CVS will pay Cardinal a penalty for late payment an amount equal to [***]% (an effective annual percentage rate of [***]%) per weighted average payment day, from the first day, that CVS' payments are late in excess of [***] ([***]) days (i.e., where CVS' weighted average payment days are greater than ). Cardinal will pay CVS for early payment an amount equal to [***]% (an effective annual percentage rate of [***]%) per weighted average day CVS' payments are early (i.e., where CVS' weighted average payment days are less than [***]). Notwithstanding the foregoing, no payment will be made either by CVS or Cardinal in the event that CVS' weighted average payment days are greater than but equal to or less than [***] (i.e., [***]). For example:
ACTUAL WAPD (CREDIT) CALENDAR AMOUNT REQUIRED DURING WAPD ADJUSTMENT /DEBIT TO QUARTER PAID WAPD QUARTER VARIANCE FACTOR CVS - -------- ------ -------- ------- -------- ---------- --------- 1st [***] [***] [***] [***] [***] [***] 2nd [***] [***] [***] [***] [***] [***] 3rd [***] [***] [***] [***] [***] [***] 4th [***] [***] [***] [***] [***] [***]
Cardinal will deliver to CVS an analysis of CVS' payment history in aggregate format, or other mutually acceptable format, on a weekly basis for informational purposes (i.e., to assist CVS in managing its payment compliance). If the above calculation indicates that CVS owes Cardinal, then CVS will pay Cardinal such 43 amounts within [***] ([***]) days from the date of Cardinal's invoice for such amounts. If the above calculation indicates that Cardinal owes CVS, then Cardinal will pay CVS such amounts in the form of a credit memo to be used toward future purchases of Merchandise from Cardinal within [***] ([***]) days following the end of the applicable quarter. The parties may, but will not be obligated to, agree to a payment arrangement whereby CVS may make [***] on some [***] and [***] on other [***] (among other terms). In such event, no penalty (other than that to which the parties mutually agree) will be assessed on the agreed upon late payments, and no payment will be made to CVS relating to the agreed upon early payments (other than that to which the parties mutually agree), as long as payments are made when due in accordance with the agreed upon schedule. BROKERAGE PURCHASES. CVS will cause Cardinal to receive payment in full for all Brokerage Purchases that are not filled by product from Cardinal's [***] not later than [***] ([***]) days prior to the date upon which Cardinal would be required to pay the manufacturer's invoice to achieve a cash discount pursuant to the manufacturer's then-standard stated payment terms. If payment is due on Saturday, CVS will cause Cardinal to receive payment in full on the immediately preceding [***], and if payment is due on Sunday, CVS will cause Cardinal to receive payment in full on the immediately following [***]. CVS will cause Cardinal to receive payment in full for all Brokerage Purchases that are filled by product from Cardinal's [***] not later than [***] ([***]) days after the date of the invoice (invoice date will equal ship date) for such product. Notwithstanding the above paragraph, Cardinal and CVS agree to adjust payment terms for Brokerage Purchases in order to accommodate operational efficiencies of CVS purchasing [***] as a result of the Warehouse Logistics Program as detailed in Section 12 Disclosure Schedule. Cardinal and CVS agree and acknowledge that timely payment is a material and critical part of this Agreement and Cardinal's pricing to CVS along with CVS' willingness to enter into such an Agreement. Accordingly, in the event Cardinal or CVS identifies that payments, rebates, funding or incentives are not received when due under this Agreement, Cardinal or CVS will notify the other of such payment problems, and the offending party will ensure that timely payment is made thereafter. If the problem is not cured to Cardinal's or CVS' satisfaction, then such party will bill back to the offending party for such amounts and any corresponding late payment finance charge, as further described below, that applies to such late payment. Notwithstanding the foregoing, CVS or Cardinal will remain responsible to make payments, rebates, funding or incentives when due under this Agreement. Any delay or failure by Cardinal or CVS to notify the other party as provided above will not relieve CVS or Cardinal of such obligations. Cardinal and CVS will work together in obtaining full value for such concealed shortages or damaged Merchandise as further set forth in the indirect [***] process described in Section 2(b) Disclosure Schedule. Further, CVS and Cardinal will be responsible to maintain detailed support documentation for any [***] or [***] request and will make such documentation, 44 upon request, available to the requesting party. Cardinal and CVS will not [***] if such [***] are not supported by detailed documentation. With respect to Brokerage Purchases only, CVS will pay a late payment finance charge calculated at the rate of [***]% per month (or the maximum rate allowed by law, if such rate is less than [***]% per month) on any amount not paid by CVS to Cardinal when due (other than legitimately disputed amounts) under the terms of this Agreement from the first (1st) day of delinquency until such amount is paid in full. Failure or delay by Cardinal to bill CVS for any such late payment finance charge will not waive Cardinal's right to receive the same. With respect to all payments, rebates, funding, or incentives due CVS, Cardinal will pay a late payment finance charge calculated at the rate of [***]% per month (or the maximum rate allowed by law, if such rate is less than [***]% per month) on any amount not paid by Cardinal to CVS when due (other than legitimately disputed amounts) under the terms of this Agreement from the first (1st) day of delinquency until such amount is paid in full. Failure or delay by CVS to bill Cardinal for any such late payment finance charge will not waive CVS' right to receive the same. The parties may, but will not be obligated to, agree to a payment arrangement whereby CVS may make [***] on some [***] and on other [***] (among other terms). In such event, no penalty (other than that to which the parties mutually agree) will be assessed on the agreed upon late payments, and no payment will be made to CVS relating to the agreed upon early payments (other than that to which the parties mutually agree), as long as payments are made when due in accordance with the agreed upon schedule. 45 SECTION 6(A) DISCLOSURE SCHEDULE CARDINAL COMPUTER SERVICES PRICE SCHEDULE CARDINALCHOICE(R)-HQ
CVS' Cost ------------------- Hardware Estimate [***] Cost of Goods Upgrades [***] Cost of Goods Software Initialization Version 2.1 [***] Cost of Goods Version 3.0 [***] Cost of Goods Upgrades and new releases and enhancements [***] Cost of Goods Support Help Desk & Maintenance [***] Cost of Goods
Cardinal will make available to all CVS' locations (Pharmacies, CVS Pharmacy DCs, and support locations) Cardinal.com. CVS may access Cardinal.com, a healthcare internet web portal, [***], during the term of this Agreement. Cardinal will assist in the transitioning of CVS locations to Cardinal.com by making reasonable changes to their web portal, limiting access to CVS proprietary information, and providing additional support as needed, [***]. In-stock visibility to CVS Pharmacies to be implemented by January of 2004 or as soon as [***]' systems can support [***]. 46 SECTION 6(B) DISCLOSURE SCHEDULE BASE SERVICE PACKAGE
PROGRAMS & SERVICES FREQUENCY - ------------------- ----------------------------------- EOE Machines One per store Custom Invoices With each order Custom Price Stickers With each order Auto [***] and Package [***] Program Ongoing Auto Repack [***] Program Ongoing Microfiche Service Once per quarter, upon CVS' request Catalog Once per quarter, upon CVS' request
REPORTS FREQUENCY - ------- ----------------------- Category Purchase Summary Monthly, upon request Item Purchases Report Monthly, upon request Rx Velocity Report - Top 200 Items Quarterly, upon request Generic Purchase Report Quarterly, upon request Price Change Notification Weekly, upon request Controlled Substance Variance Report Monthly, upon request Ad Hoc Reports Daily, upon request
BASE PACKAGE FEE: NO ADDITIONAL CHARGE (included in Cost of Goods) 47 SECTION 6(D) DISCLOSURE SCHEDULE EMPLOYEE FUNDING Cardinal will partially fund the cost of a CVS DSD Manager ("EMPLOYEE") who will serve as an intermediary between Cardinal and CVS specifically related to the management of the Store Rx Purchases. It is understood that the Employee shall be employed solely by CVS and that the Employee's salary and other employment benefits shall be the sole responsibility of CVS. CVS agrees to indemnify and hold Cardinal harmless for all claims and liabilities, whether alleged or actual, relating to the Employee. Cardinal will provide for the funding of this Employee pursuant to the schedule defined below: [***] $[***]
48 SECTION 6(E) DISCLOSURE SCHEDULE PROFITPAK(R) PROGRAM The ProfitPak(R) program allows CVS Pharmacies to purchase selected Rx Products at a savings compared to the manufacturer equivalent package size on a DSD basis. These Rx Products have been acquired from a division of Cardinal Health registered with the Food and Drug Administration ("FDA"), that repackages Rx Products from a larger quantity or bulk containers into smaller quantities. Rx Products are repackaged into FDA approved bottles with original lot numbers, manufacturer NDCs, and expiration dates. Cost savings are driven by the difference in pricing between the bulk size and the equivalent in a smaller package size. Depending on difference in pricing by item, Cardinal establishes a discount percentage that is applied to the smaller equivalent package size. CVS' Cost of Goods is also factored into the price of the repackaged Rx Product to further maximize savings. For example: The brand price for Product A, 30's is $[***]. In reducing this price to reflect CVS' Cost of Goods adjustment ([***]%) the final brand [***] price would be $[***]. Assuming the ProfitPak price for this item is $[***], there in reducing this price to reflect CVS' Cost of Goods adjustment ([***]%), the final ProfitPak invoice price would be [***]. The difference between the net manufacturer product ($[***]) and the net ProfitPak price ($[***]) is $[***] ("REPACK SAVINGS"). In order to maximize overall efficiency and profitability Cardinal will not ship any ProfitPak item which does not appear in the CVS Authorized [***] as amended from time to time by CVS. CVS' Authorized [***] as of execution of this Agreement is detailed below. Cardinal will also maintain the [***] CVS [***] as it relates to ProfitPak items and detailed within Section 6(e) Disclosure Schedule. As part of this program, Cardinal will invoice CVS' Pharmacies at the [***] for such Rx Product as of CVS' PO date for all ProfitPak items purchased by Pharmacies. Then on a [***] basis payment will be paid to CVS in the form of a credit so that CVS receives such credit within [***] ([***]) days from the close of said [***]. The credit will be mailed in hard copy form to CVS' Manager of Wholesaler Programs Cardinal will provide CVS with funding equal to the cumulative Repack Savings related to all ProfitPak items. Such credit will be accompanied by a report detailing CVS' Repack Savings for said [***]. The accompanying report will include but not be limited to: label name, manufacturer, CVS item number, NDC, quantity, branded WAC, Branded net cost, Repack net cost, incremental unit savings, and incremental total savings. 49 CVS AUTHORIZED REPACK PORTFOLIO. CVS' REPACK PORTFOLIO AS OF 12/1/03
LABEL NAME MANUFACTURER ITEM NUMBER NDC ---------- ------------ ----------- --- AUTHORIZED WAREHOUSE ITEMS [***] [***] [***] [***] [***] AUTHORIZED DSD ONLY ITEMS [***] [***] [***] [***] [***]
REPACK SUBSTITUTION. - -------------------- [***] [***] 50 SECTION 7(A) DISCLOSURE SCHEDULE CVS GENERIC ITEM AND PACKAGE SIZE [***] LOGIC [***] UNIT [***] PACKAGE SIZE [***]. [***] PACKAGE SIZE [***] QUANTITY ADJUSTMENT. CVS requires the ability to adjust (up or down) the quantity of product our stores receive. This adjustment will be made on an NDC by NDC basis and will include a Threshold Quantity and an Adjustment Percentage. Both the Threshold Quantity and Adjustment Percentage can be set to any value CVS deems appropriate [***] If [***] Ship [***] If [***] then: [***] [***] must then be rounded up to the nearest whole unit. EXAMPLE: CVS has instructed Cardinal to apply the following Quantity Adjustment to NDC 55555-4444-22: [***] After going through the Substitution Logic and the Package [***] Formula, it has been determined that [***] units of NDC 55555-4444-22 should be sent to a store. The following Quantity Adjustment must then take place: [***][***][***][***] [***] [***] [***] [***], CARDINAL WILL SHIP [***] UNITS INSTEAD OF THE ORIGINAL [***] UNITS. 51 SECTION 7(B) DISCLOSURE SCHEDULE [***] WRAP-AROUND REBATE FOR THE PHARMACIES CVS will be eligible for the following discount on the Pharmacies' [***] Rx Product purchases ("[***] WRAP-AROUND REBATE"):
[***] QUALIFIED ANNUAL PURCHASES OF [***] RX PRODUCTS BY THE PHARMACIES PER PROGRAM YEAR (000) REBATE - ----------------------------------------- ------ $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***]+ [***]%
Cardinal will provide CVS with a monthly report detailing the Pharmacies' aggregate qualified monthly purchases of [***] Rx Products to date. At the end of each Program Year, Cardinal and CVS will evaluate CVS' aggregate qualified annual purchases of [***] Rx Products by the Pharmacies during such Program Year. The [***] Wrap-Around Rebate will be equal to a percentage (as set forth in the table above) of CVS' aggregate qualified annual purchases of [***] Rx Products by the Pharmacies during the applicable Program Year. The [***] Wrap-Around Rebate, if any, will be calculated and paid to CVS in the form of a credit so that CVS receives such credit within [***] ([***]) days from the close of said Program Year. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. In the event that the [***] Wrap-Around Rebate will not be paid for any reason, Cardinal will use reasonable efforts to give CVS notice no later than [***] ([***]) days prior to the end of the then-current Program Year. The [***] Wrap-Around Rebate is a "discount or other reduction in price" as such term is used under section 1128(B)(3)(A) of the Social Security Act, 42 U.S.C. 1320a-7b(b)(3)(a). CVS will disclose the [***] Wrap-Around Rebate and any other "discounts or other reductions in price" received by CVS from Cardinal under any state or federal program which provides cost or charge-based reimbursement to CVS for the Merchandise purchased by CVS under this Agreement. 52 SECTION 9 DISCLOSURE SCHEDULE PHARMACIES SERVICE LEVEL Cardinal will exercise best efforts to provide the Pharmacies with the following average aggregate monthly Adjusted Service Level and Overall DSD Service Level (as defined within this disclosure schedule), calculated monthly as described below: (a) [***]% adjusted with respect to [***] Rx Products; (b) [***]% adjusted with respect to CardinalSOURCE(SM) [***]drugs; (c) [***]% adjusted with respect to the CVS [***]; and (d) at a percentage to be mutually agreed upon by the parties with respect to home health care products (the "SERVICE LEVEL COMMITMENT"). CVS GENERIC FORMULARY SERVICE LEVEL. For purposes of this Agreement, "ADJUSTED SERVICE LEVEL" for CVS [***] Formulary items during any particular [***] will be calculated using the following formula: [[***] of CVS [***] formulary (which includes [***] Rx Products and certain other products [***]) by NDC (eleven digit) shipped] [***] ([***] NDC's [***] shipped within the same [***] as defined by FDB [***] Authorized Adjustments). All orders submitted to Cardinal will be included in the Adjusted Service Level calculation, including, but not limited to: store telxon orders, [***] orders, [***] orders, verbal orders, and CII orders. The following items of merchandise are excluded from the Adjusted Service Level calculation and in aggregate constitute all "AUTHORIZED ADJUSTMENTS": 1. Validated long-term backorders - long-term backorders will only be considered valid upon agreement between Cardinal and CVS that said supplier is unable to provide Cardinal with merchandise necessary for Cardinal to maintain an adequate inventory position. Cardinal will verbally communicate any long term back order situations for which an adjustment to the service level calculation is requested to CVS' Assistant Category Manager - [***], in the event that person is unavailable, Cardinal will notify the Director, Category Management - [***]. Notification to CVS should only be made after Cardinal has exhausted all avenues to resolve such product shortage on its own. Upon notification from Cardinal, CVS will contact the respective supplier to validate the long term backorder status of said product or assist Cardinal with securing adequate inventory. Upon CVS receiving validation from supplier of a long term backorder status or said supplier's inability to ship the related product, the affected products will be considered an Authorized Adjustment. Only CVS validated long term backorders or CVS validated circumstances where a supplier is unable to ship the products in question will be considered in the Adjusted Service Level calculation. Each month Cardinal will provide a list detailing the agreed upon items to be excluded from CVS' Adjusted Service Level calculation and the number of units to be adjusted. 53 2. CVS specific do-not-substitute requests - CVS may specifically request that no substitution be performed for specific items; CVS' Assistant Category Manager - [***] will notify Cardinal in writing of these items. In addition, individual CVS stores may place verbal orders to Cardinal; if the Pharmacy specifically requests (phone in orders without a documented detailed specific request by CVS will not be considered an Authorized Adjustment) Cardinal not to perform a substitution for a specific item, then said item will be considered an Authorized Adjustment. Cardinal will provide CVS on a monthly basis a report by item of the number of store specific do not substitute requests to include but not be limited to: CVS store number, NDC, item description, date, and quantity. Reports should be provided no later than five (5) days following the close of the respective month. 3. Excessive demand - an adjustment to the Adjusted Service Level will be allowed in validated cases where an items total month's GCN usage has increased at least [***]% above the average monthly GCN demand for the previous [***] ([***]) months or CVS' [***] formulary forecast as provided from time to time, which ever is greater. Adjustment amount will only be for the number of units surpassing the applicable baseline. For example, if the average monthly demand for the prior [***] ([***]) month period is equal to [***] units per month, Authorized Adjustment will only be given for orders surpassing [***] units (([***]%) + [***]) during that month. Cardinal must provide CVS with reporting detailing the applicable baseline usage figure and the current month usage figure to be eligible for the adjustment. Increase in usage is determined by global CVS usage. 4. Non-previously stocked items - CVS at its discretion can choose to adjust the CVS [***] Formulary for additions, deletions, change in supplier, change in package size, etc. CVS commits to the timely notification of all such changes in an electronic format; in addition, on a monthly basis CVS will provide an updated complete CVS [***] Formulary. Cardinal will make available to CVS non-previously Cardinal stocked items within [***] ([***]) days from notification. [***] service level calculation will be adjusted for the [***] ([***]) day period following CVS notification, during which Cardinal may service CVS stores using the previous formulary item if applicable. Cardinal's average monthly Adjusted Service Level commitment for CVS will become effective as of January 1, 2004, however, CVS will not be eligible for [***] until June 1, 2004. Both Cardinal and CVS agree the achievement of the [***]% Adjusted Service Level on a monthly basis represents a material aspect of this Agreement. Failure by Cardinal to maintain a monthly Adjusted Service Level of [***]% with respect to the CVS [***] Formulary (which includes Schedule II Rx Products and certain other products as CVS designates) (a "[***] SERVICE LEVEL FAILURE") will entitle CVS to be [***] for its [***] (as defined herein). For purposes of this Schedule 9 Disclosure Schedule, the term "[***]" means an amount equal to the difference between the [***] for the month and 54 [***]% multiplied by [***] for the month multiplied by [***]percent ([***]%). CVS will calculate and present [***], if any, to Cardinal before processing any financial transaction related to any funds being owed to CVS in connection with [***]. For example, if the [***] Service Level is calculated at % for any given month, and the monthly [***] for that month was $[***], then CVS may process [***] for $[***] after notifying Cardinal of such transaction (([***]%-[***]%) x $[***] x [***]%). Cardinal and CVS agree to meet at CVS' Support Center as necessary to review the Adjusted Service Level performance and to use best efforts in order to maximize CVS' Adjusted Service Level defined within this Section 9 Disclosure Schedule. BRANDED RX PRODUCTS AND STORE OTHER PURCHASES -DSD SERVICE LEVEL. Cardinal recognizes the significant impact of branded Rx Products and Store Other Purchases service level ("OVERALL DSD SERVICE LEVEL") can have on CVS' ability to service their customers. Therefore, both Cardinal and CVS agree that the Overall DSD Service Level is material to this Agreement. To that end, Cardinal and CVS will mutually agree to terms that will reflect the significance of Overall DSD Service Level. The terms will be specific towards each party's responsibilities, the calculation of Overall DSD Service Level, and remedies up to and including [***]. CVS and Cardinal agree that the arrived at structure of the Overall DSD Service Level will provide CVS with industry leading performance commitments. 55 SECTION 10(A) DISCLOSURE SCHEDULE PHARMACIES MERCHANTABLE PRODUCT ONLY RETURN GOODS POLICY GENERAL POLICY. The parties acknowledge that returns are costly to both parties. Product in "merchantable condition" (as defined below) may generally be returned to Cardinal from which the product was originally purchased if the return is made within the timeframes and subject to the terms and conditions described below: The return of [***] product is detailed in Section 10(b) Disclosure Schedule.
RETURN MADE WITHIN: NORMAL CREDIT AMOUNT: - ------------------- --------------------- 1 - 90 Days from Invoice Date [***]% of original invoice amount paid by customer. This policy covers all ordering/filling errors. More than 90 Days [***]% of original contract or other "cost" paid by customer (i.e., not including any [***] and not to [***]) [***] a [***]% restocking fee invoiced seperately to net at [***]%.
Merchandise will be considered to be in "MERCHANTABLE CONDITION" except for the following: A. Any item which has been used or opened, is a partial dispensing unit or unit of sale, is without all original packaging, labeling, inserts, or operating manuals, or that is stickered, marked, damaged, defaced, or otherwise cannot readily be resold by Cardinal for any reason. B. [***]-dated (less than [***] ([***]) months expiration dating, unless received by CVS with less than [***] ([***]) months dating), outdated, or seasonal product and items purchased on a "special order" basis, including non-stock and dropship items. C. Any [***] merchandise, unless Cardinal agrees and is specially assured that such merchandise was properly stored and protected at all times and such merchandise is returned separately in a package marked as such and accompanied by a separate credit request form. D. In order for CVS to achieve compliance with Cardinal's excess returns policy, CVS will return product (in Merchantable Condition) to Cardinal only if such product is not stocked in the CVS Pharmacy DCs (excluding [***] or [***] that is delivered to CVS [***] or [***]). Further, CVS agrees that Cardinal may implement an [***] of the return of items which are stocked in the CVS Pharmacy DCs, as indicated in the CVS monthly on-hand inventory electronic report provided to Cardinal by CVS. CONTROLLED SUBSTANCES. Credit for the return of controlled substances requires a separate Merchandise Return Authorization Form ("MRA FORM") and must comply with all federal and state procedures and requirements in addition to the terms and conditions described herein. 56 SHORTS AND DAMAGED MERCHANDISE. Claims of order shortages (i.e., invoiced but not received), order errors and damage must be reported within [***] ([***]) business days from the applicable invoice date. Controlled substance shortage claims must be reported immediately per DEA requirements. EXCESS RETURNS. CVS Pharmacy returns in dollars will not exceed [***] percent ([***]%) of qualified monthly purchases of all of the Pharmacies (in dollars, each calendar month) excluding filling errors or damaged product. Because CVS agrees only to [***] product to Cardinal if such product is not stocked in the CVS Pharmacy DCs (excluding [***] or [***] that is delivered to CVS [***] or [***] Rx Products [***]), CVS and Cardinal mutually agree that Cardinal will implement an [***] of the return of those items which are included in the CVS monthly on-hand inventory electronic report provided to Cardinal by CVS. This [***] is designed to limit returns in excess of [***]%. CVS and Cardinal may agree from time to time to implement a Pharmacies [***] in cases where CVS Pharmacies are [***] inventory. The parties will agree to the terms of such a [***] on an individual basis. Returns made under the [***] will not be included in the excess returns calculation. ONGOING ASSURANCE AND CARDINAL CREDIT REQUEST FORM. Prior to returning any product to Cardinal, each customer must execute and deliver to Cardinal an Ongoing Assurance verifying that all returned merchandise has been kept under proper conditions for storage, handling, and shipping. All requests for credit must be submitted via EOE, on the CardinalCHOICE(R) system or by approved EDI interface. A fully completed MRA must accompany all merchandise to be returned. A fully completed form includes, but is not limited to, the following information: the invoice number and invoice date for the merchandise to be returned. All return credit memos will have corresponding reference numbers that will provide CVS with a complete audit trail for reconciliation. SHIPPING OF RETURN GOODS. Return merchandise must be placed in a proper shipping container and, for merchandise valued at more than $250, signed for by the driver when the product is picked up. All MRAs will be reviewed by Cardinal for compliance with the returned goods policy within this Section 10(a) Disclosure Schedule. Cardinal will process credits within [***] ([***]) days of receipt of merchantable product from CVS. In instance were credit has not been received for product returned to Cardinal for which Cardinal has no record of said return, CVS and Cardinal will use reasonable efforts to research and reach a mutually acceptable resolution. 57 MONTHLY REPORTING. Cardinal will provide an electronic report on a monthly basis, which will detail (1) CVS' excess return percentage, (2) claims of order shortages, order errors and damaged products that are reported in excess of three (3) business days from invoice date, (3) information relating to returns in excess of [***] ([***]) days, and (4) any restocking fees. OTHER RESTRICTIONS. This policy is further subject to modification as may be deemed necessary to comply with applicable federal and/or state regulations, FDA guidelines, and state law. 58 SECTION 10(B) DISCLOSURE SCHEDULE THIRD PARTY [***] POLICY The process relating to all other indirect manufacturer or supplier [***] is described in the Section 2(b) Disclosure Schedule. The following process applies to [***] pharmaceutical [***]: GENERAL POLICY. The following process applies to [***] pharmaceutical [***] ([***] etc.) that are often [***] through a [***]. If CVS no longer [***] with a manufacturer or supplier and CVS reasonably believes such manufacturer or supplier [***] (as determined by [***]), then CVS and Cardinal will follow the process detailed below to ensure CVS [***] the appropriate [***] CVS. CVS and Cardinal will be responsible to maintain detailed support documentation for any [***] or [***] and will make such documentation, upon request, available to the requesting party. Instead of [***] all indirect manufacturer or supplier (warehoused or non-warehoused) [***] to Cardinal for [***], CVS will first attempt to [***] to which CVS [***] it is [***] to [***] for the [***] through the process outlined within this disclosure schedule. CVS' [***] as in effect from time to time will be the basis of [***] all of CVS' [***] pharmaceutical [***]. Product may be [***] to those [***]: (a) with which Cardinal has a current relationship, (b) are not either insolvent or subject to a petition in bankruptcy, or (c) which do not have an [***] Cardinal at the date on which such [***] is submitted for [***]. If CVS elects to utilize a [***], product may only be [***] through a [***] that agrees to communicate with Cardinal via EDI or other mutually acceptable electronic format ("THIRD PARTY") in accordance with the terms and conditions described in this policy. CVS may decide at its own discretion the most efficient process to [***] to indirect manufacturers or suppliers or Cardinal, if applicable. Any Third Party selected by CVS must enter into a confidentiality agreement, in a form mutually acceptable to Cardinal and CVS, prior to accepting any returns from CVS. PROCEDURES FOR [***]. CVS and Cardinal will notify each pharmaceutical manufacturer or supplier of their relationship as CVS/wholesaler. CVS will send all [***] under this policy to its selected [***], if applicable. The [***] will identify the amount to which CVS believes it is [***] in exchange for [***]. CVS will instruct the [***] to provide Cardinal with documentation (in electronic format) to substantiate each [***] submitted to pharmaceutical [***] on [***] of CVS. CVS will instruct each pharmaceutical [***] to [***] any and all [***] or [***] for merchandise that was purchased by CVS and is [***] through a [***], and to reference the [***] corresponding to the [***] prepared by the [***]. CVS and Cardinal acknowledge that CVS will handle, [***], all matters relating to [***] to pharmaceutical manufacturer or supplier with which [***]. 59 CVS will pay the [***] for all of such [***] fees relating to [***] hereunder, including, but not limited to, [***] fees, [***], delivery and [***] fees, reporting, EDI transactions, which will be CVS' sole responsibility. CVS' account will be adjusted in accordance with the following procedure: 1) Once per week, Cardinal will [***] CVS' [***] with the [***] CVS [***] Third Party [***] during the previous week, [***] the [***] Fee (defined below) (if applicable). Cardinal will [***] all [***] information for a minimum of [***] ([***]) years and will provide said information to CVS upon request in a mutually acceptable electronic format. 2) Cardinal will [***] CVS' [***] upon the earlier of Cardinal's [***] of an from a pharmaceutical manufacturer or supplier, or within [***] ([***]) days following the date of a [***] ([***] to be [***] within [***] ([***]) days of CVS' [***], unless otherwise directed by CVS in writing) received by Cardinal which has been submitted to a pharmaceutical manufacturer or supplier. CVS will [***] from any [***] to Cardinal, any [***] relating to the [***] of product through a [***] unless Cardinal does not [***] CVS' [***] within such [***] ([***]) day period. If Cardinal fails to [***] CVS' [***] after the [***] ([***]) day period, CVS may [***] such [***] from [***] Cardinal. Cardinal may, at its sole discretion, correspondingly [***] from [***] Cardinal [***] such manufacturer or supplier. 3) In addition, Cardinal is not [***] for [***] related to product [***] to the indirect manufacturer or supplier through such [***]. For manufacturer or supplier [***] made through a [***] to an indirect manufacturer or supplier, Cardinal should [***] these [***] to CVS for [***]. CVS' [***] process will include, but not be limited to, the following: initial [***] to review said [***], an internal financial [***] to review said [***] and the [***], a [***] with the manufacturer, and a [***] when applicable. CVS and Cardinal recognize that this general process will vary [***] with respect to the methods as well as the associated timelines. That being said, CVS takes these matters [***] and understands that they [***] and Cardinal. CVS will use all reasonable means to expeditiously resolve identified issues to the satisfaction of all associated parties. For return [***] related to product directly [***] to Cardinal, Cardinal will address directly. 4) At the end of each calendar [***], Cardinal will [***] a single [***] to CVS' [***] and CVS will [***] a [***] in the [***] of such entry. This [***] will consist of the [***] from the following detailed transactions completed in the current calendar[***]: (a) [***] or [***], plus, (b) CVS [***] by Cardinal, [***], (c) [***] of previously [***] CVS [***], for which the [***] has now [***], plus, (d) CVS [***][***] Cardinal. Cardinal will execute the appropriate [***] so that CVS [***] and [***] of CVS' [***]. Accordingly, Cardinal will process [***] and [***] in an [***] so that [***] the pharmaceutical manufacturer or supplier plus [***] and held are equal to [***]% of CVS' [***]. Cardinal may not [***] a [***] if the [***] from the manufacturer are (a) [***] or [***] of CVS' [***] or (b) if a CVS [***] has a [***] of [***] after processing [***] from a manufacturer. CVS, at its discretion, may notify Cardinal in writing in order to change either of the two [***] detailed in the preceding sentence. Cardinal will not [***] 60 any CVS [***] ([***], etc.) to any manufacturer or supplier outside of, or make any changes to, the process detailed within this disclosure schedule without first receiving written permission from CVS. Furthermore, CVS stipulates that CVS has the [***] to satisfy any necessary [***] of a CVS [***] to the extent it is deemed [***] by CVS. Therefore, Cardinal may [***] any [***] without CVS'[***]. In addition, upon Cardinal's request (as often as monthly), CVS will provide Cardinal on a confidential basis (subject to Section 17 of this Agreement) a [***] that summarizes all [***] goods [***] CVS has [***] with [***] manufacturers ("[***]"). Cardinal will not contact any [***] related to the information contained in the [***]. In return for Cardinal's strict confidentiality as it pertains to CVS' [***], CVS will [***] Cardinal [***] any [***] related to a [***] listed in the [***]. Any [***] of a [***] identified in the [***] shall be directed to CVS for [***]. CVS will not be financially responsible if Cardinal takes actions that are not consistent with this Section 10 (b) Disclosure Schedule. The [***] will not be subject to Section 16 of this Agreement; instead the following audit process will apply. Not more than once in any [***] ([***]) month period, and following [***] ([***]) days' advance written notice to CVS, Cardinal will have the right to appoint an agent(s) (as further described below) to review those relevant records applicable to such [***]. Said audit will be strictly limited to verifying the following: 1) that each [***] contained in the [***] is included in a [***], and 2) that such [***] has been executed by both [***] and the applicable [***]. No other terms or conditions contained within the [***] or any other information gained through such audit process shall be disclosed to Cardinal. Cardinal may only review records relating to the [***] through an employee of one of the top national accounting firms deemed reasonably acceptable to CVS (i.e., not a Cardinal employee). Any such review will be limited to [***] ([***]) months of historical information as of the date such review begins. The information will be subject to a confidentiality agreement prepared by CVS and signed by Cardinal and its agent(s) who will have access to the information prior to beginning the review. Notwithstanding the foregoing, Cardinal may only appoint agents who are employees of one of the top national accounting firms, as may be deemed reasonably acceptable to CVS. In addition, the parties hereby acknowledge and agree that upon reasonable written request from Cardinal, CVS shall deliver to Cardinal a good [***] of the [***] that CVS [***] may exist at the date of the [***] with respect to the [***] and [***] that Cardinal has [***] its suppliers for product that CVS purchased directly from Cardinal and subsequently [***] directly to the [***] rather than [***]. The good [***] will include the population of [***] and [***] by Cardinal that fall within the [***] ([***]) month period ending approximately [***] ([***]) days prior to the date of Cardinal's written request. The [***] provided will indicate that: (i) CVS has established [***] its potential [***] at the date of the [***], (ii) CVS will continue to establish [***] its [***] and (iii) Cardinal has, and will have, [***] on [***] contained in the [***] so long as Cardinal does not take actions that are inconsistent with the provisions of this Disclosure Schedule. If Cardinal believes it will be harmed due to manufacturer or supplier [***] related to [***], then Cardinal may at its option [***] CVS [***] of the manufacturer [***] and [***] an [***] to such manufacturer or supplier. This resolution process will be executed 61 so that the related transactions are [***] to CVS; CVS is [***] as stipulated in CVS' [***]. With that being said, CVS will work with Cardinal to [***] all [***] to the mutual satisfaction of [***] parties. 5) As long as CVS causes the [***] (if applicable) to transmit to Cardinal information required by Cardinal in an electronic format acceptable to Cardinal, then Cardinal will [***] the [***] fee of [***]% of the [***] by Cardinal from all pharmaceutical manufacturers or suppliers (the "[***] FEE"). However, due to the excessive labor expenses Cardinal will incur if the information is not transmitted in an electronic format acceptable to Cardinal, including but not limited to [***] the Cardinal [***] to CVS' [***], CVS will [***] Cardinal the [***] Fee each month until the format is corrected to Cardinal's satisfaction. In addition, Cardinal will use its reasonable efforts to notify CVS promptly if the Third Party is unable to deliver the required information in Cardinal's desired format. With the weekly credit information, Cardinal will provide CVS with a report of all manufacturer and supplier [***] and [***] during such week. As well, as often as monthly, Cardinal will provide CVS with a historical detailed [***] transaction report by [***] by [***]. Cardinal will not perform a [***] of the [***] by pharmaceutical manufacturers or suppliers as compared to the original [***]. If Cardinal [***] from a supplier who is in [***] with Cardinal, Cardinal will arrange for an [***] of such [***] CVS. [***] VENDORS. If Cardinal is unable to execute the process detailed within this disclosure schedule with any [***] or [***] for any reason, then CVS may [***] said [***] or [***] to Cardinal in accordance with [***] financial process established within this disclosure schedule. Cardinal may, at its sole discretion, correspondingly [***] Cardinal [***] to such manufacturer or supplier for said [***] or [***] said product according to its own [***] to the applicable manufacturer or supplier. With that being said, CVS will work with Cardinal to resolve all [***] to the mutual satisfaction of both parties. [***] VENDORS. CVS currently receives, based on CVS' [***] and DSD purchases, a [***] which is [***] by CVS. In the event that a vendor would begin to pass an "[***]" [***] to Cardinal, Cardinal would [***] of this [***] to CVS, based on CVS' purchases (Pharmacies and CVS Pharmacy DCs, if applicable). Notwithstanding the foregoing, Cardinal will not accept any other [***] on CVS' behalf relating to CVS' purchase [***] without CVS' expressed written consent. It will be Cardinal's sole responsibility to notify in writing any pharmaceutical supplier (with copy to CVS subject to Section 13) [***] a [***] to Cardinal related to CVS' purchase [***] that CVS utilizes its own [***]. 62 Cardinal and CVS may mutually agree to modify this [***] policy in writing from time to time, except where required by law (in which case, Cardinal or CVS may modify this [***] without mutual agreement). 63 SECTION 11(H) DISCLOSURE SCHEDULE TERMINATION FEE In the event that CVS terminates this Agreement without cause pursuant to Section 11(h) prior to the expiration of the Initial Term, then CVS will pay to Cardinal, within ninety (90) days after the date of such termination, an amount equal to [***] Dollars ($[***]) multiplied by a fraction, the numerator of which shall be the number of months between the month of such termination and the end of the Initial Term and the denominator of which shall be fifty four (54) (the "CVS Termination Fee"). In the event that Cardinal terminates this Agreement without cause pursuant to Section 11(h) prior to the expiration of the Initial Term, then Cardinal will pay to CVS an amount equal to [***] Dollars ($[***]) within ninety (90) days after the date of such termination (the "Cardinal Termination Fee"). The parties hereby acknowledge and agree that the amount of the CVS Termination Fee represents, among other factors, a [***] of [***] that Cardinal would have generated during the Initial Term of this Agreement. The parties hereby acknowledge and agree that the amount of the Cardinal Termination Fee represents, among other factors, a [***] of [***] that CVS would have realized during the Initial Term of this Agreement. Furthermore, the parties acknowledge and agree that the Termination Fees have been negotiated in good faith and is not intended to be a penalty. Finally, upon termination or expiration of this Agreement for any reason, CVS will work with Cardinal in accordance with a reasonable schedule agreed to by the parties so that all outstanding amounts due and owing to Cardinal are paid on or before the termination or expiration date and all outstanding issues are resolved. 64 SECTION 12 DISCLOSURE SCHEDULE WAREHOUSE LOGISTICS PROGRAM The goal of the "WAREHOUSE LOGISTICS PROGRAM" ("WLP") is to develop the most efficient purchasing and distribution processes for CVS with pharmaceutical manufacturers under which Cardinal will [***] ([***]%) of CVS' purchase requirements for [***] Rx Products (excluding repack items) ("[***]") [***] of all CVS [***] which are or become part of this Agreement. The parties agree and acknowledge that this WLP is part of this Agreement, and is not a separate or distinct agreement. Notwithstanding anything in this Agreement to the contrary, the WLP is intended and structured to provide [***]% incremental financial and operational value to CVS and at no time shall Cardinal take any action in connection with the WLP which may negatively impact CVS' ability to service its Pharmacies, CVS Pharmacy DCs, or CVS' abilities to secure regular [***] merchandise, including [***] stock, [***] a manufacturer. The WLP is designed to provide incremental financial value to CVS; CVS is to be [***] on [***], etc. CVS will [***] all other [***] that CVS would otherwise be entitled to if CVS [***] the [***] on a [***] (i.e., [***], etc.). As part of the WLP, Cardinal will pass to CVS funding ("INCENTIVE") in the form of a credit within [***] ([***]) days of the end of each CVS [***] equal to [***]% times CVS Pharmacy [***] (in addition to passing the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. Additionally, Cardinal will provide CVS with the Warehoused Service Level detailed in Section 2(b) Disclosure Schedule through leveraging Cardinal's procurement and logistical expertise. In return for both the Incentive and the Warehouse Service Level, Cardinal will [***] the [***] created through certain "[***] CREATION ACTIVITIES" as defined below. Current [***] will remain in place as of the execution of this Agreement with the exception of [***], which will [***] from a CVS [***] to an [***] (as detailed in and subject to Section 12 Disclosure Schedule). Cardinal will [***] as it does for any other indirect vendor. In return for [***] on an [***] from February 1, 2004 until December 31, 2004, by May 1, 2004, Cardinal will authorize CVS to [***] in the amount of $[***] ("[***] PAYMENT"). The timing of said payment will be made so that CVS receives these funds by [***]. CVS will not be required to [***] or [***] any other pharmaceutical [***] as a [***]. Any further [***] of pharmaceutical [***] from [***], will be at CVS' sole determination. The [***] Warehouse [***] Exhibit below details which [***] CVS will purchase from Cardinal on an indirect basis (subject to Section 12 Disclosure Schedule) and the corresponding [***] terms to be amended in writing pursuant to Section 13 upon mutual agreement of CVS and Cardinal. While CVS and Cardinal may both agree that it is in the best interest of both parties to [***] a [***] from [***] to [***] or visa versa, said decisions will always be made to reflect incremental value to CVS and will occur at CVS' sole discretion. 65 CVS is under no obligation to purchase any specific [***] and may eliminate (POX) or discontinue any item at its sole discretion. With that said, CVS and Cardinal may investigate the best methods of [***] any [***] inventory [***] at CVS' sole discretion. So that Cardinal and CVS can effectively and efficiently manage Cardinal's [***] that is [***] to CVS through the [***], Cardinal will provide to CVS in an electronic format a detailed weekly report detailing said [***] ("[***] REPORT"). The [***] Report will include but not be limited to the following elements as it pertains to Cardinal [***] to CVS: [***], description, NDC, [***] on hand, extended [***], and [***] date. As it pertains to populating the [***] date [***] of the [***] Report only, Cardinal will fully populate and update [***] on a monthly basis and will supply to CVS a fully updated [***] Report by the first Friday following Cardinal's commencement of recording said [***]. All other data elements will be updated weekly and immediately sent to CVS each Friday accurately representing Cardinal's [***] available to CVS as of the creation of the [***] Report. [***] CALCULATION. For all of CVS Pharmacy DCs [***] ([***], or Brokerage Purchases, etc), CVS will receive an [***] within [***] ([***]) days of the end of each CVS fiscal quarter in the form of a [***] equal to [***]% times CVS Pharmacy DCs [***] (in addition to [***] the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The [***] will be calculated based on CVS' receipt date of such [***] for each fiscal month. CVS and Cardinal will agree with the method used to calculate each month's [***] totals. For example; CVS' total [***] volume for a specific CVS fiscal quarter equals $[***], then Cardinal will [***] to CVS within [***] ([***]) days of the end of the respective fiscal quarter $[***] ($[***] x [***]). Further terms and conditions of the [***] calculation are as follows: 1) CVS and Cardinal will publish the agreed to monthly [***] volume eligible for the [***] on a monthly basis; within [***] ([***]) days of the respective CVS fiscal month's end or as soon as practical. 2) The [***] will not be applied on [***] or [***] volume that is [***]. The [***] will be automatically applied on this inventory when [***] as a [***]. 3) CVS contract pricing on select [***] items established by CVS after January 1, 2004 will not be eligible for the [***] since Cardinal does not have the ability to [***] from this applicable [***]. 4) The [***] is based on the assumption that Cardinal will not [***] CVS any [***] related to [***] on code [***] and code [***] purchase orders. 5) Cardinal will not apply the [***] on CVS [***] or [***] that was specifically [***] through CVS that Cardinal [***] CVS with the explicit purpose of this 66 product being [***] the manufacturer. However, Cardinal will [***] on any [***] CVS [***] said product to the respective manufacturer. a. This inventory will be [***] to CVS on the earliest date that the applicable manufacturer would accept said product [***] at [***] percent ([***]%). b. If CVS believes the [***] to be [***] and that it will be [***] in any way by [***] said product [***] a manufacturer, then CVS can at its sole discretion opt not to [***] in such a [***]. c. CVS and Cardinal agree that [***] are costly to both parties and lead to operational inefficiencies and will therefore work together to develop a process which limits the amount of [***] . 6) At the start of this Agreement, Cardinal will [***] related to the previous agreement. To that end, CVS and Cardinal have agreed that Cardinal will adjust CVS' 4Q 2003 [***] by $[***] in order for this [***] to qualify for the [***]. With this adjustment made, [***] of CVS' [***] will be eligible for the [***] under this Agreement. 7) The calculation of the [***] will be based off the [***] ([***] at the [***] of [***] or the [***]) [***] to the application of the cash discount. For example, if the [***] is $[***], then the [***] would be calculated based on the $[***], not the $[***] ([***]% cash discount is applied). 8) For all CVS warehouse purchases made through Cardinal, cash discount [***] to CVS is defined as the [***]. 9) If CVS [***] a [***] from [***] to [***] after the establishment of the [***] and [***], then Cardinal will [***] the [***] calculation on that affected volume. 10) If CVS enters into an [***] (as defined below) with a [***] that prohibits Cardinal from any [***] with this [***], then Cardinal will not apply the [***] calculation on that affected volume. [***] CREATION ACTIVITIES. As a function of the WLP, Cardinal will [***] the margin created through certain [***] Creation Activities as defined below. Through the WLP, Cardinal will [***]% of the margin associated with all [***] related to [***] detailed below, and [***] related to [***] (this [***] was [***] to CVS via [***]) as further defined below. Notwithstanding anything else in this Agreement to the contrary, Cardinal will not place [***]purchases or conduct [***] activities related to CVS [***] for which Cardinal has entered into an[***] such activities. The "[***] CREATION OPPORTUNITIES" for the WLP are limited to: a) [***] - all purchases of [***] Rx Products (excluding repack) designed to generate an [***] which result from the [***] (by way of illustration only and not as a limitation, one example of an [***] is [***] of a [***]). 67 b) [***] or [***] - [***] or [***] that are made available to Cardinal from [***] under which Cardinal [***] related to CVS' [***]. c) [***] - all purchases of [***] Rx Products (excluding repack) for a specified [***] of [***] offered by manufacturers [***], or [***], a [***], thereby [***]. (by way of illustration only and not as a limitation, one example of an [***] is where a vendor [***] at a [***] for a certain [***] Rx Product (excluding repack) [***]). This [***] was [***] to CVS via [***]. Further terms and conditions of the [***] Creation Activities are as follows: 1) CVS will [***] other historically [***] ([***] and [***] manufacturers); CVS will not be required to [***] to Cardinal. 2) CVS to [***] all [***] it has historically [***] to include but not limited to: a) [***] b) [***] c) [***] d) [***] 3) The [***] CVS receives based on CVS' [***] purchases, is [***]% by CVS. In the event that a [***] would begin to [***] "[***]" [***] to Cardinal, Cardinal would [***]% of this [***] to CVS, based on CVS purchases (Pharmacies and CVS Pharmacy DCs, if applicable). Notwithstanding the foregoing, Cardinal will not accept any other [***] on CVS' behalf relating to CVS' purchase [***] (warehouse or DSD) without CVS' expressed written consent. It will be Cardinal's sole responsibility to notify any pharmaceutical supplier in writing (with copy to CVS subject to Section 13) [***] a [***] to Cardinal related to CVS' [***] of CVS' Return Goods Policy. 4) CVS will only accept product shipped from Cardinal Brokerage Inventory to CVS Pharmacy DCs that has at least [***] ([***]) [***] remaining. All products shipped with less than [***] ([***]) [***] remaining will be considered "[***] PRODUCT". On an exception basis, CVS will allow Cardinal to ship [***] Product Brokerage Inventory with at least [***] ([***]) months [***] remaining. However, both parties agree that no more than $[***] worth of [***]Product will be shipped to CVS Pharmacy DCs during any Program Year. In addition, upon CVS request (as often as monthly), Cardinal will provide CVS a detailed report that summarizes all [***] Product shipped from Cardinal's Brokerage Inventory to CVS Pharmacy DCs ("[***] REPORT"). The [***] Report will contain all [***] Product shipped to CVS Pharmacy DCs within the current Program Year and will include but not be limited to the following data elements: date shipped, vendor, description, NDC, quantity shipped, extended cost, and [***] totaled by month and year-to-date(both CVS and Cardinal agree that the [***] Report will be made available to CVS no later than September 1, 2004). Notwithstanding anything in this Agreement to the contrary, at no time will Cardinal ship Brokerage Inventory with less than [***] ([***]) months [***] remaining to CVS Pharmacy DCs. With that said, CVS will work with Cardinal to assist in the management of the [***]. 68 Additional terms and conditions of the WLP are as follows: 1. Term - The WLP will commence as of January 1, 2004, and terminate upon the termination of the Agreement. 2. [***] Generation - Cardinal will [***] ([***]%) of CVS' [***] for [***] Rx Products (excluding repack) [***] all CVS Pharmacy DCs for routine [***] and [***] (the "PURCHASING ACTIVITIES"). 3. [***] - If Cardinal's [***] on CVS' [***] are [***] or [***] by a [***], and if CVS is eligible to [***] from such [***], then CVS will, upon request by Cardinal, effect a direct [***] of the applicable Rx Product [***] by Cardinal. With respect to the foregoing purchases, [***] will [***] the applicable [***] according to the [***], including [***] for any available [***]. CVS will [***] the [***] to the [***] from [***] Cardinal, which will also be [***] the [***]. This [***] process is designed to be "[***]" for both parties. (a) [***]. On the same day as CVS [***] a shipment of Rx Product ordered as part of a [***] related to this WLP, CVS will [***] Cardinal. Cardinal will [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. CVS will [***] from the applicable [***], and CVS will pay the [***], [***] for all [***], based on the applicable payment terms. CVS will [***] to the [***] from [***], and Cardinal will [***] the CVS [***] to the applicable [***]. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. (b) [***] and [***]. As it pertains to [***] purchases only, on the same day as CVS [***] the shipment of Rx Product, CVS will [***] Cardinal. Cardinal will [***] to [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. [***] purchases will be [***] by Cardinal at the servicing Cardinal DC [***] the need for CVS to [***] such product. As it pertains to the payment of [***] and [***] purchases, Cardinal will receive an [***] from the applicable [***] for the ordered Rx Product, and Cardinal will [***] the [***] directly, [***] for all [***], based on the applicable payment terms. As the Rx Product is ordered from Cardinal by CVS for [***], Cardinal will [***] CVS, and CVS will [***] Cardinal for such Rx Product in accordance with the terms of this Agreement. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. 4. Purchase Information - CVS will provide Cardinal with [***] electronic feeds updating information regarding CVS' [***] of [***] Rx Products [***] from [***] and from [***] on behalf of the CVS Pharmacy DCs pursuant to the WLP. Such information will include details regarding all purchase orders, [***] or [***] for items [***] and [***] and other information reasonably required by Cardinal to administer the WLP. To assist Cardinal with [***], CVS will provide Cardinal with information 69 reasonably requested by Cardinal including but not limited to new product [***], [***] fluctuations, [***] promotions, and new store openings , and a change in CVS Pharmacy DC that services a particular Pharmacy. 5. Limitations - All [***] for [***] Products must be executed exactly as [***]. [***] will be generated and submitted to any vendor, other than those [***], without [***]. All [***] will be on behalf of the CVS Pharmacy DCs. CVS will not make any [***] (outside of this [***]) on behalf of the Pharmacies [***]. It is understood and agreed that Cardinal will not be required to reduce or otherwise [***] its own [***] associated with a manufacturer imposed [***]. Furthermore, the parties acknowledge and agree that all information associated with the WLP is confidential information subject to the provisions of Section 17 of this Agreement. 6. Records, Audit and Confidentiality - The WLP is subject to the record keeping and audit provisions set forth in Section 16 of this Agreement. Cardinal may disclose CVS' [***] information (such as inventory [***], on-order or [***]) to [***] as reasonably required by Cardinal to [***] related to the WLP. Cardinal will notify CVS in writing (subject to Section 13) prior to the disclosure of any such information and will provide the nature of the information that Cardinal intends to disclose. Further, Cardinal will use reasonable efforts to obtain applicable [***] consent to disclose such information to CVS if needed. 7. ACH - All payments for invoicing under the WLP will be made via ACH. 8. Waiver - Neither party's failure to enforce any provision of this WLP will be considered a waiver of any future right to enforce such provision. 9. Dispute Resolution Relating to the WLP - CVS and Cardinal acknowledge that either party may from time to time may, in good faith, dispute any portion of the WLP. In the event that either party disputes any portion on the WLP, each party agrees to use all reasonable efforts to resolve all such disputes as expeditiously as possible on a fair and equitable basis. To that end, Cardinal and CVS will assemble a panel consisting of at least one (1) executive from CVS and one (1) executive from Cardinal (but in any event, an even number in the aggregate) (the "EXECUTIVE COMMITTEE") to resolve disputes relating to the WLP and address other issues as they may determine. With respect to reporting disputes, a copy of the terms of this Agreement, as amended from time to time, agreed upon facts and areas of disagreement, and a concise summary of the basis for each side's contentions will be provided to the executives who will review the same, confer, and attempt to reach a mutual resolution of the issue within thirty (30) days following either party's receipt of notice of dispute. 70 [***] VENDOR EXHIBIT.
[***] VENDOR [***] PURCHASE PAYMENT TERMS - ------------ ---------------------------- [***] [***]
71 SECTION 19 DISCLOSURE SCHEDULE INSURANCE During the term of the Agreement, CVS and Cardinal will each maintain commercial general liability insurance having a limit of not less than $[***] million, pursuant to one or more insurance policies with reputable insurance carriers. Upon request, each party will deliver to the other certificates evidencing such insurance. Cardinal's certificate of insurance to CVS will reflect that CVS is named as an additional insured under such policy and will provide evidence of broad form vendor's coverage. Neither party will cause nor permit such insurance to be canceled or modified (exclusive of appropriate replacement policies) to materially reduce its scope or limits of coverage during the term of the Agreement. 72
EX-10.03 3 l16445aexv10w03.txt EX-10.03 EXHIBIT 10.03 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. FIRST AMENDMENT TO WHOLESALE SUPPLY AGREEMENT This first amendment ("FIRST AMENDMENT") dated May 26, 2004 amends the Wholesale Supply Agreement dated January 1, 2004 ("AGREEMENT") between CVS and Cardinal Health. CVS and Cardinal Health ("PARTIES") desire to enter into this First Amendment to amend Sections 1(a), 1(b), 3(c), 6(d), 7(b), 10(a), and 12 Disclosure Schedules all as more particularly set forth below. The Parties agree as follows: 1. Effective Date of Amendment. This First Amendment shall be effective as of the date of the closing of the transaction pursuant to which CVS will purchase from J.C. Penney Company, Inc. ("JC PENNEY") approximately 1,260 retail pharmacies and approximately 3 distribution centers as publicly announced by CVS on April 5, 2004 ("TRANSACTION"). In the event that the Transaction does not close on or before September 1, 2004, then this First Amendment shall become null and void and shall be of no force or effect. 2. Scope. Notwithstanding anything else in the Agreement or this First Amendment, in no event will CVS be required to designate any acquired retail pharmacy as a Pharmacy or acquired distribution center as a CVS Pharmacy DC under the Agreement, if such pharmacy is subject to an existing wholesaler agreement which cannot be terminated by CVS for any reason, or which, if terminated by CVS would or could, in CVS' reasonable business judgment, result in termination penalties/fees of any type, or result in CVS compromising CVS' business operations. 3. Disclosure Schedules. The Agreement is amended by deleting therefrom the following disclosure schedules in their entirety: "Section 1(a) Disclosure Schedule", "Section 1(b) Disclosure Schedule", "Section 3(c) Disclosure Schedule", "Section 6(d) Disclosure Schedule", "Section 7(b) Disclosure Schedule", "Section 10(a) Disclosure Schedule", and "Section 12 Disclosure Schedule" and replacing them with the following new Disclosure Schedules: "Section 1(a) Disclosure Schedule", 1 "Section 1(b) Disclosure Schedule", "Section 3(c) Disclosure Schedule", "Section 6(d) Disclosure Schedule", "Section 7(b) Disclosure Schedule", "Section 10(a) Disclosure Schedule", and "Section 12 Disclosure Schedule" attached to this First Amendment and incorporated into this First Amendment and into the Agreement by this reference, which shall be attached by the Parties to their respective copies of the Agreement. 4. Generally. It is the Parties' intent for the Agreement and this Amendment (if the Transaction closes on or before September 1, 2004) to be applied and construed as a single instrument. The Agreement, as modified by this First Amendment, remains in full force and effect and constitutes the entire agreement among the Parties regarding this subject matter and supersedes all prior or contemporaneous writings and understandings among the Parties with respect thereto. This First Amendment will be binding on the Parties and their successor and assigns. If any term or provision of this First Amendment is determined to be illegal or unenforceable by a court of competent jurisdiction, the remaining terms and provisions of this First Amendment and the Agreement will remain in full force and effect. Only a subsequent writing signed by both Parties may amend this First Amendment or further amend the Agreement. CVS Pharmacy, Inc Cardinal Health* By: /s/ Matthew J. Leonard By: /s/ Michael J. Bender --------------------------------- ------------------------------------ Print Name: Matthew J. Leonard Print Name: Michael J. Bender Title: VP Pharmacy Merchandising Title: EVP, Retail Sales & Marketing * The term "CARDINAL HEALTH" means the following pharmaceutical distribution companies: Cardinal Health 106, Inc. (formerly known as James W. Daly, Inc.), a Massachusetts corporation (Peabody, Massachusetts); Cardinal Health 103, Inc. (formerly known as Cardinal Southeast, Inc.), a Mississippi corporation (Madison, Mississippi); Cardinal Health 110, Inc. (formerly known as Whitmire Distribution Corporation), a Delaware corporation (Folsom, California) and any other subsidiary of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI. 2 SECTION 1(A) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 DETERMINATION OF PHARMACIES THAT WILL DESIGNATE CARDINAL AS PRIMARY WHOLESALE PHARMACEUTICAL SUPPLIER As of the Commencement Date, and throughout the term of this Agreement, CVS will designate Cardinal as primary wholesale pharmaceutical supplier to the Pharmacies existing as of January 1, 2004 plus or minus the organic growth related to these specific Pharmacies. Furthermore, CVS will designate Cardinal as primary wholesale pharmaceutical supplier to the Pharmacies acquired from JC Penney which are located in the States of [***] and [***] and which Cardinal was designated as the primary wholesaler by [***] (approximately [***] Pharmacies, [***] in [***] and [***] in [***]), and which remain open and continue to operate ("JC PENNEY ACQUIRED PHARMACIES"). In the event CVS acquires by purchase, merger or other combination, a retail pharmacy (or multiple retail pharmacies) representing: (a) less than [***]% of CVS' Pharmacies as of January 1, 2004, then CVS will designate Cardinal as primary wholesale pharmaceutical supplier to such pharmacies pursuant to the terms and conditions of this Agreement in a timeframe so as not to compromise CVS' business operations; or (b) greater than or equal to [***]% of CVS' Pharmacies as of the January 1, 2004 (the date of this Agreement), then CVS may decide to award Cardinal any portion of said retail pharmacies at CVS' sole discretion (in which case Cardinal and CVS will meet to discuss the terms of said new business). In no event will CVS be required to terminate any wholesaler agreement which may exist related to any retail pharmacies CVS acquires by purchase, merger or other combination. DESIGNATED PHARMACY LIST. Upon Cardinal's request, as often as quarterly, CVS will provide Cardinal with the Designated Pharmacy List. For each of the Pharmacies, CVS agrees that each such Pharmacy will purchase its Primary Wholesale Requirements of Store Rx Purchases from Cardinal, as further described in the Section 2(a) Disclosure Schedule. 3 SECTION 1(B) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 TOTAL DC LIST CVS New York, Inc. CVS D.S., Inc. Three Berry Drive 10017 Kingston Pike Lumberton, NJ 08048 Knoxville, TN 37922 CVS Pharmacy, Inc. CVS IN Distribution, Inc. 150 Industrial Drive 7590 Empire Drive North Smithfield, RI 02896 Indianapolis, IN 46219 CVS Texas Distribution L.P. CVS Garland TX Distribution, L.P. 700 CVS Drive 4409 Action Street Ennis, TX 75119 Garland TX 75042 (expected open date TBD) CVS Conroe TX Distribution, L.P. CVS Orlando FL Distribution, L.L.C. Name TBD Name TBD 100 Trade Center Blvd. 8201 Chancellor Drive Conroe TX 77385 Orlando FL 32809
As CVS [***] additional [***] to support Pharmacies existing as of January 1, 2004 or additional Pharmacies related to the organic growth of the Pharmacies existing as of January 1, 2004, CVS will [***] such pharmacy [***] Cardinal as its/their [***] pursuant to the terms and conditions of this Agreement. For each of the CVS Pharmacy DCs set forth above, CVS agrees that each such CVS Pharmacy DC will purchase its Primary Wholesale Requirements of Brokerage Purchases from Cardinal, as further described in the Section 2(a) Disclosure Schedule. CVS will keep the Total DC List current and notify Cardinal of anticipated additions to or deletions from the Total DC List at least thirty (30) days prior to such addition or deletion. If such addition or deletion could not have been reasonably foreseen [***] ([***]) days in advance, CVS will notify Cardinal as soon as possible thereafter. In no event will Cardinal be required to service any CVS Pharmacy DC pursuant to the terms of this Agreement until [***] ([***]) days after CVS first notified Cardinal that the CVS Pharmacy DC would be added to the Total DC List. A CVS Pharmacy DC may only be deleted if it ceases operations. If CVS acquires or opens an additional distribution center or centers in support of acquired retail pharmacies (acquired by purchase, merger or other combination), CVS may designate Cardinal as the primary wholesale pharmaceutical supplier to such distribution centers (in which case Cardinal and CVS will meet to discuss the terms of said new business) in a timeframe so as not to compromise CVS' business operations. In no event will CVS be required to terminate any wholesaler agreement which may exist related to acquired retail pharmacies. 4 SECTION 3(A) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 PHARMACIES PURCHASE PRICE PHARMACY MINIMUM VOLUME REQUIREMENTS. During the term of this Agreement (January 1, 2004 through June 30, 2008), the Pharmacies' aggregate purchases of generic Rx Products will meet or exceed $689 million (collectively referred to herein as the "PHARMACY MINIMUM VOLUME REQUIREMENT"). During Cardinal's quarterly business review, Cardinal will provide CVS with purchasing information to substantiate the Pharmacy Minimum Volume Requirement performance. Cost of Goods for Store Rx Purchases and Store Other Purchases CVS will pay to Cardinal a Cost of Goods for Store Rx Purchases and Store Other Purchases as follows: Rx Products (FDB branded) [***]% CVS Formulary Generics [***] All other Generics [***] or "[***] Retail", [***] Home Health Care/DME "[***] Retail", [***] HBC/OTC "[***] Retail" [***]% Repackaged Merchandise "[***] Retail" [***]%
For the purpose of this Agreement "[***] Retail" shall mean CVS will [***] offered by Cardinal to a retail customer in the [***] CVS (i.e. a [***] retail [***] or [***] with a minimum [***] approximately [***] to that of CVS and approximately the [***] as CVS) for all Merchandise for which a purchase order has been issued as of the date the Merchandise was offered to a third party for such [***]. The prices of a purchase order shall be deemed automatically revised (by Cardinal to CVS) to equal the [***] at which Cardinal shall have sold or shall have offered such product to such a retailer. CII orders must be shipped [***]% complete and courier must [***] when order is received and checked in by CVS. CVS reserves the right to refuse any CII order that contains any shipping errors. All Merchandise being delivered from Cardinal to CVS Pharmacies must have at least [***] ([***]) months [***]. Under no circumstances will Merchandise be delivered to Pharmacies with [***] than [***] ([***]) months [***] remaining without expressed written approval by CVS' Vice President of Pharmacy Merchandising for each occurrence. Furthermore, Cardinal represents that it is, and will continue to be during the term of this Agreement, an industry leader in implementation of processes, practices and safeguards to prevent the distribution of Merchandise will less than [***] ([***]) months [***] remaining to Pharmacies. The foregoing Cost of Goods does not apply to Merchandise which is subject to a Manufacturer Contract, which will instead be priced at the CVS contract price for the Pharmacies. Cardinal 5 reserves the right to adjust the Cost of Goods of any item of Merchandise in the event that the manufacturer of such item implements a change in policy which eliminates or decreases the [***] effective on the Commencement Date with respect to such item. The adjustment to the Cost of Goods for such item will be equal to the decrease (or elimination) of the [***]. 6 SECTION 3(C) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 PHARMACY SITE INCENTIVE Pharmacies will be eligible for the following Cost of Goods adjustment based upon the [***] qualified monthly purchases per Pharmacy during a calendar [***] (the "PHARMACY SITE INCENTIVE"):
[***] Qualified Monthly Invoice Cost Cost of Goods Net Cost of Goods Purchases per Pharmacy of Goods Adjustment after Adjustment - ----------------------- ------------ ------------- ----------------- $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] - $[***] [***]% [***]% [***]% $[***] + [***]% [***]% [***]%
If CVS' [***] qualified monthly purchases per Pharmacy during a calendar quarter is less than $[***], a Cost of Goods adjustment will be mutually determined at a percentage that is greater than the next category Cost of Goods adjustment. At the end of each calendar quarter, Cardinal and CVS will evaluate CVS' [***] qualified monthly purchases per Pharmacy during such quarter (i.e., Store Rx Purchases and Store Other Purchases only) of all Pharmacies divided by the [***], adjusted as appropriate to reflect any additional or deleted Pharmacies). Payment will be paid to CVS in the form of a credit so that CVS receives such credit within [***] ([***]) days from the close of said [***]. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. The Pharmacy Site Incentive Payment calculation will be made as follows: Cardinal and CVS will evaluate CVS' [***] qualified monthly purchases per Pharmacy during a calendar [***]. Utilizing this calculation Cardinal and CVS will determine which tier to utilize for the payout calculation. For example, during a calendar [***], CVS' [***] qualified monthly purchases per Pharmacy was $[***], then CVS' Pharmacy Site Incentive (additional Cost of Goods adjustment) will be Cardinal's [***] an additional [***]%. Conversely, if CVS' [***] qualified monthly purchases per Pharmacy was $[***] during a calendar [***], then CVS' additional Cost of Goods adjustment would be Cardinal's [***] an additional [***]%. In addition, if CVS [***] a material [***] of Pharmacies which would place CVS' qualified monthly purchases per Pharmacy into a different Pharmacy Site Incentive volume category, then CVS may elect to notify Cardinal prior to Cardinal [***] Pharmacies, and ask Cardinal [***] these Pharmacies for the [***] ([***]) month period following the date of acquisition for purposes of calculating the Pharmacy Site Incentive [***] only. If CVS does not notify Cardinal 7 prior to Cardinal servicing such Pharmacies or CVS does not ask Cardinal to [***] such Pharmacies from the calculation of the Pharmacy Site Incentive, then such Pharmacy or Pharmacies will be subject to the terms and conditions of this Agreement. Regardless of whether the acquired Pharmacies are included or excluded in the determination of the Pharmacy Site Incentive volume category, said Pharmacy purchases will be eligible for the Pharmacy Site Incentive. To that end, it has been agreed that the JC Penney Acquired Pharmacies will not be included in the determination of the Pharmacy Site Incentive volume category only, until July 1 2005. However, the Store Rx Purchases and Store Other Purchases of such Pharmacies will receive the same Site Volume Incentive cost of goods adjustment earned by CVS' core Pharmacies (Pharmacies excluding JC Penney Acquired Pharmacies). The Pharmacy Site Incentive is a "discount or other reduction in price" as such term is used under section 1128(B)(3)(A) of the Social Security Act, 42 U.S.C. 1320a-7b(b)(3)(a). CVS will disclose the Pharmacy Site Incentive and any other "discounts or other reductions in price" received by CVS from Cardinal under any state or federal program which provides cost or charge-based reimbursement to CVS for the Merchandise purchased by CVS under this Agreement. 8 SECTION 6(D) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 EMPLOYEE FUNDING Cardinal will partially fund the cost of a CVS DSD Manager ("EMPLOYEE") who will serve as an intermediary between Cardinal and CVS specifically related to the management of the Store Rx Purchases. It is understood that the Employee shall be employed solely by CVS and that the Employee's salary and other employment benefits shall be the sole responsibility of CVS. CVS agrees to indemnify and hold Cardinal harmless for all claims and liabilities, whether alleged or actual, relating to the Employee. Cardinal will provide for the funding of this Employee pursuant to the schedule defined below: [***] $[***]
9 SECTION 7(B) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 [***] WRAP-AROUND REBATE FOR THE PHARMACIES CVS will be eligible for the following discount on the Pharmacies' [***] Rx Product purchases ("[***] WRAP-AROUND REBATE"):
[***]QUALIFIED ANNUAL PURCHASES OF [***] RX PRODUCTS BY THE PHARMACIES PER PROGRAM YEAR (000) REBATE - --------------------------------- ------ $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***] - $[***] [***]% $[***]+ [***]%
Cardinal will provide CVS with a monthly report detailing the Pharmacies' aggregate qualified monthly purchases of [***] Rx Products to date. At the end of each Program Year, Cardinal and CVS will evaluate CVS' aggregate qualified annual purchases of [***] Rx Products by the Pharmacies during such Program Year. The [***] Wrap-Around Rebate will be equal to a percentage (as set forth in the table above) of CVS' aggregate qualified annual purchases of [***] Rx Products by the Pharmacies during the applicable Program Year. The [***] Wrap-Around Rebate, if any, will be calculated and paid to CVS in the form of a credit so that CVS receives such credit within [***] ([***]) days from the close of said Program Year. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. In the event that the [***] Wrap-Around Rebate will not be paid for any reason, Cardinal will use reasonable efforts to give CVS notice no later than [***] ([***]) days prior to the end of the then-current Program Year. The [***] Wrap-Around Rebate is a "discount or other reduction in price" as such term is used under section 1128(B)(3)(A) of the Social Security Act, 42 U.S.C. 1320a-7b(b)(3)(a). CVS will disclose the [***] Wrap-Around Rebate and any other "discounts or other reductions in price" received by CVS from Cardinal under any state or federal program which provides cost or charge-based reimbursement to CVS for the Merchandise purchased by CVS under this Agreement. 10 SECTION 9 DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 PHARMACIES SERVICE LEVEL Cardinal will exercise best efforts to provide the Pharmacies with the following average aggregate monthly Adjusted Service Level and Overall DSD Service Level (as defined within this disclosure schedule), calculated monthly as described below: (a) [***]% adjusted with respect to [***] Rx Products; (b) [***]% adjusted with respect to CardinalSOURCE(SM) [***] drugs; (c) [***]% adjusted with respect to the CVS [***]; and (d) at a percentage to be mutually agreed upon by the parties with respect to home health care products (the "SERVICE LEVEL COMMITMENT"). CVS GENERIC FORMULARY SERVICE LEVEL. For purposes of this Agreement, "ADJUSTED SERVICE LEVEL" for CVS [***] Formulary items during any particular [***] will be calculated using the following formula: [[***] of CVS [***] formulary (which includes [***] Rx Products and certain other products [***]) by NDC (eleven digit) shipped] [***] ([***] NDC's [***] shipped within the same [***] as defined by FDB [***] Authorized Adjustments). All orders submitted to Cardinal will be included in the Adjusted Service Level calculation, including, but not limited to: store telxon orders, [***] orders, [***] orders, verbal orders, and CII orders. The following items of merchandise are excluded from the Adjusted Service Level calculation and in aggregate constitute all "AUTHORIZED ADJUSTMENTS": 1. Validated long-term backorders - long-term backorders will only be considered valid upon agreement between Cardinal and CVS that said supplier is unable to provide Cardinal with merchandise necessary for Cardinal to maintain an adequate inventory position. Cardinal will verbally communicate any long term back order situations for which an adjustment to the service level calculation is requested to CVS' Assistant Category Manager - [***], in the event that person is unavailable, Cardinal will notify the Director, Category Management - [***]. Notification to CVS should only be made after Cardinal has exhausted all avenues to resolve such product shortage on its own. Upon notification from Cardinal, CVS will contact the respective supplier to validate the long term backorder status of said product or assist Cardinal with securing adequate inventory. Upon CVS receiving validation from supplier of a long term backorder status or said supplier's inability to ship the related product, the affected products will be considered an Authorized Adjustment. Only CVS validated long term backorders or CVS validated circumstances where a supplier is unable to ship the products in question will be considered in the Adjusted Service Level calculation. Each month Cardinal will provide a list detailing the agreed upon items to be excluded from CVS' Adjusted Service Level calculation and the number of units to be adjusted. 11 2. CVS specific do-not-substitute requests - CVS may specifically request that no substitution be performed for specific items; CVS' Assistant Category Manager - [***] will notify Cardinal in writing of these items. In addition, individual CVS stores may place verbal orders to Cardinal; if the Pharmacy specifically requests (phone in orders without a documented detailed specific request by CVS will not be considered an Authorized Adjustment) Cardinal not to perform a substitution for a specific item, then said item will be considered an Authorized Adjustment. Cardinal will provide CVS on a monthly basis a report by item of the number of store specific do not substitute requests to include but not be limited to: CVS store number, NDC, item description, date, and quantity. Reports should be provided no later than five (5) days following the close of the respective month. 3. Excessive demand - an adjustment to the Adjusted Service Level will be allowed in validated cases where an items total month's GCN usage has increased at least [***]% above the average monthly GCN demand for the previous [***] ([***]) months or CVS' [***] formulary forecast as provided from time to time, which ever is greater. Adjustment amount will only be for the number of units surpassing the applicable baseline. For example, if the average monthly demand for the prior [***] ([***]) month period is equal to [***] units per month, Authorized Adjustment will only be given for orders surpassing [***] units (([***]%) + [***]) during that month. Cardinal must provide CVS with reporting detailing the applicable baseline usage figure and the current month usage figure to be eligible for the adjustment. Increase in usage is determined by global CVS usage. 4. Non-previously stocked items - CVS at its discretion can choose to adjust the CVS [***] Formulary for additions, deletions, change in supplier, change in package size, etc. CVS commits to the timely notification of all such changes in an electronic format; in addition, on a monthly basis CVS will provide an updated complete CVS [***] Formulary. Cardinal will make available to CVS non-previously Cardinal stocked items within [***] ([***]) days from notification. [***] service level calculation will be adjusted for the [***] ([***]) day period following CVS notification, during which Cardinal may service CVS stores using the previous formulary item if applicable. Cardinal's average monthly Adjusted Service Level commitment for CVS will become effective as of January 1, 2004, however, CVS will not be eligible for [***] until June 1, 2004. As it relates to the JC Penney Acquired Pharmacies only, CVS will not be eligible for [***] until January 1, 2005. As an inducement for CVS to make the preceding concession, Cardinal will use best efforts to provide CVS with the Service Level Commitment. Both Cardinal and CVS agree the achievement of the [***]% Adjusted Service Level on a monthly basis represents a material aspect of this Agreement. Failure by Cardinal to maintain a monthly Adjusted Service Level of [***]% with respect to the CVS [***] Formulary (which includes Schedule II Rx Products and certain other products as CVS designates) (a "[***] SERVICE LEVEL FAILURE") will entitle CVS to be [***] for its [***] (as defined herein). For 12 purposes of this Schedule 9 Disclosure Schedule, the term "[***]" means an amount equal to the difference between the [***] for the month and [***]% multiplied by [***]for the month multiplied by [***] percent ([***]%). CVS will calculate and present [***], if any, to Cardinal before processing any financial transaction related to any funds being owed to CVS in connection with [***]. For example, if the [***] Service Level is calculated at [***]% for any given month, and the monthly [***] for that month was $[***], then CVS may process [***] for $[***] after notifying Cardinal of such transaction (([***]%-[***]%) x $[***] x [***]%). Cardinal and CVS agree to meet at CVS' Support Center as necessary to review the Adjusted Service Level performance and to use best efforts in order to maximize CVS' Adjusted Service Level defined within this Section 9 Disclosure Schedule. BRANDED RX PRODUCTS AND STORE OTHER PURCHASES -DSD SERVICE LEVEL. Cardinal recognizes the significant impact of branded Rx Products and Store Other Purchases service level ("OVERALL DSD SERVICE LEVEL") can have on CVS' ability to service their customers. Therefore, both Cardinal and CVS agree that the Overall DSD Service Level is material to this Agreement. To that end, Cardinal and CVS will mutually agree to terms that will reflect the significance of Overall DSD Service Level. The terms will be specific towards each party's responsibilities, the calculation of Overall DSD Service Level, and remedies up to and including [***]. CVS and Cardinal agree that the arrived at structure of the Overall DSD Service Level will provide CVS with industry leading performance commitments. 13 SECTION 10(A) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 PHARMACIES MERCHANTABLE PRODUCT ONLY RETURN GOODS POLICY GENERAL POLICY. The parties acknowledge that returns are costly to both parties. Product in "merchantable condition" (as defined below) may generally be returned to Cardinal from which the product was originally purchased if the return is made within the timeframes and subject to the terms and conditions described below: The return of [***] product is detailed in Section 10(b) Disclosure Schedule.
RETURN MADE WITHIN: NORMAL CREDIT AMOUNT: - ------------------- --------------------- 1 - 90 Days from Invoice Date [***]% of original invoice amount paid by customer. This policy covers all ordering/filling errors. More than 90 Days [***]% of original contract or other "cost" paid by customer (i.e., not including any [***] and not to [***]) [***] a [***]% restocking fee invoiced seperately to net at [***]%.
Merchandise will be considered to be in "MERCHANTABLE CONDITION" except for the following: A. Any item which has been used or opened, is a partial dispensing unit or unit of sale, is without all original packaging, labeling, inserts, or operating manuals, or that is stickered, marked, damaged, defaced, or otherwise cannot readily be resold by Cardinal for any reason. B. [***]-dated (less than [***] ([***]) months expiration dating, unless received by CVS with less than [***] ([***]) months dating), outdated, or seasonal product and items purchased on a "special order" basis, including non-stock and dropship items. C. Any [***] merchandise, unless Cardinal agrees and is specially assured that such merchandise was properly stored and protected at all times and such merchandise is returned separately in a package marked as such and accompanied by a separate credit request form. D. In order for CVS to achieve compliance with Cardinal's excess returns policy, CVS will return product (in Merchantable Condition) to Cardinal only if such product is not stocked in the CVS Pharmacy DCs (excluding [***] or [***] that is delivered to CVS [***] or [***]). Further, CVS agrees that Cardinal may implement an [***] of the return of items which are stocked in the CVS Pharmacy DCs, as indicated in the CVS monthly on-hand inventory electronic report provided to Cardinal by CVS. CONTROLLED SUBSTANCES. Credit for the return of controlled substances requires a separate Merchandise Return Authorization Form ("MRA FORM") and must comply with all federal and state procedures and requirements in addition to the terms and conditions described herein. 14 SECTION 10(A) DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 SHORTS AND DAMAGED MERCHANDISE. Claims of order shortages (i.e., invoiced but not received), order errors and damage must be reported within [***] ([***]) business days from the applicable invoice date. Controlled substance shortage claims must be reported immediately per DEA requirements. EXCESS RETURNS. CVS Pharmacy returns in dollars will not exceed [***] percent ([***]%) of qualified monthly purchases of all of the Pharmacies (in dollars, each calendar month) excluding filling errors or damaged product. Because CVS agrees only to [***] product to Cardinal if such product is not stocked in the CVS Pharmacy DCs (excluding [***] or [***] that is delivered to CVS [***] or [***] Rx Products [***]), CVS and Cardinal mutually agree that Cardinal will implement an [***] of the return of those items which are included in the CVS monthly on-hand inventory electronic report provided to Cardinal by CVS. This [***] is designed to limit returns in excess of [***]%. CVS and Cardinal may agree from time to time to implement a Pharmacies [***] in cases where CVS Pharmacies are [***] inventory. The parties will agree to the terms of such a [***] on an individual basis. Returns made under the [***] will not be included in the excess returns calculation. Cardinal will fully participate in assisting CVS with a CII returns program associated with the CIIs located in those distribution centers acquired from JC Penney. CIIs returned under this initiative will be valued at current WAC and will have at least [***] ([***]) months dating remaining. ONGOING ASSURANCE AND CARDINAL CREDIT REQUEST FORM. Prior to returning any product to Cardinal, each customer must execute and deliver to Cardinal an Ongoing Assurance verifying that all returned merchandise has been kept under proper conditions for storage, handling, and shipping. All requests for credit must be submitted via EOE, on the CardinalCHOICE(R) system or by approved EDI interface. A fully completed MRA must accompany all merchandise to be returned. A fully completed form includes, but is not limited to, the following information: the invoice number and invoice date for the merchandise to be returned. All return credit memos will have corresponding reference numbers that will provide CVS with a complete audit trail for reconciliation. SHIPPING OF RETURN GOODS. Return merchandise must be placed in a proper shipping container and, for merchandise valued at more than $250, signed for by the driver when the product is picked up. All MRAs will be reviewed by Cardinal for compliance with the returned goods policy within this Section 10(a) Disclosure Schedule. Cardinal will process credits within [***] ([***]) days of receipt of merchantable product from CVS. In instance were credit has not been received for product returned to Cardinal for which Cardinal has no record of said return, CVS and Cardinal will use reasonable efforts to research and reach a mutually acceptable resolution. 15 SECTION 12 DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 MONTHLY REPORTING. Cardinal will provide an electronic report on a monthly basis, which will detail (1) CVS' excess return percentage, (2) claims of order shortages, order errors and damaged products that are reported in excess of three (3) business days from invoice date, (3) information relating to returns in excess of [***] ([***]) days, and (4) any restocking fees. OTHER RESTRICTIONS. This policy is further subject to modification as may be deemed necessary to comply with applicable federal and/or state regulations, FDA guidelines, and state law. 16 SECTION 12 DISCLOSURE SCHEDULE AMENDED MAY 26, 2004 WAREHOUSE LOGISTICS PROGRAM The goal of the "WAREHOUSE LOGISTICS PROGRAM" (WLP") is to develop the most efficient purchasing and distribution processes for CVS with pharmaceutical manufacturers under which Cardinal will [***] ([***]%) of CVS' purchase requirements for [***] Rx Products (excluding repack items) ("[***]") [***] of all CVS [***] which are or become part of this Agreement. The parties agree and acknowledge that this WLP is part of this Agreement, and is not a separate or distinct agreement. Notwithstanding anything in this Agreement to the contrary, the WLP is intended and structured to provide [***]% incremental financial and operational value to CVS and at no time shall Cardinal take any action in connection with the WLP which may negatively impact CVS' ability to service its Pharmacies, CVS Pharmacy DCs, or CVS' abilities to secure regular [***] merchandise, including [***] stock, [***] a manufacturer. The WLP is designed to provide incremental financial value to CVS; CVS is to be [***] on [***], etc. CVS will [***] all other [***] that CVS would otherwise be entitled to if CVS [***] the [***] on a [***] (i.e., [***], etc.). As part of the WLP, Cardinal will pass to CVS funding ("INCENTIVE") in the form of a credit within [***] ([***]) days of the end of each CVS [***] equal to [***]% times CVS Pharmacy [***] (in addition to passing the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. Additionally, Cardinal will provide CVS with the Warehoused Service Level detailed in Section 2(b) Disclosure Schedule through leveraging Cardinal's procurement and logistical expertise. In return for both the Incentive and the Warehouse Service Level, Cardinal will [***] the [***] created through certain "[***] CREATION ACTIVITIES" as defined below. Current [***] will remain in place as of the execution of this Agreement with the exception of [***], which will [***] from a CVS [***] to an [***] (as detailed in and subject to Section 12 Disclosure Schedule) . Cardinal will [***] as it does for any other indirect vendor. In return for [***] on an [***] from February 1, 2004 until December 31, 2004, by May 1, 2004, Cardinal will authorize CVS to [***] in the amount of $[***] ("[***] PAYMENT"). The timing of said payment will be made so that CVS receives these funds by [***]. CVS will not be required to [***] or [***] any other pharmaceutical [***] as a [***]. Any further [***] of pharmaceutical [***] from [***], will be at CVS' sole determination. The [***] Warehouse [***] Exhibit below details which [***] CVS will purchase from Cardinal on an indirect basis (subject to Section 12 Disclosure Schedule) and the corresponding [***] terms to be amended in writing pursuant to Section 13 upon mutual agreement of CVS and Cardinal. While CVS and Cardinal may both agree that it is in the best interest of both parties to [***] a [***] from [***] to [***] or visa versa, said decisions will always be made to reflect incremental value to CVS and will occur at CVS' sole discretion. 17 CVS is under no obligation to purchase any specific [***] and may eliminate (POX) or discontinue any item at its sole discretion. With that said, CVS and Cardinal may investigate the best methods of [***] any [***] inventory [***] at CVS' sole discretion. So that Cardinal and CVS can effectively and efficiently manage Cardinal's [***] that is [***] to CVS through the [***], Cardinal will provide to CVS in an electronic format a detailed weekly report detailing said [***] ("[***] REPORT"). The [***] Report will include but not be limited to the following elements as it pertains to Cardinal [***] to CVS: [***], description, NDC, [***] on hand, extended [***], and [***] date. As it pertains to populating the [***] date [***] of the [***] Report only, Cardinal will fully populate and update [***] on a monthly basis and will supply to CVS a fully updated [***] Report by the first Friday following Cardinal's commencement of recording said [***]. All other data elements will be updated weekly and immediately sent to CVS each Friday accurately representing Cardinal's [***] available to CVS as of the creation of the [***] Report. [***] CALCULATION. For all of CVS Pharmacy DCs [***] ([***], or Brokerage Purchases, etc), CVS will receive an [***] within [***] ([***]) days of the end of each CVS fiscal quarter in the form of a [***] equal to [***]% times CVS Pharmacy DCs [***] (in addition to [***] the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The [***] will be calculated based on CVS' receipt date of such [***] for each fiscal month. CVS and Cardinal will agree with the method used to calculate each month's [***] totals. For example; CVS' total [***] volume for a specific CVS fiscal quarter equals $[***], then Cardinal will [***] to CVS within [***] ([***]) days of the end of the respective fiscal quarter $[***] ($[***] x [***]). Further terms and conditions of the [***] calculation are as follows: 1) CVS and Cardinal will publish the agreed to monthly [***] volume eligible for the [***] on a monthly basis; within [***] ([***]) days of the respective CVS fiscal month's end or as soon as practical. 2) The [***] will not be applied on [***] or [***] volume that is [***]. The [***] will be automatically applied on this inventory when [***] as a [***]. 3) CVS contract pricing on select [***] items established by CVS after January 1, 2004 will not be eligible for the [***] since Cardinal does not have the ability to [***] from this applicable [***]. 4) The [***] is based on the assumption that Cardinal will not [***] CVS any [***] related to [***] on code [***] and code [***] purchase orders. 5) Cardinal will not apply the [***] on CVS [***] or [***] that was specifically [***] through CVS that Cardinal [***] CVS with the explicit purpose of this product being 18 [***] the manufacturer. However, Cardinal will [***] on any [***] CVS [***] said product to the respective manufacturer. a. This inventory will be [***] to CVS on the earliest date that the applicable manufacturer would accept said product [***] at [***] percent ([***]%). b. If CVS believes the [***] to be [***] and that it will be [***] in any way by [***] said product [***] a manufacturer, then CVS can at its sole discretion opt not to [***] in such a [***]. c. CVS and Cardinal agree that [***] are costly to both parties and lead to operational inefficiencies and will therefore work together to develop a process which limits the amount of [***] . 6) At the start of this Agreement, Cardinal will [***] related to the previous agreement. To that end, CVS and Cardinal have agreed that Cardinal will adjust CVS' 4Q 2003 [***] by $[***] in order for this [***] to qualify for the [***]. With this adjustment made, [***] of CVS' [***] will be eligible for the [***] under this Agreement. 7) The calculation of the [***] will be based off the [***] ( at the [***] of [***] or the [***]) [***] to the application of the cash discount. For example, if the [***] is $[***], then the [***] would be calculated based on the $[***], not the $[***] ([***]% cash discount is applied). 8) For all CVS warehouse purchases made through Cardinal, cash discount [***] to CVS is defined as the [***]. 9) If CVS [***] a [***] from [***] to [***] after the establishment of the [***] and [***], then Cardinal will [***] the [***] calculation on that affected volume. 10) If CVS enters into an [***] (as defined below) with a [***] that prohibits Cardinal from any [***] with this [***], then Cardinal will not apply the [***] calculation on that affected volume. [***] CREATION ACTIVITIES. As a function of the WLP, Cardinal will [***] the margin created through certain [***] Creation Activities as defined below. Through the WLP, Cardinal will [***]% of the margin associated with all [***] related to [***] detailed below, and [***] related to [***] (this [***] was [***] to CVS via [***]) as further defined below. Notwithstanding anything else in this Agreement to the contrary, Cardinal will not place [***] purchases or conduct [***] activities related to CVS [***] for which Cardinal has entered into an [***] such activities. The "[***] CREATION OPPORTUNITIES" for the WLP are limited to: a) [***] - all purchases of [***] Rx Products (excluding repack) designed to generate an [***] which result from the [***] (by way of illustration only and not as a limitation, one example of an [***] is [***] of a [***]). 19 b) [***] or [***] - [***] or [***] that are made available to Cardinal from [***] under which Cardinal [***] related to CVS' [***]. c) [***] - all purchases of [***] Rx Products (excluding repack) for a specified [***] of [***] offered by manufacturers [***], or [***], a [***], thereby [***]. (by way of illustration only and not as a limitation, one example of an [***] is where a vendor [***] at a [***] for a certain [***] Rx Product (excluding repack) [***]). This [***] was [***] to CVS via [***]. Further terms and conditions of the [***]Creation Activities are as follows: 1) CVS will [***] other historically [***] ([***] and [***] manufacturers); CVS will not be required to [***] to Cardinal. 2) CVS to [***] all [***] it has historically [***] to include but not limited to: a) [***] b) [***] c) [***] d) [***] 3) The [***] CVS receives based on CVS' [***] purchases, is [***]% by CVS. In the event that a [***] would begin to [***] "[***]" [***] to Cardinal, Cardinal would [***]% of this [***] to CVS, based on CVS purchases (Pharmacies and CVS Pharmacy DCs, if applicable). Notwithstanding the foregoing, Cardinal will not accept any other [***] on CVS' behalf relating to CVS' purchase [***] (warehouse or DSD) without CVS' expressed written consent. It will be Cardinal's sole responsibility to notify any pharmaceutical supplier in writing (with copy to CVS subject to Section 13) [***] a [***] to Cardinal related to CVS' [***] of CVS' Return Goods Policy. 4) CVS will only accept product shipped from Cardinal Brokerage Inventory to CVS Pharmacy DCs that has at least [***] ([***]) [***] remaining. All products shipped with less than [***] ([***]) [***] remaining will be considered "[***] PRODUCT". On an exception basis, CVS will allow Cardinal to ship [***] Product Brokerage Inventory with at least [***] ([***]) months [***] remaining. However, both parties agree that no more than $[***] worth of [***] Product will be shipped to CVS Pharmacy DCs during any Program Year. In addition, upon CVS request (as often as monthly), Cardinal will provide CVS a detailed report that summarizes all [***] Product shipped from Cardinal's Brokerage Inventory to CVS Pharmacy DCs ("[***] REPORT"). The [***] Report will contain all [***] Product shipped to CVS Pharmacy DCs within the current Program Year and will include but not be limited to the following data elements: date shipped, vendor, description, NDC, quantity shipped, extended cost, and [***] totaled by month and year-to-date(both CVS and Cardinal agree that the [***] Report will be made available to CVS no later than September 1, 2004). Notwithstanding anything in this Agreement to the contrary, at no time will Cardinal ship Brokerage Inventory with less than [***] ([***]) months [***] remaining to CVS Pharmacy DCs. With that said, CVS will work with Cardinal to assist in the management of the [***]. 20 Additional terms and conditions of the WLP are as follows: 1. Term - The WLP will commence as of January 1, 2004, and terminate upon the termination of the Agreement. 2. [***] Generation - Cardinal will [***] ([***]%) of CVS' [***] for [***] Rx Products (excluding repack) [***] all CVS Pharmacy DCs for routine [***] and [***] (the "PURCHASING ACTIVITIES"). 3. [***] - If Cardinal's [***] on CVS' [***] are [***] or [***] by a [***], and if CVS is eligible to [***] from such [***], then CVS will, upon request by Cardinal, effect a direct [***] of the applicable Rx Product [***] by Cardinal. With respect to the foregoing purchases, [***] will [***] the applicable [***] according to the [***], including [***] for any available [***]. CVS will [***] the [***] to the [***] from [***] Cardinal, which will also be [***] the [***]. This [***] process is designed to be "[***]" for both parties. (a) [***]. On the same day as CVS [***] a shipment of Rx Product ordered as part of a [***] related to this WLP, CVS will [***] Cardinal. Cardinal will [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. CVS will [***] from the applicable [***], and CVS will pay the [***], [***] for all [***], based on the applicable payment terms. CVS will [***] to the [***] from [***], and Cardinal will [***] the CVS [***] to the applicable [***]. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. (b) [***] and [***]. As it pertains to [***] purchases only, on the same day as CVS [***] the shipment of Rx Product, CVS will [***] Cardinal. Cardinal will [***] to [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. [***] purchases will be [***] by Cardinal at the servicing Cardinal DC [***] the need for CVS to [***] such product. As it pertains to the payment of [***] and [***] purchases, Cardinal will receive an [***] from the applicable [***] for the ordered Rx Product, and Cardinal will [***] the [***] directly, [***] for all [***], based on the applicable payment terms. As the Rx Product is ordered from Cardinal by CVS for [***], Cardinal will [***] CVS, and CVS will [***] Cardinal for such Rx Product in accordance with the terms of this Agreement. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. 4. Purchase Information - CVS will provide Cardinal with [***] electronic feeds updating information regarding CVS' [***] of [***] Rx Products [***] from [***] and from [***] on behalf of the CVS Pharmacy DCs pursuant to the WLP. Such information will include details regarding all purchase orders, [***] or [***] for items [***] and [***] and other information reasonably required by Cardinal to administer the WLP. To assist Cardinal with [***], CVS will provide Cardinal with information reasonably requested by Cardinal including but not limited to new product [***], [***] fluctuations, [***] promotions, and new store openings , and a change in CVS Pharmacy DC that services a particular Pharmacy. 21 5. Limitations - All [***] for [***] Products must be executed exactly as [***]. [***] will be generated and submitted to any vendor, other than those [***], without [***]. All [***] will be on behalf of the CVS Pharmacy DCs. CVS will not make any [***] (outside of this [***]) on behalf of the Pharmacies [***]. It is understood and agreed that Cardinal will not be required to reduce or otherwise [***] its own [***] associated with a manufacturer imposed [***]. Furthermore, the parties acknowledge and agree that all information associated with the WLP is confidential information subject to the provisions of Section 17 of this Agreement. 6. Records, Audit and Confidentiality - The WLP is subject to the record keeping and audit provisions set forth in Section 16 of this Agreement. Cardinal may disclose CVS' [***] information (such as inventory [***], on-order or [***]) to [***] as reasonably required by Cardinal to [***] related to the WLP. Cardinal will notify CVS in writing (subject to Section 13) prior to the disclosure of any such information and will provide the nature of the information that Cardinal intends to disclose. Further, Cardinal will use reasonable efforts to obtain applicable [***] consent to disclose such information to CVS if needed. 7. ACH - All payments for invoicing under the WLP will be made via ACH. 8. Waiver - Neither party's failure to enforce any provision of this WLP will be considered a waiver of any future right to enforce such provision. 9. Dispute Resolution Relating to the WLP - CVS and Cardinal acknowledge that either party may from time to time may, in good faith, dispute any portion of the WLP. In the event that either party disputes any portion on the WLP, each party agrees to use all reasonable efforts to resolve all such disputes as expeditiously as possible on a fair and equitable basis. To that end, Cardinal and CVS will assemble a panel consisting of at least one (1) executive from CVS and one (1) executive from Cardinal (but in any event, an even number in the aggregate) (the "EXECUTIVE COMMITTEE") to resolve disputes relating to the WLP and address other issues as they may determine. With respect to reporting disputes, a copy of the terms of this Agreement, as amended from time to time, agreed upon facts and areas of disagreement, and a concise summary of the basis for each side's contentions will be provided to the executives who will review the same, confer, and attempt to reach a mutual resolution of the issue within thirty (30) days following either party's receipt of notice of dispute. [***] VENDOR EXHIBIT.
[***] VENDOR [***] PURCHASE PAYMENT TERMS - ------------ ---------------------------- [***] [***]
22
EX-10.04 4 l16445aexv10w04.txt EX-10.04 EXHIBIT 10.04 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. SECOND AMENDMENT TO WHOLESALE SUPPLY AGREEMENT This second amendment ("SECOND AMENDMENT") dated June 2, 2004 amends the Wholesale Supply Agreement dated January 1, 2004 ("AGREEMENT") and subsequently amended on May 26, 2004 between CVS and Cardinal Health. CVS and Cardinal Health ("PARTIES") desire to enter into this Second Amendment to amend Section 1 and Section 12 Disclosure Schedule to include two (2) mail-order facilities being acquired by CVS' affiliate PharmaCare Management Services Inc. ("PharmaCare") located in Pittsburgh, Pennsylvania and Largo, Florida (MAIL-ORDER FACILITIES"). The Parties agree as follows: 1. Effective Date of Amendment. This Second Amendment shall be effective as of the date of the closing of the transaction pursuant to which CVS will purchase from J.C. Penney Company, Inc. ("JC PENNEY") approximately 1,260 retail pharmacies, approximately three (3) distribution centers, and approximately two (2) mail-order facilities located in Pittsburgh, Pennsylvania and Largo, Florida (to be acquired by CVS' affiliate PharmaCare from Eckerd Health Services) as publicly announced by CVS on April 5, 2004 ("TRANSACTION"). In the event that the Transaction does not close on or before September 1, 2004, then this Second Amendment shall become null and void and shall be of no force or effect. Furthermore, CVS reserves the right to provide Cardinal with notification ("NOTICE") before the close of the Transaction that CVS has determined in its sole discretion that it will not undertake the wholesale supply arrangement as described in the Second Amendment in which case this Second Amendment shall become null and void and shall be of no force or effect. 2. Scope. Notwithstanding anything else in the Agreement, as amended, in no event will CVS, at any time, be obligated to designate Cardinal as a primary means of pharmaceutical products replenishment for the Mail-order Facilities, if such Mail-order Facilities are subject to an existing wholesaler agreement which cannot be terminated by CVS or its affiliates for any reason, or which, if terminated by CVS or its affiliates in its business judgment, may result in breach of contractual obligations, termination penalties/fees of any type, or result in CVS or its affiliates compromising its business operations. 3. Disclosure Schedules. The Agreement is amended by deleting therefrom the following disclosure schedules in their entirety: "Section 1", and 1 "Section 12 Disclosure Schedule" and replacing them with the following new Disclosure Schedules: "Section 1", and "Section 12 Disclosure Schedule" attached to this Second Amendment and incorporated into this Second Amendment and into the Agreement by this reference, which shall be attached by the Parties to their respective copies of the Agreement. 4. Generally. It is the Parties' intent for the Agreement and this Amendment (if the Transaction closes on or before September 1, 2004 and CVS has not provided Cardinal with Notice before the close of the Transaction) to be applied and construed as a single instrument. The Agreement, as modified by this Second Amendment, remains in full force and effect and constitutes the entire agreement among the Parties regarding this subject matter and supersedes all prior or contemporaneous writings and understandings among the Parties with respect thereto. This Second Amendment will be binding on the Parties and their successor and assigns. If any term or provision of this Second Amendment is determined to be illegal or unenforceable by a court of competent jurisdiction, the remaining terms and provisions of this Second Amendment and the Agreement will remain in full force and effect. Only a subsequent writing signed by both Parties may amend this Second Amendment or further amend the Agreement. CVS Pharmacy, Inc Cardinal Health* By: /s/ Matthew J. Leonard By: /s/ Michael J. Bender --------------------------------- ------------------------------------ Print Name: Matthew J. Leonard Print Name: Michael J. Bender Title: VP Pharmacy Merchandising Title: EVP, Retail Sales & Marketing *The term "CARDINAL HEALTH" means the following pharmaceutical distribution companies: Cardinal Health 106, Inc. (formerly known as James W. Daly, Inc.), a Massachusetts corporation (Peabody, Massachusetts); Cardinal Health 103, Inc. (formerly known as Cardinal Southeast, Inc.), a Mississippi corporation (Madison, Mississippi); Cardinal Health 110, Inc. (formerly known as Whitmire Distribution Corporation), a Delaware corporation (Folsom, California) and any other subsidiary of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI. Cc: Tina Egan, Assistant General Counsel CVS Paul Williams, General Counsel Cardinal Health 2 SECTION 1 AMENDED JUNE 2, 2004 SECTION 1. DESIGNATION AS PRIMARY WHOLESALER. (a) Retail Pharmacies. During the term of this Agreement, CVS will designate Cardinal as the primary wholesale pharmaceutical supplier to designated pharmacies operated by CVS (collectively, the "PHARMACIES" and individually, a "PHARMACY") subject to Section 1(a) Disclosure Schedule. A list of the Pharmacies (the "DESIGNATED PHARMACY LIST") will be provided by CVS to Cardinal from time to time during the term of this Agreement. (b) Distribution Centers. During the term of this Agreement, CVS will designate Cardinal as the primary wholesale pharmaceutical supplier to all distribution centers operated by CVS ("CVS PHARMACY DCS") subject to Section 1(b) Disclosure Schedule. A comprehensive list of all of the CVS Pharmacy DCs as of January 1, 2004 (the date of this agreement) (the "TOTAL DC LIST") is set forth in the Section 1(b) Disclosure Schedule. (c) CVS PharmaCare. This Agreement specifically excludes purchases which are made by CVS on behalf of the CVS division known as PharmaCare with the following one exception: In return for an [***]% ([***] % [***]%) [***] the [***] as described in the Section 12 Disclosure Schedule, CVS will service the [***] and [***] facilities that were acquired from JC Penney and operated by PharmaCare ("[***] FACILITIES") from a CVS Pharmacy DC being serviced by Cardinal for a period of [***] ("FIRST TERM"). If at anytime after the First Term, CVS discontinues servicing said [***] Facilities from a CVS Pharmacy DC being serviced by Cardinal, then the [***] as described in the Section 12 Disclosure Schedule will [***]% [***]%. If CVS continues servicing said [***] Facilities from a CVS Pharmacy DC being serviced by Cardinal after the First Term, then the [***] as described in the Section 12 Disclosure Schedule will [***] at [***]% for as long as CVS continues servicing said [***] from a CVS Pharmacy DC being serviced by Cardinal. This Agreement specifically excludes any secondary, drop ships, direct, or direct-store-delivery purchases made by PharmaCare on behalf of the Mail-order Facilities. As it concerns the Mail-order Facilities only, in the event either party desires not to continue to service the Mail-order Facilities from a CVS Pharmacy DC being serviced by Cardinal at the expiration of the First Term or any renewal term, that party shall provide the other party with at least [***] ([***]) days written notice prior to the expiration of the then current term. In the event such notification is not provided with at least the [***] ([***]) day notice or if no notice is given, the then current term shall be extended for a period of [***] ([***]) days after the expiration of such term to provide for an adequate transition period. (d) CVS Commitment. This Agreement pertains only to CVS' Pharmacies and CVS Pharmacy DCs as of January 1, 2004 plus or minus the organic growth related to Pharmacies. 3 SECTION 12 DISCLOSURE SCHEDULE AMENDED JUNE 2, 2004 WAREHOUSE LOGISTICS PROGRAM The goal of the "WAREHOUSE LOGISTICS PROGRAM" (WLP") is to develop the most efficient purchasing and distribution processes for CVS with pharmaceutical manufacturers under which Cardinal will [***] ([***]%) of CVS' purchase requirements for [***] Rx Products (excluding repack items) ("[***]") [***] of all CVS [***] which are or become part of this Agreement. The parties agree and acknowledge that this WLP is part of this Agreement, and is not a separate or distinct agreement. Notwithstanding anything in this Agreement to the contrary, the WLP is intended and structured to provide [***]% incremental financial and operational value to CVS and at no time shall Cardinal take any action in connection with the WLP which may negatively impact CVS' ability to service its Pharmacies, CVS Pharmacy DCs, or CVS' abilities to secure regular [***] merchandise, including [***] stock, [***] a manufacturer. The WLP is designed to provide incremental financial value to CVS; CVS is to be [***] on [***], etc. CVS will [***] all other [***] that CVS would otherwise be entitled to if CVS [***] the [***] on a [***] (i.e., [***], etc.). As part of the WLP, Cardinal will pass to CVS funding ("INCENTIVE") in the form of a credit within [***] ([***]) days of the end of each CVS [***] equal to [***]% times CVS Pharmacy [***] (in addition to passing the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The credit will be faxed and subsequently mailed in hard copy form to CVS' Manager of Wholesaler Programs. Additionally, Cardinal will provide CVS with the Warehoused Service Level detailed in Section 2(b) Disclosure Schedule through leveraging Cardinal's procurement and logistical expertise. In return for both the Incentive and the Warehouse Service Level, Cardinal will [***] the [***] created through certain "[***] CREATION ACTIVITIES" as defined below. Current [***] will remain in place as of the execution of this Agreement with the exception of [***], which will [***] from a CVS [***] to an [***] (as detailed in and subject to Section 12 Disclosure Schedule) . Cardinal will [***] as it does for any other indirect vendor. In return for [***] on an [***] from February 1, 2004 until December 31, 2004, by May 1, 2004, Cardinal will authorize CVS to [***] in the amount of $[***] ("[***] PAYMENT"). The timing of said payment will be made so that CVS receives these funds by [***]. CVS will not be required to [***] or [***] any other pharmaceutical [***] as a [***]. Any further [***] of pharmaceutical [***] from [***], will be at CVS' sole determination. The [***] Warehouse [***] Exhibit below details which [***] CVS will purchase from Cardinal on an indirect basis (subject to Section 12 Disclosure Schedule) and the corresponding [***] terms to be amended in writing pursuant to Section 13 upon mutual agreement of CVS and Cardinal. While CVS and Cardinal may both agree that it is in the best interest of both parties to [***] a [***] from [***] to [***] or visa versa, said decisions will always be made to reflect incremental value to CVS and will occur at CVS' sole discretion. 4 CVS is under no obligation to purchase any specific [***] and may eliminate (POX) or discontinue any item at its sole discretion. With that said, CVS and Cardinal may investigate the best methods of [***] any [***] inventory [***] at CVS' sole discretion. So that Cardinal and CVS can effectively and efficiently manage Cardinal's [***] that is [***] to CVS through the [***], Cardinal will provide to CVS in an electronic format a detailed weekly report detailing said [***] ("[***] REPORT"). The [***] Report will include but not be limited to the following elements as it pertains to Cardinal [***] to CVS: [***], description, NDC, [***] on hand, extended [***], and [***] date. As it pertains to populating the [***] date [***] of the [***] Report only, Cardinal will fully populate and update [***] on a monthly basis and will supply to CVS a fully updated [***] Report by the first Friday following Cardinal's commencement of recording said [***]. All other data elements will be updated weekly and immediately sent to CVS each Friday accurately representing Cardinal's [***] available to CVS as of the creation of the [***] Report. [***] CALCULATION. For all of CVS Pharmacy DCs [***] ([***], or Brokerage Purchases, etc), CVS will receive an [***] within [***] ([***]) days of the end of each CVS fiscal quarter in the form of a [***] equal to [***]% times CVS Pharmacy DCs [***] (in addition to [***] the [***]) for the respective CVS fiscal quarter during the term of this Agreement. The [***] will be calculated based on CVS' receipt date of such [***] for each fiscal month. CVS and Cardinal will agree with the method used to calculate each month's [***] totals. For example; CVS' total [***] volume for a specific CVS fiscal quarter equals $[***], then Cardinal will [***] to CVS within [***] ([***]) days of the end of the respective fiscal quarter $[***] ($[***] x [***]). Further terms and conditions of the [***] calculation are as follows: 1) CVS and Cardinal will publish the agreed to monthly [***] volume eligible for the [***] on a monthly basis; within [***] ([***]) days of the respective CVS fiscal month's end or as soon as practical. 2) The [***] will not be applied on [***] or [***] volume that is [***]. The [***] will be automatically applied on this inventory when [***] as a [***]. 3) CVS contract pricing on select [***] items established by CVS after January 1, 2004 will not be eligible for the [***] since Cardinal does not have the ability to [***] from this applicable [***]. 4) The [***] is based on the assumption that Cardinal will not [***] CVS any [***] related to [***] on code [***] and code [***] purchase orders. 5) Cardinal will not apply the [***] on CVS [***] or [***] that was specifically [***] through CVS that Cardinal [***] CVS with the explicit purpose of this product being 5 [***] the manufacturer. However, Cardinal will [***] on any [***] CVS [***] said product to the respective manufacturer. a. This inventory will be [***] to CVS on the earliest date that the applicable manufacturer would accept said product [***] at [***] percent ([***]%). b. If CVS believes the [***] to be [***] and that it will be [***] in any way by [***] said product [***] a manufacturer, then CVS can at its sole discretion opt not to [***] in such a [***]. c. CVS and Cardinal agree that [***] are costly to both parties and lead to operational inefficiencies and will therefore work together to develop a process which limits the amount of [***] . 6) At the start of this Agreement, Cardinal will [***] related to the previous agreement. To that end, CVS and Cardinal have agreed that Cardinal will adjust CVS' 4Q 2003 [***] by $[***] in order for this [***] to qualify for the [***]. With this adjustment made, [***] of CVS' [***] will be eligible for the [***] under this Agreement. 7) The calculation of the [***] will be based off the [***] ([***] at the [***] of [***] or the [***]) [***] to the application of the cash discount. For example, if the [***] is $[***], then the [***] would be calculated based on the $[***], not the $[***] ([***]% cash discount is applied). 8) For all CVS warehouse purchases made through Cardinal, cash discount [***] to CVS is defined as the [***]. 9) If CVS [***] a [***] from [***] to [***] after the establishment of the [***] and [***], then Cardinal will [***] the [***] calculation on that affected volume. 10) If CVS enters into an [***] (as defined below) with a [***] that prohibits Cardinal from any [***] with this [***], then Cardinal will not apply the [***] calculation on that affected volume. [***] CREATION ACTIVITIES. As a function of the WLP, Cardinal will [***] the margin created through certain [***] Creation Activities as defined below. Through the WLP, Cardinal will [***]% of the margin associated with all [***] related to [***] detailed below, and [***] related to [***] (this [***] was [***] to CVS via [***]) as further defined below. Notwithstanding anything else in this Agreement to the contrary, Cardinal will not place [***] purchases or conduct [***] activities related to CVS [***] for which Cardinal has entered into an [***] such activities. The "[***] CREATION OPPORTUNITIES" for the WLP are limited to: a) [***] - all purchases of [***] Rx Products (excluding repack) designed to generate an [***] which result from the [***] (by way of illustration only and not as a limitation, one example of an [***] is [***] of a [***]). 6 b) [***] or [***] - [***] or [***] that are made available to Cardinal from [***] under which Cardinal [***] related to CVS' [***]. c) [***] - all purchases of [***] Rx Products (excluding repack) for a specified [***] of [***] offered by manufacturers [***], or [***], a [***], thereby [***]. (by way of illustration only and not as a limitation, one example of an [***] is where a vendor [***] at a [***] for a certain [***] Rx Product (excluding repack) [***]). This [***] was [***] to CVS via [***]. Further terms and conditions of the [***] Creation Activities are as follows: 1) CVS will [***] other historically [***] ([***] and [***]manufacturers); CVS will not be required to [***] to Cardinal. 2) CVS to [***] all [***] it has historically [***] to include but not limited to: a) [***] b) [***] c) [***] d) [***] 3) The [***] CVS receives based on CVS' [***] purchases, is [***]% by CVS. In the event that a [***] would begin to [***] "[***]" [***] to Cardinal, Cardinal would [***]% of this [***] to CVS, based on CVS purchases (Pharmacies and CVS Pharmacy DCs, if applicable). Notwithstanding the foregoing, Cardinal will not accept any other [***] on CVS' behalf relating to CVS' purchase [***] (warehouse or DSD) without CVS' expressed written consent. It will be Cardinal's sole responsibility to notify any pharmaceutical supplier in writing (with copy to CVS subject to Section 13) [***] a [***] to Cardinal related to CVS' [***] of CVS' Return Goods Policy. 4) CVS will only accept product shipped from Cardinal Brokerage Inventory to CVS Pharmacy DCs that has at least [***] ([***]) [***] remaining. All products shipped with less than [***] ([***]) [***] remaining will be considered "[***] PRODUCT". On an exception basis, CVS will allow Cardinal to ship [***] Product Brokerage Inventory with at least [***] ([***]) months [***] remaining. However, both parties agree that no more than $[***] worth of [***] Product will be shipped to CVS Pharmacy DCs during any Program Year. In addition, upon CVS request (as often as monthly), Cardinal will provide CVS a detailed report that summarizes all [***] Product shipped from Cardinal's Brokerage Inventory to CVS Pharmacy DCs ("[***] REPORT"). The [***] Report will contain all [***] Product shipped to CVS Pharmacy DCs within the current Program Year and will include but not be limited to the following data elements: date shipped, vendor, description, NDC, quantity shipped, extended cost, and [***] totaled by month and year-to-date(both CVS and Cardinal agree that the [***] Report will be made available to CVS no later than September 1, 2004). Notwithstanding anything in this Agreement to the contrary, at no time will Cardinal ship Brokerage Inventory with less than [***] ([***]) months [***] remaining to CVS Pharmacy DCs. With that said, CVS will work with Cardinal to assist in the management of the [***]. 7 Additional terms and conditions of the WLP are as follows: 1. Term - The WLP will commence as of January 1, 2004, and terminate upon the termination of the Agreement. 2. [***] Generation - Cardinal will [***] ([***]%) of CVS' [***] for [***] Rx Products (excluding repack) [***] all CVS Pharmacy DCs for routine [***] and [***] (the "PURCHASING ACTIVITIES"). 3. [***] - If Cardinal's [***] on CVS' [***] are [***] or [***] by a [***], and if CVS is eligible to [***] from such [***], then CVS will, upon request by Cardinal, effect a direct [***] of the applicable Rx Product [***] by Cardinal. With respect to the foregoing purchases, [***] will [***] the applicable [***] according to the [***], including [***] for any available [***]. CVS will [***] the [***] to the [***] from [***] Cardinal, which will also be [***] the [***]. This [***] process is designed to be "[***]" for both parties. (a) [***]. On the same day as CVS [***] a shipment of Rx Product ordered as part of a [***] related to this WLP, CVS will [***] Cardinal. Cardinal will [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. CVS will [***] from the applicable [***], and CVS will pay the [***], [***] for all [***], based on the applicable payment terms. CVS will [***] to the [***] from [***], and Cardinal will [***] the CVS [***] to the applicable [***]. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. (b) [***] and [***]. As it pertains to [***]purchases only, on the same day as CVS [***] the shipment of Rx Product, CVS will [***] Cardinal. Cardinal will [***] to [***] such Rx Product [***] the applicable CVS [***], and [***] the applicable Cardinal [***]. [***] purchases will be [***] by Cardinal at the servicing Cardinal DC [***] the need for CVS to [***] such product. As it pertains to the payment of [***] and [***] purchases, Cardinal will receive an [***] from the applicable [***] for the ordered Rx Product, and Cardinal will [***] the [***] directly, [***] for all [***], based on the applicable payment terms. As the Rx Product is ordered from Cardinal by CVS for [***], Cardinal will [***] CVS, and CVS will [***] Cardinal for such Rx Product in accordance with the terms of this Agreement. The process outlined in the Section 2(b) Disclosure Schedule will apply to any discrepancies. 4. Purchase Information - CVS will provide Cardinal with [***] electronic feeds updating information regarding CVS' [***] of [***] Rx Products [***] from [***] and from [***] on behalf of the CVS Pharmacy DCs pursuant to the WLP. Such information will include details regarding all purchase orders, [***] or [***] for items [***] and [***] and other information reasonably required by Cardinal to administer the WLP. To assist Cardinal with [***], CVS will provide Cardinal with information reasonably requested by Cardinal including but not limited to new product [***], [***] fluctuations, [***] promotions, and new store openings , and a change in CVS Pharmacy DC that services a particular Pharmacy. 8 5. Limitations - All [***] for [***] Products must be executed exactly as [***]. [***] will be generated and submitted to any vendor, other than those [***], without [***]. All [***] will be on behalf of the CVS Pharmacy DCs. CVS will not make any [***] (outside of this [***]) on behalf of the Pharmacies [***]. It is understood and agreed that Cardinal will not be required to reduce or otherwise [***] its own [***] associated with a manufacturer imposed [***]. Furthermore, the parties acknowledge and agree that all information associated with the WLP is confidential information subject to the provisions of Section 17 of this Agreement. 6. Records, Audit and Confidentiality - The WLP is subject to the record keeping and audit provisions set forth in Section 16 of this Agreement. Cardinal may disclose CVS' [***] information (such as inventory [***], on-order or [***]) to [***] as reasonably required by Cardinal to [***] related to the WLP. Cardinal will notify CVS in writing (subject to Section 13) prior to the disclosure of any such information and will provide the nature of the information that Cardinal intends to disclose. Further, Cardinal will use reasonable efforts to obtain applicable [***] consent to disclose such information to CVS if needed. 7. ACH - All payments for invoicing under the WLP will be made via ACH. 8. Waiver - Neither party's failure to enforce any provision of this WLP will be considered a waiver of any future right to enforce such provision. 9. Dispute Resolution Relating to the WLP - CVS and Cardinal acknowledge that either party may from time to time may, in good faith, dispute any portion of the WLP. In the event that either party disputes any portion on the WLP, each party agrees to use all reasonable efforts to resolve all such disputes as expeditiously as possible on a fair and equitable basis. To that end, Cardinal and CVS will assemble a panel consisting of at least one (1) executive from CVS and one (1) executive from Cardinal (but in any event, an even number in the aggregate) (the "EXECUTIVE COMMITTEE") to resolve disputes relating to the WLP and address other issues as they may determine. With respect to reporting disputes, a copy of the terms of this Agreement, as amended from time to time, agreed upon facts and areas of disagreement, and a concise summary of the basis for each side's contentions will be provided to the executives who will review the same, confer, and attempt to reach a mutual resolution of the issue within thirty (30) days following either party's receipt of notice of dispute. [***] VENDOR EXHIBIT.
[***] VENDOR [***] PURCHASE PAYMENT TERMS - ------------ ---------------------------- [***] [***]
9
EX-10.06 5 l16445aexv10w06.txt EX-10.06 EXHIBIT 10.06 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. SECOND AMENDMENT TO PRIME VENDOR AGREEMENT THIS SECOND AMENDMENT TO PRIME VENDOR AGREEMENT ("SECOND AMENDMENT") is among Cardinal Health*, formerly known as Cardinal Distribution, ("CARDINAL"), and Express Scripts, Inc. ("BUYER"). WHEREAS, Cardinal and Buyer executed a Prime Vendor Agreement, dated July 1, 2001 (the "AGREEMENT"), and executed a First Amendment to Prime Vendor Agreement, dated January ___, 2003 ("FIRST AMENDMENT"). WHEREAS, the parties desire to further amend the Agreement, as amended, to reflect the terms of a new returned goods policy for unmerchantable product. NOW THEREFORE, in consideration of the foregoing recitals, the parties hereby agree as follows: 1. RETURNED GOODS POLICY FOR UNMERCHANTABLE PRODUCT. Attached as EXHIBIT A and incorporated herein by reference is a returned goods policy for unmerchantable product, which describes a return process whereby Cardinal will assist Buyer in receiving value for certain unmerchantable product. 2. MISCELLANEOUS. Capitalized terms not defined herein will have the same meaning ascribed to them in the Agreement, as amended by the First Amendment, it being the intent of the parties that the Agreement, as amended by the First Amendment, and this Second Amendment will be applied and construed as a single instrument. The Agreement, as amended by the First Amendment and as modified by this Second Amendment, constitutes the entire agreement between Cardinal and Buyer regarding the subject matter of the Agreement, as amended by the First Amendment, and this Second Amendment and supersedes all prior or contemporaneous writings and understandings between the parties regarding the same. This Second Amendment will be binding upon the parties, their heirs, legal representatives, successors and assigns. The terms and provisions of this Second Amendment are severable. If any term or provision of this Second Amendment is determined to be illegal or unenforceable by a court of competent jurisdiction, the remaining terms and provisions of this Second Amendment and the Agreement, as amended by the First Amendment will remain in full force and effect. This Second Amendment may only be amended in a writing signed by Cardinal and Buyer. 3. EFFECTIVE DATE. This Second Amendment shall be effective as of the date of full execution ("EFFECTIVE DATE"). Except as otherwise amended herein, the terms and conditions of the Restated Agreement shall remain in full force and effect. CARDINAL HEALTH* EXPRESS SCRIPTS, INC. By: /s/ John E. Grimm By: /s/ George Paz --------------------------------- ------------------------------------ Name: John E. Grimm Name: George Paz Title: SVP, Alternate Care Title: President Date: 11-19-03 Date: 11/12/03 * The term "CARDINAL HEALTH" means the following pharmaceutical distribution companies including: Cardinal Health 106, Inc. (formerly known as James W. Daly, Inc.), a Massachusetts corporation (Peabody, Massachusetts); Cardinal Health 103, Inc. (formerly known as Cardinal Southeast, Inc.), a Mississippi corporation (Madison, Mississippi); Cardinal Health 110, Inc. (formerly known as Whitmire Distribution Corporation), a Delaware corporation (Folsom, California) and any other subsidiary of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI. EXHIBIT A RETURNED GOODS POLICY FOR UNMERCHANTABLE PRODUCT Cardinal and Buyer have agreed to pursue a return process whereby Cardinal will assist Buyer in receiving value for certain unmerchantable Product. Product which may not be returned pursuant to Cardinal's Standard Returned Goods Policy may be returned to an authorized manufacturer through a third party pursuant to this policy. Products which are "UNMERCHANTABLE" include, but are not limited to, those items which Cardinal determines are not in "merchantable condition" (as defined in Cardinal's Returned Goods Policy), and the following: A. Any item which has been used or opened, is a partial dispensing unit or unit of sale, is without all original packaging, labeling, inserts or operating manuals, or that is stickered, marked, damaged, defaced or otherwise cannot readily be resold by Cardinal for any reason. B. Short-dated (less than seven (7) months expiration dating), outdated, or seasonal product and items purchased on a "special order" basis, including non-stock and drop ship items. C. Any sterile or refrigerated Merchandise, unless Cardinal is specially assured that such Merchandise was properly stored and protected at all times and such Merchandise is returned separately in a package marked as such and accompanied by a separate credit request form. D. Any low stability product, including Epogen(TM), Eminase(TM), or other products which are usually sensitive to temperature and handling conditions. E. Any product not intended for return to a wholesaler in accordance with the return policies of the applicable manufacturer. Product in "unmerchantable condition" may generally be returned to vendors (a) with which Cardinal has a current relationship, (b) are not either insolvent or subject to a petition in bankruptcy, or (c) which do not have an outstanding balance due Cardinal at the date on which such Product is submitted for return (each such vendor, an "ACTIVE MANUFACTURER"). Unmerchantable Product may only be returned through a third party return processor ("THIRD PARTY") in accordance with the terms and conditions described in this policy. Cardinal will provide the Third Party selected by Buyer with a current list of all Active Manufacturers. Any Third Party selected by Buyer must enter into a Confidentiality Agreement, in a form acceptable to Cardinal, prior to accepting any returns from Buyer. PROCEDURES FOR RETURNS Buyer and Cardinal will notify each Active Manufacturer of their relationship as customer/wholesaler. Buyer will send all returns of unmerchantable Product to its selected Third Party. The amount identified by the Third Party as the amount to which Buyer is entitled in exchange for the return will be determined in accordance with the return policy of the applicable Active Manufacturer as described in the Third Party's database, which will reflect Buyer's cost of goods purchased through Cardinal. Buyer will instruct the Third Party to provide Cardinal with documentation (either in paper or electronic format) to substantiate each debit memo submitted to Active Manufacturers on behalf of Buyer. Buyer will instruct each Active Manufacturer to issue any and all credits to Cardinal for Merchandise that was purchased by Buyer from Cardinal and is returned through a Third Party in unmerchantable condition, and to reference the debit memo number corresponding to the debit memo prepared by the Third Party. Buyer and Cardinal acknowledge that Buyer will handle, without Cardinal's involvement, all matters relating to returns to manufacturers with which Buyer has a direct contracting relationship (whether or not such manufacturer is an Active Manufacturer). Buyer will pay the Third Party directly for all of such Third Party's fees. In addition, Buyer will reimburse Cardinal for all costs billed by the Third Party to Cardinal that relate to Buyer's returns hereunder, including, but not limited to, processing fees, postage, delivery and destruction fees. 2 Cardinal will be paid [***]% of the net returns received by Cardinal from all Active Manufacturers as a processing fee (the "PROCESSING FEE") in accordance with the following procedure: (1) Cardinal will adjust Buyer's account upon the earlier of receipt of an actual credit from an Active Manufacturer, or within sixty (60) days following the date of a debit memo submitted to an Active Manufacturer. Buyer will not deduct from any UNAUTHORIZED amounts owed to Cardinal, any UNAUTHORIZED amounts relating to the return of Merchandise through a Third Party. (2) Each calendar month, Cardinal will (a) track credits due Buyer'S account in the amount received by Cardinal from each Active Manufacturer during such month for Buyer returns (or, if not received within sixty (60) days, the amount anticipated to be received as shown on the debit memo), and (b) adjust previously made credits to Buyer's account to reflect actual credits authorized to Cardinal for returned Product, so that a net credit may be determined. (3) Within five (5) business days after the end of the previous calendar month, Cardinal will credit Buyer's account with the net amount due Buyer for all Third Party Returns activities during the previous month, less the Processing Fee. With the monthly credit, Cardinal will provide Buyer with a report of all Active Manufacturer credits and debit memos posted during such month. Cardinal will not perform a detail line reconciliation of the amounts authorized by Active Manufacturers as compared to the original debit memo. Notwithstanding the foregoing, if the applicable Active Manufacturer (a) is in a debit balance in Cardinal's accounts payable system, or (b) is subject to a petition in bankruptcy or is deemed insolvent, then no credit will be issued to Buyer, and the credit will accrue to Cardinal's benefit, until such time as the Active Manufacturer is no longer in a debit balance, bankruptcy proceeding or insolvent. In addition, the Third Party will be exclusively responsible for resolving discrepancies relating to returned Product through such Third Party. To the extent that Buyer desires to return Product to a supplier which is not an approved Active Manufacturer, Cardinal will credit Buyer's account only after Cardinal receives payment either through check, money order or wire transfer. If check, wire transfer or any other payment method is employed which does not guarantee Cardinal immediately available funds, Cardinal will credit Buyer's account only upon receiving such funds in Cardinal's account. Buyer may not offset payments due from Buyer to Cardinal for Product purchases against any amounts Buyer deems are due and owing pursuant to this Third Party Returned Goods Policy. Cardinal may modify this Third Party Returned Goods Policy in its reasonable discretion from time to time. The Buyer is to be notified within thirty (30) days of a modification and such modification is subject to mutual agreement. 3 EX-10.07 6 l16445aexv10w07.txt EX-10.07 EXHIBIT 10.07 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. THIRD AMENDMENT TO PRIME VENDOR AGREEMENT THIS THIRD AMENDMENT TO PRIME VENDOR AGREEMENT ("THIRD AMENDMENT") is among Cardinal Health*, formerly known as Cardinal Distribution, ("CARDINAL"), and Express Scripts, Inc. ("BUYER"). WHEREAS, Cardinal and Buyer executed a Prime Vendor Agreement, dated July 1, 2001, executed a First Amendment to Prime Vendor Agreement, dated January 15, 2003 ("FIRST AMENDMENT"), and a Second Amendment to Prime Vendor Agreement, dated November 19, 2003 ("SECOND AMENDMENT"), (collectively, the "AGREEMENT"). WHEREAS, the parties desire to further amend the Agreement as further set forth herein. NOW THEREFORE, in consideration of the foregoing recitals, the parties hereby agree as follows: 1. SECTION 2, SALE OF MERCHANDISE. The following language shall be deleted in its entirety from the definition of Primary Requirements as set forth in Section 2, Sale of Merchandise, as amended by the First Amendment: "and Monthly". 2. SECTION 3, PURCHASE PRICE. The second paragraph of Section 3 shall be amended to add "[***]" to the definition of [***]. 3. SECTION 5, PAYMENT TERMS. Section 5(a)(i), as amended by the First Amendment, shall be deleted in its entirety and replaced with the following: "The payment terms applicable to Buyer for all DIRECT STORE DELIVERY PURCHASES shall be [***] calculated pursuant to either of the options set forth below. Buyer will notify Cardinal of its desire to switch from one option to the other no less than thirty (30) days prior to the effective date of such change, unless otherwise agreed to in writing by Buyer and Cardinal. In the event a payment due date falls on a Saturday, that payment due date will become the preceding Friday. In the event a payment due date falls on a Sunday, that payment due date will become the following Monday. In the event a due date falls on a Monday holiday, invoices due on Sunday and Monday will be due on Tuesday. In the event a due date falls on a Tuesday through Friday holiday, payment will be due the preceding day. OPTION 1 The payment terms applicable to Buyer for all DIRECT STORE DELIVERY PURCHASES shall be [***] as follows: Buyer will cause Cardinal to receive payment in full: (1) by the [***] day of each calendar month of the amount due for all invoiced Merchandise delivered and services provided during the first (1st) [***] of such calendar month; (2) by the [***] day of each calendar month, of the amount due for all invoiced Merchandise delivered and services provided during the [***] through the [***] day of such calendar month; and (3) by the [***] day of each calendar month, of the amount due for all invoiced Merchandise delivered and services provided during the period beginning on the [***] day of the preceding calendar month and ending on the last day of such preceding calendar month. OPTION 2 The payment terms applicable to Buyer for all DIRECT STORE DELIVERY PURCHASES shall be [***] as follows: Buyer will cause Cardinal to receive payment in full: (1) by the [***] day of each calendar month of the amount due for all invoiced Merchandise delivered and services provided from and including the [***] calendar day of each calendar month through and including the[***] calendar day of each calendar month; (2) by the [***] day of each calendar month of the amount due for all invoiced Merchandise delivered and services provided from and including the [***] calendar day of each calendar month through and including the [***] calendar day of each calendar month; (3) by the last Business Day (as hereinafter defined) of each calendar month of the amount due for all invoiced Merchandise delivered and services provided from and including the [***] calendar day of each calendar month through and including the [***] calendar day of each calendar month; (4) by the [***] day of each calendar month of the amount due for all invoiced Merchandise delivered and services provided from and including the [***] calendar day of each preceding calendar month through and including the [***] calendar day of each preceding calendar month; (5) by the [***] day of each calendar month of the amount due for all invoiced Merchandise delivered and services provided from and including the [***] calendar day of each preceding calendar month through and including the [***] calendar day of the each calendar [***]. For purposes of this Agreement, the term "Business Day" shall be defined as Monday through Friday, with the exception of the following holidays: New Year's Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day and Christmas Day." 4. SECTION 5, PAYMENT TERMS. The first sentence of the third paragraph of Section 5(b) shall be deleted in its entirety and replaced with the following: "All payments for invoiced Merchandise delivered and services provided by Cardinal will be made to the applicable servicing division specified in Cardinal's invoice (or as otherwise specified by Cardinal) by electronic funds transfer or other method acceptable to Cardinal so as to provide Cardinal with good funds by the due date; provided, however, if Option 2 (as set forth in Section 5(a)(i)) is chosen by Buyer, then Buyer will have the option to make the payment due on the last Business Day of the month via check (instead of ACH/electronic funds transfer) as long as the check is delivered to Cardinal on the last Business Day of the month at the address designated by Cardinal for these payments." 5. SECTION 6, ORDERING AND DELIVERY. The third sentence of Section 6, Ordering and Delivery, as amended by the First Amendment shall be deleted in its entirety and replaced with the following: 2 "Pharmacies having Qualified Monthly Purchases in excess of $[***] (except Pharmacies located outside of the contiguous United States or other Pharmacies mutually agreed upon by the parties from time to time) will have two delivery options: OPTION 1 [***]. In addition, Pharmacies may receive [***] deliveries; provided, however, such deliveries will be at a charge equal to Cardinal's cost for such delivery. OPTION 2 [***]. All [***] deliveries will be subject to the order cut-off times at the applicable servicing distribution center." 5. SECTION 12, SERVICE LEVEL. Section 12, Service Level, as amended by the First Amendment, shall be further amended as follows: all references to the average monthly service level on Rx Products (excluding Buyer's Top [***] Items (as defined in the First Amendment)) shall be changed from [***] percent ([***]%) to [***] percent ([***]%), and all references to the average monthly service level on Buyer's Top [***] Items shall be changed from [***] percent ([***]%) to [***] percent ([***]%). 6. SECTION 13, RETURNED GOODS POLICY. The second paragraph and items 1-6 of Section 13 related to the annual inventory clean-ups shall be deleted in their entirety. The following paragraph shall be added to Section 13 of the Agreement, as if fully rewritten therein: "Subject to the requirements of the Cardinal Returns Policy, Buyer may return Merchandise for up to twelve (12) months from the date of purchase for 100% of original invoice amount paid by Buyer (i.e., Buyer's contract or other "cost" plus the applicable mark-up or less the applicable mark down), provided: (i) the Merchandise was originally purchased from Cardinal and is in full (no partials), unopened packages in a unit of sale routinely sold by Cardinal; (ii) the Merchandise carries a minimum of nine (9) months' dating; (iii) no repackaged Merchandise may be returned; (iv) Merchandise must be returned to the respective Cardinal distribution center from which it was purchased; (v) andthe total returns in any [***] do not to exceed [***] percent ([***]%) of Buyer's Qualified Purchases during such [***]. After twelve (12) months from the date of purchase, Merchandise may not be returned; provided, however, this twelve (12) month limitation shall not apply for returns made during the period from April 1, 2004, through September 30, 2004." In addition, the following paragraph shall be added to Section 13, as if fully rewritten therein: "Unless otherwise notified by the servicing distribution center, returned goods will be processed within five (5) Business Days of receipt of the returned goods at the Cardinal 3 distribution center, and credit for those returned goods will be issued within three (3) Business Days following processing." 7. SECTION 14, TERM. The initial term of the Agreement shall be extended through June 30, 2007. 8. NEW SECTION 30, GENERIC PURCHASE REQUIREMENT. The following paragraph shall be added to the Agreement as a new Section 30, titled "Generic Purchase Requirement": "During calendar years 2004 and 2005, calculated on a quarterly basis, Buyer will use commercially reasonable efforts to cause not less than [***]% of Buyer's total Qualified Purchases from Cardinal to be generic Rx Products. During calendar year 2006 and the initial six (6) months of calendar year 2007, calculated on a quarterly basis, Buyer will use commercially reasonable efforts to cause not less than [***]% of Buyer's total Qualified Purchases from Cardinal to be generic Rx Products. The foregoing requirements shall be referred to as the "Generic Purchase Requirements." To support Buyer's achievement of the Generic Purchase Requirements, Cardinal will use commercially reasonable efforts to make generic Rx Products available to Buyer at prices that are equal to or better than those prices that Buyer can obtain directly from the generic Rx Product manufacturers. Pricing for Buyer's purchases of generic Rx Products shall be pursuant to Cardinal's Mail Order Preferred Source program. If Buyer does not achieve the Generic Purchase Requirements, Cardinal and Buyer will meet to review Buyer's purchases of generic Rx Products and develop a strategy to support Buyer's achievement of the Generic Purchase Requirements during the quarter following the quarter in which the Generic Purchase Requirements were not met. If, during such following quarter, Buyer does not achieve the Generic Purchase Requirements, Buyer shall be considered in breach of the then current agreement between Buyer and Cardinal, pursuant to Section 14 of this Agreement, and Buyer shall have ninety (90) days to cure such breach to the reasonable satisfaction of Cardinal. In the event that Buyer does not cure such breach within such ninety (90) day period, Cardinal may terminate this Agreement immediately in accordance with Section 14 hereof." 9. NEW SECTION 31, EDI INITIATIVES. The following sentence shall be added to the Agreement as a new Section 31, titled "EDI Initiatives": "Cardinal will support mutually agreed upon Buyer standards, policies and service level agreements for all existing business-to-business processes and new initiatives. These processes and initiatives include, but are not limited to, EDI, VAN, Direct Connect, Collaborative Commerce, and adding new transactions (e.g., 832). Buyer will work closely with Cardinal to ensure seamless connectivity and smooth processing of data between the two parties is achieved." 4 10. EXHIBIT A, PHARMACIES. The following Pharmacies shall be deleted from Exhibit A, as amended by the First Amendment: Express Access Pharmacy, Inc. dba Express Scripts, Inc. 767 Electronic Drive Horsham, Pennsylvania 19020 Central Fill, Inc. 721 Ridgedale Avenue East Hanover, New Jersey 07936 11. EXHIBIT B, PRICING MATRIX. Section 1 of Exhibit B, Pricing Matrix, as amended by the First Amendment, shall be deleted in its entirety and replaced with Section 1 of Exhibit A attached to this Amendment. 12. EXHIBIT D, DEDICATED RESOURCES. The Dedicated Resource section of Exhibit D shall be amended to provide [***] Cardinal employees who will be dedicated to servicing Buyer's account and will act as a liaison between Buyer and Cardinal in order to enhance Buyer-Cardinal relations. The Cardinal employees will be based in the St. Louis, Bensalem and Tempe Pharmacies. 13. MISCELLANEOUS. Capitalized terms not defined herein will have the same meaning ascribed to them in the Agreement, it being the intent of the parties that the Agreement and this Third Amendment will be applied and construed as a single instrument. The Agreement, as modified by this Third Amendment, constitutes the entire agreement between Cardinal and Buyer regarding the subject matter of the Agreement and this Third Amendment and supersedes all prior or contemporaneous writings and understandings between the parties regarding the same. This Third Amendment will be binding upon the parties, their heirs, legal representatives, successors and assigns. The terms and provisions of this Third Amendment are severable. If any term or provision of this Third Amendment is determined to be illegal or unenforceable by a court of competent jurisdiction, the remaining terms and provisions of this Third Amendment and the Agreement will remain in full force and effect. This Third Amendment may only be amended in a writing signed by Cardinal and Buyer. 14. EFFECTIVE DATE. This Third Amendment shall be effective as of January 1, 2004 ("EFFECTIVE DATE"). Except as otherwise amended herein, the terms and conditions of the Agreement shall remain in full force and effect. CARDINAL HEALTH* EXPRESS SCRIPTS, INC. By: /s/ Mark W. Parrish By: /s/ Barrett Toan --------------------------------- ------------------------------------ Name: Mark W. Parrish Name: Barrett Toan Title: Group President Title: CEO Date: 4/9/04 Date: 3-30-04 * The term "CARDINAL HEALTH" means the following pharmaceutical distribution companies including: Cardinal Health 106, Inc. (formerly known as James W. Daly, Inc.), a Massachusetts corporation (Peabody, Massachusetts); Cardinal Health 103, Inc. (formerly known as Cardinal Southeast, Inc.), a Mississippi corporation (Madison, Mississippi); Cardinal Health 110, Inc. (formerly known as Whitmire Distribution Corporation), a Delaware corporation (Folsom, California) and any other subsidiary of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI. 5 EXHIBIT A 1. DIRECT STORE DELIVERY PURCHASES. The Direct Store Delivery Purchases Pricing Matrix has been established based upon Buyer's representations that, following completion of the conversion period (as hereinafter described): (a) Buyer will purchase each Pharmacy's Primary Requirements (as defined in Section 2 of this Agreement) and Generic Purchase Requirements (as defined in Section 8 of the Third Amendment) from Cardinal; (b) Buyer's Qualified Annual Purchases for Direct Store Delivery in the aggregate during each Contract Year (as hereinafter defined) will meet or exceed Three Billion Five Hundred Million Dollars ($3,500,000,000). (collectively referred to herein as the "MINIMUM REQUIREMENTS"). If, for any reason, some or all of the Minimum Requirements are not met by Buyer, then Cardinal may modify this Direct Store Delivery Purchases Pricing Matrix as follows: for each [***] Dollars ($[***]) below the minimum Qualified Annual Purchases set forth above, Buyer's applicable price will be increased by [***]%. The term "CONTRACT YEAR" means each consecutive twelve (12) month period, beginning on the Commencement Date of this Agreement. Subject to the Minimum Requirements and Section 5 of this Agreement regarding timely payment, Buyer will be entitled to purchase Merchandise from Cardinal (that is [***] or subject to a Manufacturer Contract) for Direct Store Deliveries pursuant to the pricing matrix set forth below:
DISCOUNT FROM CARDINAL'S COST TOTAL QUALIFIED ANNUAL PURCHASES @ [***] - -------------------------------- ----------------------------- 3,500,000,000 - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - [***] [***]% [***] - greater [***]%
6 Buyer's pricing will be reviewed on a calendar quarter basis and any adjustments required based on Buyer's average Qualified Monthly Purchases and actual weighted average payment days during such calendar quarter will be loaded into Cardinal's system on the [***] of the [***] following the end of the applicable calendar quarter; provided, however, that such adjustment shall be retroactive to the [***] of the [***] immediately following the end of the applicable calendar quarter. Any amounts due to Buyer as a result of a retroactive price decrease pursuant to the terms hereof shall be paid to Buyer in the form of a check by the [***] day of the [***] immediately following the end of the applicable calendar quarter. Any amounts due to Cardinal as a result of a price increase pursuant to the terms hereof shall be paid to Cardinal in the form of a check within [***] days of receipt of a statement from Cardinal for any such amounts owed, such statement to be provided to Buyer within not less than [***], but no more than [***] days of the end of the applicable calendar quarter. In all instances, Buyer shall accurately report, as may be required, under any state or federal program which provides cost or charge based reimbursement for the products or services covered by this Agreement, the net cost actually paid by Buyer. For example, any adjustments required based on Buyer's average Qualified Monthly Purchases during [***] and [***], shall be loaded into Cardinal's system on [***], and the adjusted pricing will be retroactive to [***]. If pricing were decreased, Cardinal would provide a check to Buyer by May 30 for the amount resulting from the price decrease during [***]. If pricing was increased, Cardinal would provide a statement to Buyer for the amount resulting from the price increase during [***], and such amount shall be due to Cardinal within [***] days of the receipt of the statement from Cardinal. The pricing set forth above is conditioned upon Cardinal's ability to make [***] (as hereinafter defined) of Merchandise. "[***]" means [***] that include, but are not limited to, [***] and [***]. In the event that any government regulation, policy or other action becomes effective during the term of this Agreement which materially adversely affects [***], or in the event the [***] from any vendor are materially affected due to [***] or otherwise, then Cardinal will provide notice to Buyer of such event, including a report and reasonable supporting documentation illustrating such impact in reasonable detail. In such event, the parties agree to meet in good faith and negotiate, for a period not to exceed [***] from the date Buyer receives notice of the adverse event from Cardinal, a mutually acceptable adjustment to the pricing under this Agreement, such pricing adjustment to be retroactive to the date that Cardinal provided notice to Buyer of such adverse event. Representatives of each party shall include at least one senior-level executive. If the parties are unable to agree upon a mutually acceptable adjustment to the pricing within such [***] period, at Cardinal's election, Buyer shall continue to purchase Merchandise from Cardinal pursuant to the terms and conditions of this Agreement or Cardinal may terminate this Agreement upon providing [***] prior written notice thereof to Buyer; provided, however, the pricing applicable to Buyer's purchases during such [***]period shall be the pricing in effect as of the date of the notice to Buyer hereunder. ANNUAL DISCOUNT. Within seven (7) calendar days of January 1, 2004, 2005 and 2006, provided Buyer is in compliance with the terms and conditions of this Agreement, Buyer will be eligible to receive a discount in an amount equal to [***]Dollars ($[***]) to be applied to Buyer's purchases of Merchandise under this Agreement during such month. The discount will be provided in the form of a credit memo. This discount constitutes a "discount or other reduction in price," as such terms are defined under the Medicare/Medicaid Anti-Kickback Statute, on the 7 Merchandise purchased by Buyer under the terms of this Agreement. Cardinal and Buyer agree to use their best efforts to comply with any and all requirements imposed on sellers and buyers, respectively, under 42 U.S.C. Section 1320a-7b(b)(3)(A) and the "safe harbor" regulations regarding discounts or other reductions in price set forth in 42 C.F.R. Section 1001.952(h). In this regard, Buyer may have an obligation to accurately report, as may be required, under any state or federal program which provides cost or charge based reimbursement for the products or services covered by this Agreement, or as otherwise requested or required by any governmental agency, the net cost actually paid by Buyer. 8
EX-31.03 7 l16445aexv31w03.txt EX-31.03 Exhibit 31.03 I, Robert D. Walter, certify that: 1. I have reviewed this Form 10-K/A of Cardinal Health, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. [Not applicable]; 4. [Not applicable]; and 5. [Not applicable]. Dated: November 8, 2005 /s/ Robert D. Walter ------------------------------ Robert D. Walter Chairman and Chief Executive Officer EX-31.04 8 l16445aexv31w04.txt EX-31.04 Exhibit 31.04 I, Jeffrey W. Henderson, certify that: 1. I have reviewed this Form 10-K/A of Cardinal Health, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. [Not applicable]; 4. [Not applicable]; and 5. [Not applicable]. Dated: November 8, 2005 /s/ Jeffrey W. Henderson ------------------------------- Jeffrey W. Henderson Executive Vice President and Chief Financial Officer
-----END PRIVACY-ENHANCED MESSAGE-----